Filed Pursuant to Rule 424(b)(3)
Registration No. 333-295408

CRESCENT PRIVATE CREDIT INCOME CORP.

SUPPLEMENT NO. 5 DATED AUGUST 17, 2026

TO THE PROSPECTUS DATED APRIL 29, 2026

This prospectus supplement (“Supplement”) contains information that amends, supplements or modifies certain information contained in the accompanying prospectus of Crescent Private Credit Income Corp. (the “Fund”), dated April 29, 2026 (as amended and supplemented to date, the “Prospectus”). This Supplement is part of and should be read in conjunction with the Prospectus. Unless otherwise indicated, all other information included in the Prospectus, or any previous supplements thereto, that is not inconsistent with the information set forth in this Supplement remains unchanged. Unless otherwise defined herein, capitalized terms used in this Supplement shall have the same meanings as in the Prospectus.

Effective immediately, the Prospectus is updated to include (i) the Current Report on Form 8-K filed with the Securities and Exchange Commission on August 14, 2026 (the “Form 8-K”); and (ii) the Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 filed with the Securities and Exchange Commission on August 14, 2026 (the “Form 10-Q”). The Form 8-K and Form 10-Q are attached to this Supplement as Appendix A and Appendix B, respectively.

Pursuant to Rule 429 under the Securities Act of 1933, as amended, the Prospectus included herein is a combined prospectus that relates to (i) the Registration Statement (File No. 333-268622), dated December 1, 2022, as amended, previously filed by the Fund on Form N-2 (the “Prior Registration Statement”) and (ii) the Registration Statement (File No. 333-295408), dated April 29, 2026, previously filed by the Fund on Form N-2. This Supplement also constitutes a supplement to the Prior Registration Statement.

Please retain this Supplement with your Prospectus.

 


 

 

Appendix A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): August 14, 2026 (August 10, 2026)

CRESCENT PRIVATE CREDIT INCOME CORP.

(Exact name of registrant as specified in its charter)

 

 

 

Maryland

814-01599

88-4283363

(State or Other Jurisdiction of Incorporation)

(Commission

File Number)

(IRS Employer Identification No.)

 

 

11100 Santa Monica Blvd.,

Suite 2000, Los Angeles, CA

90025

(Address of Principal Executive Offices)

(Zip Code)

(310) 235-5900

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

 


 

 

 

 

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

 

 

 


 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) Departure of Officer.

 

On and effective as of 12:00 a.m. midnight on August 10, 2026, the Board of Directors (the “Board”) of Crescent Private Credit Income Corp. (the “Company”) accepted the resignation of Raymond Barrios as the Company’s President. Mr. Barrios’ decision to resign was not the result of any disagreement with management or the Board, or related to the Company’s operations, policies or practices. The Company and its Board appreciate the support and guidance Mr. Barrios has provided as an officer of the Company.

 

(c) Appointment of Officer.

 

Additionally, on and effective as of August 11, 2026, the Board appointed Eric Hall as the Company’s President. Mr. Hall has served as Chief Executive Officer of the Company since 2023 and will continue to serve as Chief Executive Officer. Mr. Hall also serves as co-chief executive officer, director, and chairman of the board of CCS IX Portfolio Holdings, LLC, a business development company managed by an affiliate of the Company’s investment adviser. In addition, Mr. Hall serves as a Managing Director of Crescent Capital Group LP (“Crescent”), the parent of the Company’s investment adviser, within private credit. Prior to joining Crescent in 2007, Mr. Hall worked as a Financial Analyst in Lehman Brothers’ Investment Banking Division. Mr. Hall received a B.A. in Business Economics from the University of California, Los Angeles.

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

CRESCENT PRIVATE CREDIT INCOME CORP.

 

 

 

 

Date: August 14, 2026

By:

/s/ George P. Hawley

Name:

George P. Hawley

Title:

Secretary

 

 


 

Appendix B

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2026

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 814-01599

Crescent Private Credit Income Corp.

(Exact Name of Registrant as Specified in Its Charter)

Maryland

88-4283363

(State or Other Jurisdiction of

Incorporation or Organization)

(I.R.S. Employer

Identification No.)

11100 Santa Monica Blvd., Suite 2000, Los Angeles, CA

90025

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s Telephone Number, Including Area Code: (310) 235-5900

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol

Name of each exchange on which registered

None

None

None

 

 

 

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-Accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The number of shares of the Registrant’s common stock, par value $0.01 per share outstanding at August 14, 2026 was 21,020,533 shares of Class I Common Stock (“Class I Shares”), 7,116 shares of Class S Common Stock (“Class S Shares”), and 0 shares of Class D Common Stock (“Class D shares”).

Common shares outstanding exclude August 1, 2026 subscriptions since the issuance price is not yet finalized at the date of this filing.

 

11


 

CRESCENT PRIVATE CREDIT INCOME CORP.

 

FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 2026

 

Table of Contents

 

 

 

PART I

FINANCIAL INFORMATION

5

Item 1.

Financial Statements

5

 

Consolidated Statements of Assets and Liabilities as of June 30, 2026 (Unaudited) and December 31, 2025

5

 

Consolidated Statements of Operations for the three and six months ended June 30, 2026 and 2025 (Unaudited)

7

 

Consolidated Statements of Changes in Net Assets for the three and six months ended June 30, 2026 and 2025 (Unaudited)

7

 

Consolidated Statements of Cash Flows for the six months ended June 30, 2026 and 2025 (Unaudited)

9

 

Consolidated Schedule of Investments as of June 30, 2026 (Unaudited)

11

 

Consolidated Schedule of Investments as of December 31, 2025

29

 

Notes to Consolidated Financial Statements (Unaudited)

47

Item 2.

Managements Discussion and Analysis of Financial Condition and Results of Operations

75

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

87

Item 4.

Controls and Procedures

88

Part II

OTHER INFORMATION

89

Item 1.

Legal Proceedings

89

Item 1A.

Risk Factors

89

Item 2.

Unregistered Sales Of Equity Securities And Use Of Proceeds

89

Item 3.

Defaults Upon Senior Securities

89

Item 4.

Mine Safety Disclosures

89

Item 5.

Other Information

89

Item 6.

Exhibits

90

 

2


 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This report contains forward-looking statements that involve substantial risks and uncertainties. Such statements involve known and unknown risks, uncertainties and other factors and undue reliance should not be placed thereon. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about Crescent Private Credit Income Corp (together, with its consolidated subsidiaries, the “Company”, “we” or “our”), our current and prospective portfolio investments, our industry, our beliefs and opinions, and our assumptions. Words such as “anticipates,” “expects,” “intends,” “plans,” “will,” “may,” “continue,” “believes,” “seeks,” “estimates,” “would,” “could,” “should,” “targets,” “projects,” “outlook,” “potential,” “predicts” and variations of these words and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including without limitation:

the ability of our investment adviser to locate suitable investments for us and to monitor and administer our investments;
regulations governing our operation as a business development company;
financing investments with borrowed money;
operation in a highly competitive market for investment opportunities;
risks associated with original issue discount (“OID”) and payment-in-kind (“PIK”) interest income;
changes in interest rates may affect our cost of capital and net investment income;
the impact of changes in Secured Overnight Financing Rate (“SOFR”), or other benchmark rates on our operating results;
uncertainty as to the value of certain portfolio investments;
our ability to deploy any capital raised in sales of our Common Shares;
lack of liquidity in investments;
the impact of changes in laws or regulations (including the interpretation thereof), including tax laws, governing our operations or the operations of our portfolio companies;
political and regulatory conditions that contribute to uncertainty and market volatility, including the impact of any prolonged U.S. government shutdown as well as the legislative, regulatory, trade, immigration and other policies associated with the current U.S. presidential administration;
ongoing global conflict, including war and conflicts in the Middle East and the Russia-Ukraine war;
the timing, form and amount of any dividend distributions;
risks regarding distributions;
potential resignation of the Adviser and/or the Administrator;
potential adverse effects of price declines and illiquidity in the corporate debt markets;
potential impact of economic recessions or downturns;
defaults by portfolio companies;
the outcome and impact of any litigation;
uncertainty surrounding the financial stability of the United States, Europe and China;
an increase in negative global media coverage relating to the private credit industry;
adverse developments in the credit markets; and
potential fluctuation in quarterly operating results.

Although we believe that the assumptions on which these forward-looking statements are based upon are reasonable, some of those assumptions may be based on the work of third parties and any of those assumptions could prove to be inaccurate; as a result, forward-looking statements based on those assumptions also could prove to be inaccurate. In light of these and other uncertainties, the inclusion of a projection or forward-looking statement in this Quarterly Report on Form 10-Q (the “Quarterly Report”) should not be regarded as a representation by us that our plans and objectives will be achieved. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this Quarterly Report, or other information incorporated herein by reference, as applicable. We do not undertake any obligation to update or revise any forward-looking statements or any other information contained herein, except as required by applicable law. You are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the SEC, including registration statements on Form N-2, annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. The safe harbor provisions of Section 21E of the Securities

3


 

Exchange Act of 1934 (the “Exchange Act”), which preclude civil liability for certain forward-looking statements, do not apply to the forward-looking statements in this report because we are an investment company.

4


 

PART I. Financial Information
Item 1. Financial Statements

 

Crescent Private Credit Income Corp.

 

Consolidated Statements of Assets and Liabilities

 

(in thousands, except for per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

As of June 30, 2026

 

 

As of December 31, 2025

 

Assets

(Unaudited)

 

 

 

 

Investments, at fair value

 

 

 

 

 

Non-controlled non-affiliated investments (cost of $944,000 and $870,675, respectively)

$

944,685

 

 

$

879,592

 

Cash and cash equivalents

 

11,655

 

 

 

84,758

 

Restricted cash and cash equivalents

 

17,873

 

 

 

13,208

 

Interest and dividend receivable

 

3,142

 

 

 

2,402

 

Receivable from unsettled transactions

 

3,132

 

 

 

1,881

 

Deferred offering costs

 

488

 

 

 

366

 

Unrealized appreciation on foreign currency forward contracts

 

104

 

 

 

-

 

Other assets

 

10

 

 

 

-

 

Total assets

$

981,089

 

 

$

982,207

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

Debt (net of deferred financing costs of $6,163 and $6,873, respectively)

$

412,672

 

 

$

413,099

 

Interest and other debt financing costs payable

 

5,308

 

 

 

3,770

 

Distribution payable

 

4,416

 

 

 

3,437

 

Accrued expenses and other liabilities

 

2,455

 

 

 

1,842

 

Payable for investments purchased

 

2,279

 

 

 

49,687

 

Management fees payable

 

1,685

 

 

 

1,313

 

Unrealized depreciation on foreign currency forward contracts

 

58

 

 

 

-

 

Subscriptions received in advance

 

-

 

 

 

43,990

 

Total liabilities

$

428,873

 

 

$

517,138

 

 

 

 

 

 

 

Commitments and Contingencies (Note 8)

 

 

 

 

 

Net assets

 

 

 

 

 

Common stock, par value $0.01 per share (300,000,000 shares authorized, 21,027,323 and 17,187,406 shares issued and outstanding, respectively)

 

210

 

 

 

172

 

Paid-in capital in excess of par value

 

556,843

 

 

 

454,557

 

Accumulated earnings/(losses)

 

(4,837

)

 

 

10,340

 

Total net assets

 

552,216

 

 

 

465,069

 

Total liabilities and net assets

$

981,089

 

 

$

982,207

 

See accompanying notes

 

 

 

 

 

 

 

 

 

 

 

 

 

5


 

 

 

Crescent Private Credit Income Corp.

 

Consolidated Statements of Assets and Liabilities

 

(in thousands, except for per share data)

 

 

 

 

 

 

 

NET ASSET VALUE PER SHARE

As of June 30, 2026

 

 

As of December 31, 2025

 

 

(Unaudited)

 

 

 

 

Class I Shares:

 

 

 

 

 

Net assets

$

552,006

 

 

$

465,005

 

Common Shares outstanding ($0.01 par value, 100,000,000 shares authorized)

 

21,019,303

 

 

 

17,185,048

 

Net asset value per share

$

26.26

 

 

$

27.06

 

Class S Shares:

 

 

 

 

 

Net assets

$

186

 

 

$

64

 

Common Shares outstanding ($0.01 par value, 100,000,000 shares authorized)

 

7,091

 

 

 

2,358

 

Net asset value per share

$

26.26

 

 

$

27.06

 

Class D Shares:

 

 

 

 

 

Net assets

$

24

 

 

$

-

 

Common Shares outstanding ($0.01 par value, 100,000,000 shares authorized)

 

929

 

 

 

-

 

Net asset value per share

$

26.26

 

 

$

-

 

See accompanying notes

 

6


 

 

Crescent Private Credit Income Corp.

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated Statements of Operations

 

 

 

 

 

 

 

 

 

 

 

 

 

(in thousands, except for per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

(Unaudited)

 

For the three months ended June 30,

 

 

For the six months ended June 30,

 

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

 

Investment Income:

 

 

 

 

 

 

 

 

 

 

 

 

 

From non-controlled non-affiliated investments:

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

$

19,883

 

 

$

8,876

 

 

$

39,133

 

 

$

15,762

 

 

Paid-in-kind interest

 

 

337

 

 

 

330

 

 

 

489

 

 

 

736

 

 

Dividend income

 

 

267

 

 

 

100

 

 

 

842

 

 

 

232

 

 

Other income

 

 

106

 

 

 

213

 

 

 

286

 

 

 

413

 

 

Total investment income

 

 

20,593

 

 

 

9,519

 

 

 

40,750

 

 

 

17,143

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest and other debt financing costs

 

 

6,384

 

 

 

2,765

 

 

 

12,692

 

 

 

4,886

 

 

Management fees

 

 

1,705

 

 

 

804

 

 

 

3,273

 

 

 

1,386

 

 

Income based incentive fees

 

 

1,410

 

 

 

482

 

 

 

2,753

 

 

 

842

 

 

Administrative services expenses

 

 

382

 

 

 

336

 

 

 

764

 

 

 

670

 

 

Professional fees

 

 

194

 

 

 

361

 

 

 

670

 

 

 

548

 

 

Offering costs

 

 

205

 

 

 

1,061

 

 

 

416

 

 

 

2,021

 

 

Directors’ fees

 

 

48

 

 

 

51

 

 

 

102

 

 

 

157

 

 

Other general and administrative expenses

 

 

365

 

 

 

213

 

 

 

773

 

 

 

598

 

 

Capital gains based incentive fees

 

 

-

 

 

 

373

 

 

 

(462

)

 

 

185

 

 

Total expenses

 

 

10,693

 

 

 

6,446

 

 

 

20,981

 

 

 

11,293

 

 

Management fees waiver

 

 

(20

)

 

 

(15

)

 

 

(38

)

 

 

(24

)

 

Income based incentive fees waiver

 

 

(1,410

)

 

 

(482

)

 

 

(2,753

)

 

 

(842

)

 

Capital gains based incentive fees waiver

 

 

-

 

 

 

(373

)

 

 

462

 

 

 

(185

)

 

Expense support

 

 

-

 

 

 

(2,022

)

 

 

-

 

 

 

(3,994

)

 

Expense support reimbursement

 

 

618

 

 

 

-

 

 

 

618

 

 

 

-

 

 

Net expenses

 

 

9,881

 

 

 

3,554

 

 

 

19,270

 

 

 

6,248

 

 

Net investment income before taxes

 

 

10,712

 

 

 

5,965

 

 

 

21,480

 

 

 

10,895

 

 

Provision for excise taxes

 

 

46

 

 

 

81

 

 

 

73

 

 

 

162

 

 

Net investment income

 

 

10,666

 

 

 

5,884

 

 

 

21,407

 

 

 

10,733

 

 

Net realized and unrealized gains (losses) on investments:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net realized gain (loss) on:

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-controlled non-affiliated investments

 

 

93

 

 

 

(379

)

 

 

(7,578

)

 

 

(576

)

 

Foreign currency forward contracts

 

 

473

 

 

 

-

 

 

 

473

 

 

 

-

 

 

Foreign currency transactions

 

 

50

 

 

 

(47

)

 

 

50

 

 

 

(74

)

 

Net change in unrealized appreciation (depreciation) on:

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-controlled non-affiliated investments

 

 

(1,005

)

 

 

5,630

 

 

 

(8,408

)

 

 

4,903

 

 

Foreign currency forward contracts

 

 

(193

)

 

 

-

 

 

 

46

 

 

-

 

 

Foreign currency translation

 

 

949

 

 

 

(2,208

)

 

 

1,446

 

 

 

(2,771

)

 

Net realized and unrealized gains (losses) on investments

 

 

367

 

 

 

2,996

 

 

 

(13,971

)

 

 

1,482

 

 

Net increase (decrease) in net assets resulting from operations

 

$

11,033

 

 

$

8,880

 

 

$

7,436

 

 

$

12,215

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes

 

 

 

 

 

 

 

7


 

Crescent Private Credit Income Corp.

 

Consolidated Statements of Changes in Net Assets

 

(in thousands, except share and per share data)

 

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the three months ended June 30,

 

 

For the six months ended June 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

 Net increase (decrease) in net assets resulting from operations:

 

 

 

 

 

 

 

 

 

 

 

 Net investment income

$

10,666

 

 

$

5,884

 

 

$

21,407

 

 

$

10,733

 

 Net realized gain (loss) on investments and foreign currency forward contracts

 

616

 

 

 

(426

)

 

 

(7,055

)

 

 

(650

)

 Net change in unrealized appreciation (depreciation)

 

(249

)

 

 

3,422

 

 

 

(6,916

)

 

 

2,132

 

 Total net increase (decrease) in net assets resulting from operations:

 

11,033

 

 

 

8,880

 

 

 

7,436

 

 

 

12,215

 

 

 

 

 

 

 

 

 

 

 

 

 

Share Transactions

 

 

 

 

 

 

 

 

 

 

 

Class I:

 

 

 

 

 

 

 

 

 

 

 

Issuance of common stock

 

48,924

 

 

 

72,425

 

 

 

102,141

 

 

 

80,925

 

Distributions reinvested

 

19

 

 

 

-

 

 

 

31

 

 

 

-

 

Distributions to Stockholders

 

(11,232

)

 

 

(6,334

)

 

 

(22,606

)

 

 

(10,949

)

 Net increase (decrease) from share transactions - Class I

 

37,711

 

 

 

66,091

 

 

 

79,566

 

 

 

69,976

 

Class S:

 

 

 

 

 

 

 

 

 

 

 

Issuance of common stock

 

-

 

 

 

48

 

 

 

124

 

 

 

48

 

Distributions reinvested

 

2

 

 

 

1

 

 

 

3

 

 

 

1

 

Distributions to Stockholders

 

(3

)

 

 

(1

)

 

 

(6

)

 

 

(1

)

 Net increase (decrease) from share transactions - Class S

 

(1

)

 

 

48

 

 

 

121

 

 

 

48

 

Class D:

 

 

 

 

 

 

 

 

 

 

 

Issuance of common stock

 

-

 

 

 

-

 

 

 

25

 

 

 

-

 

Distributions reinvested

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Distributions to Stockholders

 

(1

)

 

 

-

 

 

 

(1

)

 

 

-

 

 Net increase (decrease) from share transactions - Class D

 

(1

)

 

 

-

 

 

 

24

 

 

 

-

 

 Total increase (decrease) in net assets

 

48,742

 

 

 

75,019

 

 

 

87,147

 

 

 

82,239

 

Net assets, beginning of period

$

503,474

 

 

$

187,945

 

 

$

465,069

 

 

$

180,725

 

Net assets, end of period

$

552,216

 

 

$

262,964

 

 

$

552,216

 

 

$

262,964

 

 

See accompanying notes

 

 

 

 

 

 

 

 

 

 

 

8


 

Crescent Private Credit Income Corp.

 

 

 

 

 

 

Consolidated Statements of Cash Flows

 

 

 

 

 

 

(in thousands)

 

 

 

 

 

 

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the six months ended June 30,

 

 

 

 

2026

 

 

 

2025

 

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

Net increase (decrease) in net assets resulting from operations

 

$

7,436

 

 

 

$

12,215

 

 

Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used for) operating activities:

 

 

 

 

 

 

 

Purchases of investments

 

 

(398,068

)

 

 

 

(264,663

)

 

Paid-in-kind interest income

 

 

(489

)

 

 

 

(736

)

 

Proceeds from sales of investments and principal repayments

 

 

319,218

 

 

 

 

64,852

 

 

Net realized (gain) loss on investments and foreign currency transactions

 

7,435

 

 

 

 

650

 

 

Net change in unrealized (appreciation) depreciation on investments, foreign currency translation

 

6,941

 

 

 

 

(2,132

)

 

Net change in unrealized (appreciation) depreciation on foreign currency forward contracts

 

(46

)

 

 

 

-

 

 

Amortization of premium and accretion of discount, net

 

(1,577

)

 

 

 

(703

)

 

Amortization of deferred offering costs

 

416

 

 

 

 

2,021

 

 

Amortization of deferred financing costs

 

 

710

 

 

 

 

274

 

 

Change in operating assets and liabilities:

 

 

 

 

 

 

 

 

(Increase) decrease in receivable from unsettled transactions

 

 

(1,251

)

 

 

 

(2,466

)

 

(Increase) decrease in interest and dividend receivable

 

 

(740

)

 

 

 

(5

)

 

(Increase) decrease in other assets

 

 

(10

)

 

 

 

(12

)

 

Increase (decrease) in payable for investments purchased

 

 

(47,408

)

 

 

 

45,108

 

 

Increase (decrease) in interest and other debt financing costs payable

 

 

1,538

 

 

 

 

580

 

 

Increase (decrease) in management fees payable

 

 

372

 

 

 

 

244

 

 

Increase (decrease) in accrued expenses and other liabilities

 

 

495

 

 

 

 

(1,875

)

 

Net cash provided by (used for) operating activities

 

$

(105,028

)

 

 

$

(146,648

)

 

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Proceeds from issuance of common stock

 

 

102,290

 

 

 

 

80,973

 

 

Increase (decrease) in subscriptions received in advance

 

 

(43,990

)

 

 

 

46,455

 

 

Distributions paid

 

 

(21,600

)

 

 

 

(10,354

)

 

Offering costs paid

 

 

(420

)

 

 

 

(186

)

 

Borrowings on credit facilities

 

 

262,560

 

 

 

 

158,228

 

 

Repayments on credit facilities

 

 

(262,230

)

 

 

 

(78,050

)

 

Deferred financing and debt issuance costs paid

 

 

-

 

 

 

 

(2,253

)

 

Net cash provided by (used for) financing activities

 

 

36,610

 

 

 

 

194,813

 

 

Effect of exchange rate changes on cash denominated in foreign currency

 

(20

)

 

 

 

52

 

 

Net increase (decrease) in cash and cash equivalents

 

 

(68,438

)

 

 

 

48,217

 

 

Cash and cash equivalents, restricted cash and restricted cash equivalents, and foreign currency, beginning of period

 

97,966

 

 

 

 

21,367

 

 

Cash and cash equivalents, restricted cash and restricted cash equivalents, and foreign currency, end of period (1)

$

29,528

 

 

 

$

69,584

 

 

 

 

 

 

 

 

 

 

 

Supplemental and non-cash financing activities:

 

 

 

 

 

 

 

 

Cash paid during the period for interest

 

$

10,716

 

 

 

$

4,047

 

 

Cash paid during the period for taxes

 

$

193

 

 

 

$

327

 

 

Accrued but unpaid distributions

 

$

4,416

 

 

 

$

2,131

 

 

Reinvestment of distributions during the period

 

$

34

 

 

 

$

1

 

 

Non-cash settlement of offering costs

 

$

118

 

 

 

$

2,829

 

 

 

(1) As of June 30, 2026, the balance included cash and cash equivalents of $11,655 (including cash denominated in foreign currency of $2,252) and restricted cash and cash equivalents of $17,873 (including cash denominated in foreign currency of $966). As of June 30,

9


 

2025, the balance included cash and cash equivalents of $61,758 (including cash denominated in foreign currency of $340) and restricted cash and cash equivalents of $7,826 (including cash denominated in foreign currency of $518).

 

See accompanying notes

10


 

 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
June 30, 2026
(in thousands, except share and per share data) (Unaudited)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

Cost

 

Percentage
of Net
Assets ***

 

Fair
Value

 

Investments (1)(2)(3)

 

 

United States

 

 

Debt Investments

 

 

Capital Goods

 

 

Accurate Finance Sub, LLC (4)(5)

Senior Secured First Lien Delayed Draw Term Loan

 

09/2032

$

-

 

 

$

(1

)

 

 

-

 

%

$

-

 

Accurate Finance Sub, LLC (5)

Senior Secured First Lien Revolver

S + 450, 75 Floor

8.14%

09/2032

 

49

 

 

 

48

 

 

 

0.0

 

 

 

49

 

Accurate Finance Sub, LLC

Senior Secured First Lien Term Loan

S + 450, 75 Floor

8.23%

09/2032

 

550

 

 

 

546

 

 

 

0.1

 

 

 

550

 

Ahead DB Holdings LLC (7)

Senior Secured First Lien Term Loan

S + 250, 75 Floor

6.23%

02/2031

 

1,339

 

 

 

1,336

 

 

 

0.2

 

 

 

1,319

 

Altar Bidco, Inc. (7)

Senior Secured First Lien Term Loan

S + 335, 50 Floor

6.86%

02/2029

 

1,155

 

 

 

1,146

 

 

 

0.2

 

 

 

1,156

 

Bingo Holdings I LLC (7)

Senior Secured First Lien Term Loan

S + 475

8.48%

06/2032

 

1,336

 

 

 

1,323

 

 

 

0.2

 

 

 

1,337

 

Boxer Parent Company Inc. (7)

Senior Secured First Lien Term Loan

S + 275

6.42%

07/2031

 

1,527

 

 

 

1,524

 

 

 

0.3

 

 

 

1,381

 

Chariot Buyer (7)

Senior Secured First Lien Term Loan

S + 300

6.64%

09/2032

 

1,329

 

 

 

1,329

 

 

 

0.2

 

 

 

1,332

 

Cloud Software Group, Inc. (7)

Senior Secured First Lien Term Loan

S + 325

7.00%

03/2031

 

1,617

 

 

 

1,617

 

 

 

0.3

 

 

 

1,427

 

Corelogic, Inc. (7)

Senior Secured First Lien Term Loan

S + 350, 50 Floor

7.00%

06/2028

 

540

 

 

 

540

 

 

 

0.1

 

 

 

534

 

Dayforce Inc (7)

Senior Secured First Lien Term Loan

S + 300

6.66%

10/2032

 

1,135

 

 

 

1,134

 

 

 

0.2

 

 

 

1,039

 

GB Eagle Buyer, Inc.

Unitranche First Lien Delayed Draw Term Loan

S + 475, 100 Floor

8.40%

12/2030

 

333

 

 

 

332

 

 

 

0.1

 

 

 

336

 

GB Eagle Buyer, Inc. (4)(5)

Unitranche First Lien Revolver

 

12/2030

 

-

 

 

 

(4

)

 

 

-

 

 

 

-

 

GB Eagle Buyer, Inc.

Unitranche First Lien Term Loan

S + 475, 100 Floor

8.48%

12/2030

 

3,139

 

 

 

3,114

 

 

 

0.6

 

 

 

3,170

 

GB Eagle Buyer, Inc. (4)(5)

Unitranche First Lien Revolver

 

12/2030

 

-

 

 

 

(37

)

 

 

-

 

 

 

-

 

Genesys Cloud Services Holdings II LLC (7)

Senior Secured First Lien Term Loan

S + 250

6.14%

12/2027

 

1,563

 

 

 

1,546

 

 

 

0.3

 

 

 

1,501

 

Iron Mountain Inc (6)(7)

Senior Secured First Lien Term Loan

S + 200

5.64%

01/2031

 

1,241

 

 

 

1,241

 

 

 

0.2

 

 

 

1,241

 

Parts Town

Unitranche First Lien Term Loan

S + 650 (175 PIK), 75 Floor

10.23%

04/2030

 

5,471

 

 

 

5,445

 

 

 

1.0

 

 

 

5,389

 

Pushpay USA Inc.

Senior Secured First Lien Term Loan

S + 375

7.00%

08/2031

 

988

 

 

 

981

 

 

 

0.2

 

 

 

928

 

TransDigm Inc (6)(7)

Senior Secured First Lien Term Loan

S + 250

6.14%

02/2031

 

1,768

 

 

 

1,774

 

 

 

0.3

 

 

 

1,770

 

Zelis Payments Buyer Inc (7)

Senior Secured First Lien Term Loan

S + 275

6.39%

09/2029

 

1,341

 

 

 

1,331

 

 

 

0.2

 

 

 

1,311

 

 

 

 

 

 

26,421

 

 

 

26,265

 

 

 

4.7

 

 

 

25,770

 

Commercial and Professional Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Access Records Management (7)

Senior Secured First Lien Term Loan

S + 400, 50 Floor

8.00%

08/2030

 

1,745

 

 

 

1,741

 

 

 

0.3

 

 

 

1,557

 

AlixPartners, LLP (7)

Senior Secured First Lien Term Loan

S + 200

5.64%

08/2032

 

1,331

 

 

 

1,333

 

 

 

0.2

 

 

 

1,325

 

Allied Universal Holdco LLC (7)

Senior Secured First Lien Term Loan

S + 325

7.00%

08/2032

 

1,327

 

 

 

1,327

 

 

 

0.2

 

 

 

1,329

 

BV MRP Buyer, LLC (4)(5)

Senior Secured First Lien Delayed Draw Term Loan

 

01/2032

 

-

 

 

 

(56

)

 

 

-

 

 

 

-

 

BV MRP Buyer, LLC (4)(5)

Senior Secured First Lien Revolver

 

01/2032

 

-

 

 

 

(17

)

 

 

-

 

 

 

-

 

See accompanying notes

 

 

 

 

 

 

 

 

11


 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
June 30, 2026
(in thousands, except share and per share data) (Unaudited)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

 

Cost

 

 

Percentage
of Net
Assets ***

 

 

Fair
Value

 

BV MRP Buyer, LLC

Senior Secured First Lien Term Loan

S + 500, 100 Floor

8.73%

01/2032

 

14,564

 

 

$

14,424

 

 

 

2.6

 

%

$

14,564

 

Career Certified LLC (5)

Senior Secured First Lien Delayed Draw Term Loan

S + 500, 100 Floor

8.73%

02/2031

 

99

 

 

 

99

 

 

 

0.0

 

 

 

99

 

Career Certified LLC (4)(5)

Senior Secured First Lien Revolver

 

02/2031

 

-

 

 

 

(1

)

 

 

-

 

 

 

-

 

Career Certified LLC

Senior Secured First Lien Term Loan

S + 500, 100 Floor

8.73%

02/2031

 

743

 

 

 

738

 

 

 

0.1

 

 

 

743

 

CMG Holdco

Unitranche First Lien Delayed Draw Term Loan

S + 500, 100 Floor

8.67%

10/2028

 

410

 

 

 

408

 

 

 

0.1

 

 

 

388

 

CMG Holdco

Unitranche First Lien Delayed Draw Term Loan

S + 500, 100 Floor

8.67%

10/2028

 

1,032

 

 

 

1,026

 

 

 

0.2

 

 

 

975

 

CMG Holdco (5)

Unitranche First Lien Delayed Draw Term Loan

S + 500, 100 Floor

8.67%

10/2028

 

1,369

 

 

 

1,359

 

 

 

0.2

 

 

 

1,288

 

CMG Holdco (4)(5)

Unitranche First Lien Delayed Draw Term Loan

 

10/2028

 

-

 

 

 

(3

)

 

 

(0.0

)

 

 

(34

)

CMG Holdco (5)

Unitranche First Lien Revolver

S + 500, 100 Floor

8.60%

10/2028

 

384

 

 

 

381

 

 

 

0.1

 

 

 

355

 

CMG Holdco

Unitranche First Lien Term Loan

S + 500, 100 Floor

8.67%

10/2028

 

696

 

 

 

692

 

 

 

0.1

 

 

 

657

 

CMG Holdco (4)(5)

Unitranche First Lien Delayed Draw Term Loan

 

11/2030

 

-

 

 

 

(18

)

 

 

(0.0

)

 

 

(245

)

CMG Holdco (4)(5)

Unitranche First Lien Revolver

 

11/2030

 

-

 

 

 

(6

)

 

 

(0.0

)

 

 

(39

)

Crisis Prevention Institute, Inc. (7)

Senior Secured First Lien Term Loan

S + 400, 50 Floor

7.73%

04/2031

 

1,813

 

 

 

1,810

 

 

 

0.3

 

 

 

1,793

 

DecisionHR Holdings, Inc

Senior Secured First Lien Term Loan

S + 425, 100 Floor

7.94%

12/2031

 

698

 

 

 

694

 

 

 

0.1

 

 

 

698

 

DecisionHR Holdings, Inc (5)

Senior Secured First Lien Delayed Draw Term Loan

 

12/2031

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

DecisionHR Holdings, Inc (4)(5)

Senior Secured First Lien Revolver

 

12/2031

 

-

 

 

 

(1

)

 

 

-

 

 

 

-

 

Dispatch Acquisition Holdings, LLC (5)

Unitranche First Lien Revolver

S + 475, 75 Floor

8.48%

11/2032

 

1,885

 

 

 

1,843

 

 

 

0.3

 

 

 

1,885

 

Dispatch Acquisition Holdings, LLC

Unitranche First Lien Term Loan

S + 475, 75 Floor

8.48%

11/2032

 

25,385

 

 

 

25,155

 

 

 

4.6

 

 

 

25,618

 

Dispatch Acquisition Holdings, LLC (5)

Unitranche First Lien Delayed Draw Term Loan

 

11/2032

 

-

 

 

 

-

 

 

 

0.0

 

 

 

11

 

Dispatch Acquisition Holdings, LLC

Unitranche First Lien Term Loan

S + 475, 75 Floor

8.48%

11/2032

 

1,192

 

 

 

1,181

 

 

 

0.2

 

 

 

1,203

 

See accompanying notes

 

 

12


 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
June 30, 2026
(in thousands, except share and per share data) (Unaudited)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

 

Cost

 

 

Percentage
of Net
Assets ***

 

 

Fair
Value

 

Duraserv LLC (5)

Senior Secured First Lien Delayed Draw Term Loan

S + 500, 75 Floor

8.65%

06/2031

 

1,043

 

 

$

1,036

 

 

 

0.2

 

%

$

1,037

 

Duraserv LLC

Senior Secured First Lien Delayed Draw Term Loan

S + 500, 75 Floor

8.65%

06/2031

 

1,757

 

 

 

1,747

 

 

 

0.3

 

 

 

1,752

 

Duraserv LLC (5)

Senior Secured First Lien Revolver

S + 500, 75 Floor

8.65%

06/2030

 

321

 

 

 

315

 

 

 

0.1

 

 

 

319

 

Duraserv LLC

Senior Secured First Lien Term Loan

S + 500, 75 Floor

8.65%

06/2031

 

4,737

 

 

 

4,711

 

 

 

0.9

 

 

 

4,723

 

Duraserv LLC (4)(5)

Senior Secured First Lien Delayed Draw Term Loan

 

06/2031

 

-

 

 

 

(16

)

 

 

(0.0

)

 

 

(10

)

FS Investments (Franklin Sq.) (7)

Senior Secured First Lien Term Loan

S + 225

5.89%

04/2031

 

1,629

 

 

 

1,615

 

 

 

0.3

 

 

 

1,510

 

GN Loanco, LLC (7)

Senior Secured First Lien Term Loan

S + 450, 75 Floor

8.16%

12/2030

 

1,355

 

 

 

1,352

 

 

 

0.2

 

 

 

1,281

 

Halo Buyer Inc (5)

Unitranche First Lien Revolver

S + 600, 100 Floor

9.64%

08/2029

 

243

 

 

 

236

 

 

 

0.0

 

 

 

247

 

Halo Buyer Inc

Unitranche First Lien Term Loan

S + 600, 100 Floor

9.64%

08/2029

 

3,435

 

 

 

3,385

 

 

 

0.6

 

 

 

3,459

 

HES Facilities (5)

Senior Secured First Lien Delayed Draw Term Loan

S + 526 (288 PIK), 75 Floor

8.98%

03/2033

 

1,621

 

 

 

1,597

 

 

 

0.3

 

 

 

1,599

 

HES Facilities

Senior Secured First Lien Term Loan

S + 526 (288 PIK), 75 Floor

8.98%

03/2033

 

17,287

 

 

 

17,120

 

 

 

3.1

 

 

 

17,213

 

HES Facilities (4)(5)

Senior Secured First Lien Revolver

 

03/2033

 

-

 

 

 

(26

)

 

 

(0.0

)

 

 

(12

)

Iris Buyer, LLC

Unitranche First Lien Delayed Draw Term Loan

S + 500, 100 Floor

8.73%

10/2030

 

325

 

 

 

319

 

 

 

0.1

 

 

 

325

 

Iris Buyer, LLC (4)(5)

Unitranche First Lien Revolver

 

10/2029

 

-

 

 

 

(8

)

 

 

-

 

 

 

-

 

Iris Buyer, LLC

Unitranche First Lien Term Loan

S + 500, 100 Floor

8.66%

10/2030

 

3,443

 

 

 

3,377

 

 

 

0.6

 

 

 

3,443

 

Iris Buyer, LLC (5)

Unitranche First Lien Delayed Draw Term Loan

S + 500, 100 Floor

8.73%

10/2030

 

518

 

 

 

515

 

 

 

0.1

 

 

 

518

 

Iris Buyer, LLC

Unitranche First Lien Term Loan

S + 500, 100 Floor

8.73%

10/2030

 

100

 

 

 

99

 

 

 

0.0

 

 

 

100

 

Just Right HVAC, LLC (5)

Senior Secured First Lien Revolver

P + 375, 100 Floor

10.50%

02/2029

 

10

 

 

 

10

 

 

 

0.0

 

 

 

10

 

Just Right HVAC, LLC

Senior Secured First Lien Term Loan

S + 475, 100 Floor

8.60%

02/2029

 

249

 

 

 

248

 

 

 

0.0

 

 

 

249

 

Just Right HVAC, LLC (5)

Senior Secured First Lien Delayed Draw Term Loan

S + 475, 100 Floor

8.54%

02/2029

 

55

 

 

 

55

 

 

 

0.0

 

 

 

55

 

Lawn Star Buyer, LLC (5)

Senior Secured First Lien Revolver

S + 450, 100 Floor

8.14%

06/2031

 

140

 

 

 

134

 

 

 

0.0

 

 

 

140

 

Lawn Star Buyer, LLC

Senior Secured First Lien Term Loan

S + 450, 100 Floor

8.14%

06/2031

 

1,618

 

 

 

1,604

 

 

 

0.3

 

 

 

1,618

 

McKissock Investment Holdings LLC (Colibri) (7)

Senior Secured First Lien Term Loan

S + 500, 75 Floor

8.67%

03/2029

 

2,925

 

 

 

2,886

 

 

 

0.5

 

 

 

2,507

 

Prime Security Services Borrower, LLC (P1/ADT) (6)(7)

Senior Secured First Lien Term Loan

S + 200

5.62%

10/2030

 

1,150

 

 

 

1,151

 

 

 

0.2

 

 

 

1,144

 

Quidelortho Corp (6)(7)

Senior Secured First Lien Term Loan

S + 400

8.00%

08/2032

 

2,520

 

 

 

2,511

 

 

 

0.4

 

 

 

2,484

 

Southern Veterinary Partners LLC (7)

Senior Secured First Lien Term Loan

S + 250

6.16%

12/2031

 

1,332

 

 

 

1,326

 

 

 

0.2

 

 

 

1,332

 

Trace3 (Escape Velocity Holdings) (4)(5)(7)

Senior Secured First Lien Delayed Draw Term Loan

 

10/2032

 

-

 

 

 

-

 

 

 

(0.0

)

 

 

(3

)

Trace3 (Escape Velocity Holdings) (7)

Senior Secured First Lien Term Loan

S + 400

7.73%

10/2032

 

1,588

 

 

 

1,591

 

 

 

0.3

 

 

 

1,564

 

Unosquare, LLC (4)(5)

Senior Secured First Lien Delayed Draw Term Loan

 

06/2031

 

-

 

 

 

-

 

 

 

(0.0

)

 

 

(45

)

Unosquare, LLC (4)(5)

Senior Secured First Lien Revolver

 

06/2031

 

-

 

 

 

-

 

 

 

(0.0

)

 

 

(18

)

 

 

See accompanying notes

 

13


 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
June 30, 2026
(in thousands, except share and per share data) (Unaudited)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

 

Cost

 

 

Percentage
of Net
Assets ***

 

 

Fair
Value

 

Unosquare, LLC

Senior Secured First Lien Term Loan

S + 475, 75 Floor

8.39%

06/2031

 

3,027

 

 

$

3,002

 

 

 

0.5

 

%

$

2,930

 

 

 

 

 

 

107,101

 

 

 

106,001

 

 

 

18.7

 

 

 

105,641

 

Consumer Discretionary Distribution and Retail

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bass Pro - Great American Outdoors Group LLC (7)

Senior Secured First Lien Term Loan

S + 325, 75 Floor

6.89%

01/2032

 

1,052

 

 

 

1,055

 

 

 

0.2

 

 

 

1,057

 

Family Dollar

Senior Secured Second Lien Term Loan

S + 650, 100 Floor

10.12%

07/2030

 

7,500

 

 

 

7,441

 

 

 

1.4

 

 

 

7,722

 

Harbor Freight Tools USA, Inc (7)

Senior Secured First Lien Term Loan

S + 225

5.89%

06/2031

 

858

 

 

 

849

 

 

 

0.2

 

 

 

856

 

Inspire Brands, Inc. (Arby’s & Buffalo Wild Wings) (7)

Senior Secured First Lien Term Loan

S + 250, 75 Floor

6.14%

12/2030

 

1,166

 

 

 

1,168

 

 

 

0.2

 

 

 

1,168

 

PetSmart (7)

Senior Secured First Lien Term Loan

S + 400

8.00%

08/2032

 

1,324

 

 

 

1,319

 

 

 

0.2

 

 

 

1,324

 

 

 

 

 

 

11,900

 

 

 

11,832

 

 

 

2.2

 

 

 

12,127

 

Consumer Durables and Apparel

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

HP PHRG Borrower, LLC (7)

Senior Secured First Lien Term Loan

S + 400

7.73%

02/2032

 

884

 

 

 

882

 

 

 

0.2

 

 

 

880

 

Varsity Brands (7)

Senior Secured First Lien Term Loan

S + 275

6.48%

08/2031

 

1,067

 

 

 

1,070

 

 

 

0.2

 

 

 

1,070

 

 

 

 

 

 

1,951

 

 

 

1,952

 

 

 

0.4

 

 

 

1,950

 

Consumer Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Caesars Entertainment Inc (6)(7)

Senior Secured First Lien Term Loan

S + 225, 50 Floor

5.89%

02/2030

 

1,182

 

 

 

1,176

 

 

 

0.2

 

 

 

1,147

 

CRS TH Holdings, Corp. (4)(5)

Senior Secured First Lien Delayed Draw Term Loan

 

12/2032

 

-

 

 

 

(2

)

 

 

-

 

 

 

-

 

CRS TH Holdings, Corp. (4)(5)

Senior Secured First Lien Revolver

 

12/2032

 

-

 

 

 

(2

)

 

 

-

 

 

 

-

 

CRS TH Holdings, Corp.

Senior Secured First Lien Term Loan

S + 450, 75 Floor

8.23%

12/2032

 

1,372

 

 

 

1,362

 

 

 

0.2

 

 

 

1,372

 

Essential Services Holding Corporation (5)

Unitranche First Lien Revolver

S + 525, 75 Floor

8.93%

06/2030

 

204

 

 

 

201

 

 

 

0.0

 

 

 

187

 

Essential Services Holding Corporation

Unitranche First Lien Term Loan

S + 563 (275 PIK), 75 Floor

9.30%

06/2031

 

3,808

 

 

 

3,779

 

 

 

0.7

 

 

 

3,674

 

Golden Nugget Inc (Landry’s) (7)

Senior Secured First Lien Term Loan

S + 325, 50 Floor

6.89%

01/2029

 

1,336

 

 

 

1,337

 

 

 

0.2

 

 

 

1,336

 

J&J Ventures Gaming (7)

Senior Secured First Lien Term Loan

S + 350, 75 Floor

7.14%

04/2030

 

1,335

 

 

 

1,329

 

 

 

0.2

 

 

 

1,331

 

Landscape Workshop LLC (5)

Unitranche First Lien Delayed Draw Term Loan

S + 500, 75 Floor

8.73%

05/2032

 

6,197

 

 

 

6,170

 

 

 

1.1

 

 

 

6,172

 

Landscape Workshop LLC (4)(5)

Unitranche First Lien Revolver

 

05/2031

 

-

 

 

 

(28

)

 

 

(0.0

)

 

 

(14

)

Landscape Workshop LLC

Unitranche First Lien Term Loan

S + 500, 75 Floor

8.73%

05/2032

 

19,314

 

 

 

19,145

 

 

 

3.5

 

 

 

19,236

 

Landscape Workshop LLC (4)(5)

Unitranche First Lien Delayed Draw Term Loan

 

05/2032

 

-

 

 

 

(35

)

 

 

(0.0

)

 

 

(29

)

Landscape Workshop LLC

Unitranche First Lien Term Loan

S + 500, 75 Floor

8.73%

05/2032

 

2,432

 

 

 

2,409

 

 

 

0.4

 

 

 

2,423

 

Marriott Ownership Resorts, Inc. (6)(7)

Senior Secured First Lien Term Loan

S + 225

5.89%

03/2031

 

1,152

 

 

 

1,147

 

 

 

0.2

 

 

 

1,155

 

Tree Guardians Holdings LLC (5)

Senior Secured First Lien Delayed Draw Term Loan

S + 450, 100 Floor

8.23%

01/2032

 

633

 

 

 

629

 

 

 

0.1

 

 

 

613

 

Tree Guardians Holdings LLC

Senior Secured First Lien Term Loan

S + 450, 100 Floor

8.23%

01/2032

 

1,147

 

 

 

1,139

 

 

 

0.2

 

 

 

1,135

 

Tree Guardians Holdings LLC (4)(5)

Senior Secured First Lien Revolver

 

01/2032

 

-

 

 

 

(1

)

 

 

(0.0

)

 

 

(2

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes

 

14


 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
June 30, 2026
(in thousands, except share and per share data) (Unaudited)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

 

Cost

 

 

Percentage
of Net
Assets ***

 

 

Fair
Value

 

Voyager Parent LLC (7)

Senior Secured First Lien Term Loan

S + 425

7.98%

07/2032

 

1,330

 

 

$

1,331

 

 

 

0.2

 

%

$

1,333

 

 

 

 

 

 

41,442

 

 

 

41,086

 

 

 

7.2

 

 

 

41,069

 

Diversified Financials

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Beyond Risk Management, Inc. (4)(5)

Senior Secured First Lien Delayed Draw Term Loan

 

03/2033

 

-

 

 

 

(2

)

 

 

(0.0

)

 

 

(7

)

Beyond Risk Management, Inc.

Senior Secured First Lien Term Loan

S + 475, 75 Floor

8.39%

03/2033

 

2,300

 

 

 

2,283

 

 

 

0.4

 

 

 

2,283

 

Beyond Risk Management, Inc. (4)(5)

Senior Secured First Lien Revolver

 

03/2033

 

-

 

 

 

(3

)

 

 

(0.0

)

 

 

(3

)

RWA Wealth Partners, LLC.

Unitranche First Lien Term Loan

S + 475, 75 Floor

9.07%

11/2030

 

1,679

 

 

 

1,669

 

 

 

0.3

 

 

 

1,679

 

RWA Wealth Partners, LLC. (5)

Unitranche First Lien Delayed Draw Term Loan

S + 475, 75 Floor

8.40%

11/2030

 

328

 

 

 

326

 

 

 

0.1

 

 

 

328

 

RWA Wealth Partners, LLC. (4)(5)

Unitranche First Lien Revolver

 

11/2030

 

-

 

 

 

(2

)

 

 

-

 

 

 

-

 

 

 

 

 

 

4,307

 

 

 

4,271

 

 

 

0.8

 

 

 

4,280

 

Energy

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Delek US Holdings, Inc. (6)(7)

Senior Secured First Lien Term Loan

S + 300, 50 Floor

6.64%

05/2032

 

1,656

 

 

 

1,656

 

 

 

0.3

 

 

 

1,658

 

Qinetic, Inc.

Senior Secured First Lien Term Loan

S + 475, 75 Floor

8.41%

04/2033

 

14,000

 

 

 

13,861

 

 

 

2.5

 

 

 

13,860

 

Qinetic, Inc. (4)(5)

Senior Secured First Lien Delayed Draw Term Loan

 

04/2033

 

-

 

 

 

(20

)

 

 

(0.0

)

 

 

(40

)

Qinetic, Inc. (4)(5)

Senior Secured First Lien Revolver

 

04/2033

 

-

 

 

 

(20

)

 

 

(0.0

)

 

 

(20

)

Rockpoint Gas Storage Partners LP (6)(7)

Senior Secured First Lien Term Loan

S + 225

5.98%

09/2031

 

794

 

 

 

795

 

 

 

0.1

 

 

 

796

 

SPI Holdco, LLC (4)(5)

Senior Secured First Lien Delayed Draw Term Loan

 

04/2032

 

-

 

 

 

(1

)

 

 

(0.0

)

 

 

(2

)

SPI Holdco, LLC

Senior Secured First Lien Term Loan

S + 475, 100 Floor

8.48%

04/2032

 

1,100

 

 

 

1,092

 

 

 

0.2

 

 

 

1,092

 

SPI Holdco, LLC (4)(5)

Senior Secured First Lien Revolver

 

04/2032

 

-

 

 

 

(1

)

 

 

(0.0

)

 

 

(1

)

 

 

 

 

 

17,550

 

 

 

17,362

 

 

 

3.1

 

 

 

17,343

 

Financial Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Americana Partners LLC (4)(5)

Unitranche First Lien Delayed Draw Term Loan

 

05/2031

 

-

 

 

 

(4

)

 

 

(0.0

)

 

 

(29

)

Americana Partners LLC (4)(5)

Unitranche First Lien Revolver

 

05/2031

 

-

 

 

 

(3

)

 

 

(0.0

)

 

 

(6

)

Americana Partners LLC

Unitranche First Lien Term Loan

S + 425, 75 Floor

7.98%

05/2031

 

650

 

 

 

646

 

 

 

0.1

 

 

 

640

 

Aretec Group (Cetera) (7)

Senior Secured First Lien Term Loan

S + 300

6.64%

08/2030

 

1,323

 

 

 

1,325

 

 

 

0.2

 

 

 

1,322

 

Blackhawk Network Holdings, Inc. (7)

Senior Secured First Lien Term Loan

S + 350

7.14%

03/2029

 

1,342

 

 

 

1,347

 

 

 

0.2

 

 

 

1,338

 

Camelot US (6)(7)

Senior Secured First Lien Term Loan

S + 325

6.89%

01/2031

 

2,210

 

 

 

2,204

 

 

 

0.4

 

 

 

2,042

 

Cary Street Partners (5)

Senior Secured First Lien Delayed Draw Term Loan

S + 475, 100 Floor

8.48%

05/2031

 

309

 

 

 

296

 

 

 

0.1

 

 

 

309

 

Cary Street Partners (4)(5)

Senior Secured First Lien Revolver

 

05/2031

 

-

 

 

 

(4

)

 

 

-

 

 

 

-

 

Cary Street Partners

Senior Secured First Lien Term Loan

S + 475, 100 Floor

8.48%

05/2031

 

1,782

 

 

 

1,763

 

 

 

0.3

 

 

 

1,782

 

Foreside Financial Group, LLC (4)(5)

Unitranche First Lien Delayed Draw Term Loan

 

09/2029

 

-

 

 

 

(18

)

 

 

(0.0

)

 

 

(35

)

Foreside Financial Group, LLC (5)

Unitranche First Lien Revolver

S + 525, 100 Floor

8.99%

09/2029

 

48

 

 

 

36

 

 

 

0.0

 

 

 

36

 

Foreside Financial Group, LLC

Unitranche First Lien Term Loan

S + 525, 100 Floor

8.99%

09/2029

 

10,251

 

 

 

10,149

 

 

 

1.8

 

 

 

10,149

 

Fortress Intermediate 3 Inc (7)

Senior Secured First Lien Term Loan

S + 300

6.62%

06/2031

 

1,332

 

 

 

1,316

 

 

 

0.2

 

 

 

1,328

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes

 

 

15


 

 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
June 30, 2026
(in thousands, except share and per share data) (Unaudited)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

 

Cost

 

 

Percentage
of Net
Assets ***

 

 

Fair
Value

 

HPOne (4)(5)

Senior Secured First Lien Delayed Draw Term Loan

 

08/2031

 

-

 

 

$

(5

)

 

 

(0.0

)

%

$

(3

)

HPOne (4)(5)

Senior Secured First Lien Revolver

 

08/2031

 

-

 

 

 

(19

)

 

 

(0.0

)

 

 

(6

)

HPOne

Senior Secured First Lien Term Loan

S + 475, 75 Floor

8.00%

08/2031

 

10,800

 

 

 

10,728

 

 

 

2.0

 

 

 

10,777

 

Hudson River Trading LLC (7)

Senior Secured First Lien Term Loan

S + 250

6.14%

03/2030

 

290

 

 

 

290

 

 

 

0.1

 

 

 

289

 

Jefferies Finance LLC (6)(7)

Senior Secured First Lien Term Loan

S + 275

6.39%

10/2031

 

1,785

 

 

 

1,774

 

 

 

0.3

 

 

 

1,785

 

Modena Buyer LLC (7)

Senior Secured First Lien Term Loan

S + 425

8.00%

07/2031

 

1,668

 

 

 

1,642

 

 

 

0.3

 

 

 

1,546

 

Nexus Buyer LLC (7)

Senior Secured First Lien Term Loan

S + 350

7.14%

07/2031

 

539

 

 

 

538

 

 

 

0.1

 

 

 

521

 

Nexus Buyer LLC (7)

Senior Secured First Lien Term Loan

S + 400

8.00%

07/2031

 

448

 

 

 

449

 

 

 

0.1

 

 

 

434

 

PI Buyer LLC (5)

Unitranche First Lien Delayed Draw Term Loan

S + 500, 75 Floor

9.00%

08/2032

 

90

 

 

 

89

 

 

 

0.0

 

 

 

85

 

PI Buyer LLC (4)(5)

Unitranche First Lien Revolver

 

08/2032

 

-

 

 

 

(1

)

 

 

(0.0

)

 

 

(1

)

PI Buyer LLC

Unitranche First Lien Term Loan

S + 500, 75 Floor

8.64%

08/2032

 

597

 

 

 

593

 

 

 

0.1

 

 

 

588

 

Schellman Holdings, LLC (4)(5)

Unitranche First Lien Delayed Draw Term Loan

 

04/2033

 

-

 

 

 

(14

)

 

 

(0.0

)

 

 

(29

)

Schellman Holdings, LLC

Unitranche First Lien Term Loan

S + 475, 75 Floor

8.42%

04/2033

 

30,571

 

 

 

30,274

 

 

 

5.5

 

 

 

30,266

 

Schellman Holdings, LLC (4)(5)

Unitranche First Lien Revolver

 

04/2033

 

-

 

 

 

(42

)

 

 

(0.0

)

 

 

(43

)

Star Parents, Inc. (7)

Senior Secured First Lien Term Loan

S + 400

7.73%

09/2030

 

1,330

 

 

 

1,329

 

 

 

0.2

 

 

 

1,334

 

UHY Advisors , Inc.

Unitranche First Lien Term Loan

S + 475, 75 Floor

8.42%

11/2031

 

1,753

 

 

 

1,743

 

 

 

0.3

 

 

 

1,753

 

UHY Advisors , Inc. (5)

Unitranche First Lien Delayed Draw Term Loan

S + 475, 75 Floor

8.48%

11/2031

 

1,179

 

 

 

1,175

 

 

 

0.2

 

 

 

1,179

 

UHY Advisors , Inc. (5)

Unitranche First Lien Revolver

S + 475, 75 Floor

8.48%

11/2031

 

95

 

 

 

92

 

 

 

0.0

 

 

 

95

 

White Cap Supply Holdings, LLC (7)

Senior Secured First Lien Term Loan

S + 325

6.89%

10/2029

 

1,337

 

 

 

1,339

 

 

 

0.2

 

 

 

1,337

 

 

 

 

 

 

71,729

 

 

 

71,027

 

 

 

12.6

 

 

 

70,783

 

Food, Beverage and Tobacco

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Primary Products (7)

Senior Secured First Lien Term Loan

S + 325, 50 Floor

6.93%

04/2029

 

1,423

 

 

 

1,420

 

 

 

0.3

 

 

 

1,424

 

 

 

 

 

 

1,423

 

 

 

1,420

 

 

 

0.3

 

 

 

1,424

 

Health Care Equipment and Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1-800 Contacts (CNT Holdings I Corp) (7)

Senior Secured First Lien Term Loan

S + 250, 75 Floor

6.16%

11/2032

 

1,326

 

 

 

1,329

 

 

 

0.2

 

 

 

1,328

 

Angels of Care

Senior Secured First Lien Term Loan

S + 525, 100 Floor

8.89%

02/2030

 

3,666

 

 

 

3,640

 

 

 

0.7

 

 

 

3,640

 

Angels of Care (4)(5)

Senior Secured First Lien Revolver

 

02/2030

 

-

 

 

 

(3

)

 

 

(0.0

)

 

 

(3

)

Angels of Care

Senior Secured First Lien Delayed Draw Term Loan

S + 525, 100 Floor

8.89%

02/2030

 

846

 

 

 

843

 

 

 

0.2

 

 

 

840

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes

 

 

 

 

 

 

 

 

 

 

 

16


 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
June 30, 2026
(in thousands, except share and per share data) (Unaudited)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

 

Cost

 

 

Percentage
of Net
Assets ***

 

 

Fair
Value

 

Angels of Care

Senior Secured First Lien Term Loan

S + 525, 100 Floor

8.89%

03/2032

 

798

 

 

$

792

 

 

 

0.1

 

%

$

792

 

Angels of Care (4)(5)

Senior Secured First Lien Delayed Draw Term Loan

 

03/2032

 

-

 

 

 

(3

)

 

 

(0.0

)

 

 

(7

)

Arrow Management Acquisition, LLC (5)

Unitranche First Lien Delayed Draw Term Loan

S + 500, 75 Floor

8.73%

07/2032

 

936

 

 

 

902

 

 

 

0.2

 

 

 

1,073

 

Arrow Management Acquisition, LLC (5)

Unitranche First Lien Revolver

S + 500, 75 Floor

8.73%

07/2032

 

710

 

 

 

692

 

 

 

0.1

 

 

 

710

 

Arrow Management Acquisition, LLC

Unitranche First Lien Term Loan

S + 500, 75 Floor

8.73%

07/2032

 

19,143

 

 

 

18,971

 

 

 

3.5

 

 

 

19,526

 

Avalign Technologies, Inc. (5)(13)

Unitranche First Lien Revolver

 

12/2028

 

629

 

 

 

599

 

 

 

0.0

 

 

 

240

 

Avalign Technologies, Inc. (13)

Unitranche First Lien Term Loan

 

12/2028

 

7,512

 

 

 

7,222

 

 

 

0.8

 

 

 

4,348

 

Bristol Hospice, LLC (4)(5)

Unitranche First Lien Revolver

 

08/2032

 

-

 

 

 

(21

)

 

 

(0.0

)

 

 

(46

)

Bristol Hospice, LLC

Unitranche First Lien Term Loan

S + 525, 75 Floor

9.00%

08/2032

 

24,118

 

 

 

23,905

 

 

 

4.3

 

 

 

23,635

 

Bristol Hospice, LLC

Unitranche First Lien Term Loan

S + 525, 75 Floor

8.89%

08/2032

 

7,974

 

 

 

7,819

 

 

 

1.4

 

 

 

7,815

 

Buyer Cascade Acquiror, Inc. (4)(5)

Unitranche First Lien Revolver

 

05/2033

 

-

 

 

 

(36

)

 

 

(0.0

)

 

 

(36

)

Buyer Cascade Acquiror, Inc.

Unitranche First Lien Term Loan

S + 500, 75 Floor

8.68%

05/2033

 

33,914

 

 

 

33,583

 

 

 

7.3

 

 

 

33,574

 

BVI Medical Inc. (5)

Unitranche First Lien Delayed Draw Term Loan

S + 1100 (500 PIK), 75 Floor

14.67%

03/2032

 

268

 

 

 

265

 

 

 

0.0

 

 

 

244

 

BVI Medical Inc. (5)

Unitranche First Lien Revolver

S + 1100 (500 PIK), 75 Floor

14.61%

03/2032

 

101

 

 

 

93

 

 

 

0.0

 

 

 

57

 

BVI Medical Inc.

Unitranche First Lien Term Loan

S + 625 (500 PIK), 75 Floor

9.91%

03/2032

 

8,564

 

 

 

8,460

 

 

 

1.4

 

 

 

7,991

 

Cvet Midco 2, L.P. (7)

Senior Secured First Lien Term Loan

S + 500, 50 Floor

8.73%

10/2029

 

2,085

 

 

 

1,980

 

 

 

0.4

 

 

 

2,025

 

Embecta Corp. (6)(7)

Senior Secured First Lien Term Loan

S + 300, 50 Floor

6.73%

03/2029

 

1,586

 

 

 

1,585

 

 

 

0.2

 

 

 

1,264

 

Global Medical Response Inc (7)

Senior Secured First Lien Term Loan

S + 325

6.89%

10/2032

 

1,076

 

 

 

1,073

 

 

 

0.2

 

 

 

1,080

 

Headlands Buyer, Inc. (4)(5)

Unitranche First Lien Delayed Draw Term Loan

 

09/2032

 

-

 

 

 

(12

)

 

 

(0.0

)

 

 

(5

)

Headlands Buyer, Inc. (5)

Unitranche First Lien Revolver

S + 450, 100 Floor

8.24%

09/2032

 

110

 

 

 

98

 

 

 

0.0

 

 

 

108

 

Headlands Buyer, Inc.

Unitranche First Lien Term Loan

S + 450, 100 Floor

8.19%

09/2032

 

6,780

 

 

 

6,718

 

 

 

1.2

 

 

 

6,767

 

HP Irish Merger Sub, Inc. (4)(5)

Unitranche First Lien Delayed Draw Term Loan

 

05/2033

 

-

 

 

 

(14

)

 

 

(0.0

)

 

 

(21

)

HP Irish Merger Sub, Inc. (4)(5)

Unitranche First Lien Revolver

 

05/2033

 

-

 

 

 

(25

)

 

 

(0.0

)

 

 

(19

)

HP Irish Merger Sub, Inc.

Unitranche First Lien Term Loan

S + 475, 75 Floor

8.48%

05/2033

 

13,419

 

 

 

13,285

 

 

 

2.4

 

 

 

13,320

 

IVX Health Holdings, Inc. (4)(5)

Unitranche First Lien Revolver

 

06/2030

 

-

 

 

 

(24

)

 

 

-

 

 

 

-

 

IVX Health Holdings, Inc.

Unitranche First Lien Term Loan

S + 500, 100 Floor

8.73%

06/2030

 

28,324

 

 

 

28,060

 

 

 

5.2

 

 

 

28,658

 

IVX Health Holdings, Inc. (4)(5)

Unitranche First Lien Revolver

 

06/2030

 

-

 

 

 

(19

)

 

 

-

 

 

 

-

 

IVX Health Holdings, Inc.

Unitranche First Lien Term Loan

S + 500, 100 Floor

8.73%

06/2030

 

6,725

 

 

 

6,627

 

 

 

1.2

 

 

 

6,805

 

Laseraway Intermediate Holdings II, LLC (7)

Senior Secured First Lien Term Loan

S + 575, 75 Floor

9.43%

10/2027

 

5,168

 

 

 

5,150

 

 

 

0.9

 

 

 

5,152

 

LifePoint Health Inc (7)

Senior Secured First Lien Term Loan

S + 375

7.42%

11/2028

 

1,337

 

 

 

1,337

 

 

 

0.2

 

 

 

1,319

 

LifePoint Health Inc (7)

Senior Secured First Lien Term Loan

S + 350

7.18%

05/2031

 

1,337

 

 

 

1,340

 

 

 

0.2

 

 

 

1,316

 

LTC Ally Inc (4)(5)

Senior Secured First Lien Revolver

 

04/2031

 

-

 

 

 

(1

)

 

 

-

 

 

 

-

 

See accompanying notes

 

17


 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
June 30, 2026
(in thousands, except share and per share data) (Unaudited)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

 

Cost

 

 

Percentage
of Net
Assets ***

 

 

Fair
Value

 

LTC Ally Inc

Senior Secured First Lien Term Loan

S + 450, 100 Floor

8.18%

04/2031

 

2,718

 

 

$

2,701

 

 

 

0.5

 

%

$

2,718

 

MB2 Dental

Unitranche First Lien Term Loan

S + 550, 75 Floor

9.14%

02/2031

 

5,420

 

 

 

5,383

 

 

 

1.0

 

 

 

5,420

 

MB2 Dental (5)

Unitranche First Lien Revolver

S + 550, 75 Floor

9.14%

02/2031

 

58

 

 

 

55

 

 

 

0.0

 

 

 

58

 

MB2 Dental

Unitranche First Lien Delayed Draw Term Loan

S + 550, 75 Floor

9.14%

02/2031

 

1,119

 

 

 

1,112

 

 

 

0.2

 

 

 

1,119

 

MB2 Dental

Unitranche First Lien Delayed Draw Term Loan

S + 550, 75 Floor

9.14%

02/2031

 

785

 

 

 

774

 

 

 

0.1

 

 

 

785

 

MB2 Dental (5)

Unitranche First Lien Delayed Draw Term Loan

S + 600, 75 Floor

9.65%

02/2031

 

218

 

 

 

214

 

 

 

0.0

 

 

 

218

 

Medical Review Institute of America (4)(5)

Unitranche First Lien Revolver

 

07/2030

 

-

 

 

 

(6

)

 

 

(0.0

)

 

 

(8

)

Medical Review Institute of America

Unitranche First Lien Term Loan

S + 500, 100 Floor

8.73%

07/2030

 

5,600

 

 

 

5,561

 

 

 

1.0

 

 

 

5,542

 

National Mentor Holdings, Inc. (7)

Senior Secured First Lien Term Loan

S + 600

9.64%

12/2030

 

617

 

 

 

601

 

 

 

0.1

 

 

 

623

 

Net Health Acquisition Corp. (4)(5)

Unitranche First Lien Revolver

 

07/2031

 

-

 

 

 

(8

)

 

 

-

 

 

 

-

 

Net Health Acquisition Corp.

Unitranche First Lien Term Loan

S + 475, 75 Floor

8.39%

07/2031

 

8,731

 

 

 

8,668

 

 

 

1.6

 

 

 

8,731

 

Net Health Acquisition Corp.

Unitranche First Lien Term Loan

S + 475, 75 Floor

8.39%

07/2031

 

2,925

 

 

 

2,900

 

 

 

0.5

 

 

 

2,925

 

Outcomes Group Holding Inc (7)

Senior Secured First Lien Term Loan

S + 300

6.64%

05/2031

 

1,980

 

 

 

1,974

 

 

 

0.4

 

 

 

1,988

 

Outcomes Group Holding Inc (8)

Senior Secured Second Lien Term Loan

10.00%

10.00%

05/2032

 

17,753

 

 

 

17,668

 

 

 

3.2

 

 

 

17,664

 

Premier Care Dental Management, LLC (5)

Unitranche First Lien Delayed Draw Term Loan

S + 500, 75 Floor

8.64%

08/2028

 

8,721

 

 

 

8,686

 

 

 

1.6

 

 

 

8,658

 

 

 

 

 

 

235,097

 

 

 

232,493

 

 

 

42.6

 

 

 

229,931

 

Insurance

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Acrisure, LLC (7)

Senior Secured First Lien Term Loan

S + 300

6.64%

11/2030

 

1,350

 

 

 

1,353

 

 

 

0.2

 

 

 

1,225

 

Alliant Holdings Intermediate LLC (7)

Senior Secured First Lien Term Loan

S + 250

6.14%

09/2031

 

1,331

 

 

 

1,332

 

 

 

0.2

 

 

 

1,315

 

AmWINS Group, Inc. (7)

Senior Secured First Lien Term Loan

S + 200, 75 Floor

5.73%

01/2032

 

1,330

 

 

 

1,334

 

 

 

0.2

 

 

 

1,305

 

King Risk Partners LLC

Unitranche First Lien Term Loan

S + 450, 100 Floor

8.14%

04/2031

 

2,252

 

 

 

2,239

 

 

 

0.4

 

 

 

2,252

 

King Risk Partners LLC (5)

Unitranche First Lien Delayed Draw Term Loan

S + 450, 100 Floor

8.14%

04/2031

 

1,862

 

 

 

1,858

 

 

 

0.3

 

 

 

1,862

 

King Risk Partners LLC (4)(5)

Unitranche First Lien Revolver

 

04/2031

 

-

 

 

 

(3

)

 

 

-

 

 

 

-

 

King Risk Partners LLC (4)(5)

Unitranche First Lien Delayed Draw Term Loan

 

04/2031

 

-

 

 

 

(8

)

 

 

-

 

 

 

-

 

Onedigital Borrower LLC (7)

Senior Secured First Lien Term Loan

S + 300, 50 Floor

7.00%

07/2031

 

1,344

 

 

 

1,344

 

 

 

0.2

 

 

 

1,306

 

SIG Parent Holdings, LLC

Senior Secured First Lien Term Loan

S + 475, 75 Floor

8.39%

08/2031

 

7,114

 

 

 

7,081

 

 

 

1.3

 

 

 

7,081

 

SIG Parent Holdings, LLC (4)(5)

Senior Secured First Lien Revolver

 

08/2031

 

-

 

 

 

-

 

 

 

(0.0

)

 

 

(4

)

SIG Parent Holdings, LLC (4)(5)

Senior Secured First Lien Delayed Draw Term Loan

 

08/2031

 

0

 

 

 

(77

)

 

 

(0.0

)

 

 

(77

)

The Hilb Group, LLC (5)

Unitranche First Lien Delayed Draw Term Loan

S + 475, 75 Floor

8.39%

10/2031

 

987

 

 

 

982

 

 

 

0.2

 

 

 

986

 

The Hilb Group, LLC (5)

Unitranche First Lien Revolver

S + 475, 75 Floor

8.39%

10/2031

 

164

 

 

 

159

 

 

 

0.0

 

 

 

164

 

 

 

See accompanying notes

 

 

 

18


 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
June 30, 2026
(in thousands, except share and per share data) (Unaudited)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

 

Cost

 

 

Percentage
of Net
Assets ***

 

 

Fair
Value

 

The Hilb Group, LLC

Unitranche First Lien Term Loan

S + 475, 75 Floor

8.39%

10/2031

 

5,920

 

 

$

5,876

 

 

 

1.1

 

%

$

5,917

 

Tropolis Holdings LLC

Unitranche First Lien Delayed Draw Term Loan

S + 500, 100 Floor

8.73%

02/2031

 

546

 

 

 

544

 

 

 

0.1

 

 

 

546

 

Tropolis Holdings LLC (4)(5)

Unitranche First Lien Revolver

 

02/2031

 

-

 

 

 

(1

)

 

 

-

 

 

 

-

 

Tropolis Holdings LLC

Unitranche First Lien Term Loan

S + 500, 100 Floor

8.73%

02/2031

 

346

 

 

 

343

 

 

 

0.1

 

 

 

346

 

Tropolis Holdings LLC (5)

Unitranche First Lien Delayed Draw Term Loan

S + 500, 100 Floor

8.73%

02/2031

 

296

 

 

 

296

 

 

 

0.1

 

 

 

296

 

Verscend Holding Corp (Cotiviti) (7)

Senior Secured First Lien Term Loan

S + 275

6.37%

05/2031

 

1,535

 

 

 

1,486

 

 

 

0.3

 

 

 

1,408

 

 

 

 

 

 

26,377

 

 

 

26,138

 

 

 

4.6

 

 

 

25,928

 

Materials

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Clydesdale Acquisition Holdings, Inc. (7)

Senior Secured First Lien Term Loan

S + 325

6.89%

04/2032

 

1,913

 

 

 

1,908

 

 

 

0.3

 

 

 

1,841

 

Conservice Midco LLC (4)(5)

Senior Secured First Lien Revolver

 

02/2033

 

-

 

 

 

(20

)

 

 

(0.0

)

 

 

(11

)

Conservice Midco LLC

Senior Secured First Lien Term Loan

S + 450, 75 Floor

8.23%

02/2033

 

30,872

 

 

 

30,731

 

 

 

5.6

 

 

 

30,795

 

Hexion Holdings Corporation (7)

Senior Secured First Lien Term Loan

S + 400, 50 Floor

7.65%

03/2029

 

732

 

 

 

729

 

 

 

0.1

 

 

 

710

 

Lummus Technology Holdings V LLC (7)

Senior Secured First Lien Term Loan

S + 250

6.14%

12/2029

 

584

 

 

 

584

 

 

 

0.1

 

 

 

578

 

Mauser Packaging Solutions Holding Co (BWAY) (7)

Senior Secured First Lien Term Loan

S + 350

7.12%

04/2030

 

1,350

 

 

 

1,338

 

 

 

0.2

 

 

 

1,333

 

MI Windows & Doors (Miter) (7)

Senior Secured First Lien Term Loan

S + 275

6.39%

03/2031

 

1,601

 

 

 

1,601

 

 

 

0.3

 

 

 

1,583

 

Olympus Water US Holding Corp (7)

Senior Secured First Lien Term Loan

S + 325

7.00%

07/2032

 

1,070

 

 

 

1,070

 

 

 

0.2

 

 

 

1,070

 

Online Labels Group, LLC (4)(5)

Senior Secured First Lien Revolver

 

12/2029

 

-

 

 

 

(1

)

 

 

-

 

 

 

-

 

Online Labels Group, LLC (5)

Senior Secured First Lien Delayed Draw Term Loan

S + 475, 100 Floor

8.48%

12/2029

 

86

 

 

 

86

 

 

 

0.0

 

 

 

86

 

Online Labels Group, LLC (4)(5)

Senior Secured First Lien Delayed Draw Term Loan

 

12/2029

 

-

 

 

 

(1

)

 

 

-

 

 

 

-

 

Online Labels Group, LLC

Senior Secured First Lien Term Loan

S + 475, 100 Floor

8.48%

12/2029

 

1,414

 

 

 

1,405

 

 

 

0.3

 

 

 

1,414

 

Pegasus Steel

Senior Secured First Lien Term Loan

S + 475, 75 Floor

8.48%

01/2031

 

1,537

 

 

 

1,523

 

 

 

0.3

 

 

 

1,535

 

Pegasus Steel

Senior Secured First Lien Term Loan

S + 475, 75 Floor

8.48%

01/2031

 

884

 

 

 

884

 

 

 

0.2

 

 

 

882

 

Pegasus Steel (4)(5)

Senior Secured First Lien Delayed Draw Term Loan

 

01/2031

 

-

 

 

 

(2

)

 

 

-

 

 

 

-

 

Pegasus Steel (5)

Senior Secured First Lien Delayed Draw Term Loan

P + 375, 75 Floor

10.50%

01/2031

 

58

 

 

 

58

 

 

 

0.0

 

 

 

58

 

Pegasus Steel (5)

Senior Secured First Lien Delayed Draw Term Loan

P + 375, 75 Floor

10.50%

01/2031

 

46

 

 

 

46

 

 

 

0.0

 

 

 

46

 

Plastipak Packaging Inc (7)

Senior Secured First Lien Term Loan

S + 250

6.14%

09/2032

 

1,330

 

 

 

1,330

 

 

 

0.2

 

 

 

1,331

 

Quikrete Holdings, Inc (7)

Senior Secured First Lien Term Loan

S + 225

5.89%

03/2029

 

1,152

 

 

 

1,155

 

 

 

0.2

 

 

 

1,153

 

 

 

See accompanying notes

 

 

 

 

 

 

 

 

 

 

 

19


 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
June 30, 2026
(in thousands, except share and per share data) (Unaudited)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

 

Cost

 

 

Percentage
of Net
Assets ***

 

 

Fair
Value

 

Univar / Windsor Holdings III, LLC (7)

Senior Secured First Lien Term Loan

S + 275

6.39%

08/2030

 

1,245

 

 

$

1,250

 

 

 

0.2

 

%

$

1,246

 

USALCO (7)

Senior Secured First Lien Term Loan

S + 350, 50 Floor

7.14%

09/2031

 

1,327

 

 

 

1,327

 

 

 

0.2

 

 

 

1,326

 

Wilsonart International Holdings LLC (7)

Senior Secured First Lien Term Loan

S + 425

7.98%

08/2031

 

1,457

 

 

 

1,425

 

 

 

0.2

 

 

 

1,323

 

 

 

 

 

 

48,658

 

 

 

48,426

 

 

 

8.6

 

 

 

48,299

 

Media and Entertainment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Arches Buyer Inc. (7)

Senior Secured First Lien Term Loan

S + 325

6.89%

12/2027

 

1,097

 

 

 

1,090

 

 

 

0.2

 

 

 

1,096

 

Banijay Group US Holding, Inc. (6)(11)

Senior Secured First Lien Term Loan

S + 225

5.93%

06/2033

 

157

 

 

 

157

 

 

 

0.0

 

 

 

157

 

Cengage Learning , Inc. (7)

Senior Secured First Lien Term Loan

S + 300, 100 Floor

6.64%

03/2031

 

1,176

 

 

 

1,172

 

 

 

0.2

 

 

 

1,166

 

Neptune Bidco US Inc. (7)

Senior Secured First Lien Term Loan

S + 500, 50 Floor

8.67%

01/2033

 

604

 

 

 

601

 

 

 

0.1

 

 

 

600

 

Oak-Eagle AcquireCo Inc (6)(7)(11)

Senior Secured First Lien Term Loan

S + 350

7.13%

03/2033

 

1,332

 

 

 

1,323

 

 

 

0.2

 

 

 

1,338

 

Univision Communications Inc. (7)

Senior Secured First Lien Term Loan

S + 425, 50 Floor

7.98%

06/2029

 

882

 

 

 

884

 

 

 

0.2

 

 

 

883

 

Versant Media Group Inc (7)

Senior Secured First Lien Term Loan

S + 350

7.23%

10/2030

 

1,330

 

 

 

1,324

 

 

 

0.2

 

 

 

1,336

 

Virgin Media Bristol LLC (6)(7)

Senior Secured First Lien Term Loan

S + 318

6.87%

03/2031

 

1,900

 

 

 

1,884

 

 

 

0.3

 

 

 

1,691

 

 

 

 

 

 

8,478

 

 

 

8,435

 

 

 

1.4

 

 

 

8,267

 

Pharmaceuticals, Biotechnology and Life Sciences

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Endo Finance Holdings, Inc. (6)(7)

Senior Secured First Lien Term Loan

S + 375, 50 Floor

7.39%

04/2031

 

1,519

 

 

 

1,507

 

 

 

0.3

 

 

 

1,522

 

Nephron Pharmaceuticals LLC (12)

Unitranche First Lien - Last Out Term Loan

S + 920

12.86%

12/2027

 

2,351

 

 

 

2,330

 

 

 

0.4

 

 

 

2,222

 

Parexel International Corp (7)

Senior Secured First Lien Term Loan

S + 250, 50 Floor

6.14%

12/2031

 

883

 

 

 

881

 

 

 

0.2

 

 

 

884

 

RN Enterprises, LLC (5)

Unitranche First Lien Delayed Draw Term Loan

S + 500, 75 Floor

8.41%

10/2031

 

504

 

 

 

496

 

 

 

0.1

 

 

 

502

 

RN Enterprises, LLC (5)

Unitranche First Lien Revolver

S + 500, 75 Floor

8.99%

10/2031

 

396

 

 

 

386

 

 

 

0.1

 

 

 

395

 

RN Enterprises, LLC

Unitranche First Lien Term Loan

S + 525, 75 Floor

9.08%

10/2031

 

5,405

 

 

 

5,350

 

 

 

1.0

 

 

 

5,399

 

RN Enterprises, LLC

Unitranche First Lien Term Loan

S + 525, 75 Floor

9.08%

10/2031

 

690

 

 

 

684

 

 

 

0.1

 

 

 

689

 

WCT Group Holdings, LLC

Unitranche First Lien Delayed Draw Term Loan

S + 500, 75 Floor

8.73%

12/2029

 

2,610

 

 

 

2,591

 

 

 

0.5

 

 

 

2,603

 

WCT Group Holdings, LLC (4)(5)

Unitranche First Lien Revolver

 

12/2029

 

-

 

 

 

(2

)

 

 

(0.0

)

 

 

(1

)

WCT Group Holdings, LLC (4)(5)

Unitranche First Lien Revolver

 

12/2029

 

-

 

 

 

(7

)

 

 

(0.0

)

 

 

(1

)

WCT Group Holdings, LLC

Unitranche First Lien Term Loan

S + 500, 75 Floor

8.73%

12/2029

 

3,291

 

 

 

3,238

 

 

 

0.6

 

 

 

3,283

 

WCT Group Holdings, LLC

Unitranche First Lien Delayed Draw Term Loan

S + 500, 100 Floor

9.00%

12/2029

 

1,933

 

 

 

1,925

 

 

 

0.3

 

 

 

1,928

 

WCT Group Holdings, LLC (4)(5)

Unitranche First Lien Revolver

 

12/2029

 

-

 

 

 

(2

)

 

 

(0.0

)

 

 

(1

)

 

 

 

 

 

19,582

 

 

 

19,377

 

 

 

3.6

 

 

 

19,424

 

See accompanying notes

 

 

 

 

 

 

 

 

 

 

 

20


 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
June 30, 2026
(in thousands, except share and per share data) (Unaudited)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

 

Cost

 

 

Percentage
of Net
Assets ***

 

 

Fair
Value

 

Software and Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asurion, LLC (7)

Senior Secured First Lien Term Loan

S + 425

7.91%

09/2030

 

992

 

 

$

992

 

 

 

0.2

 

%

$

984

 

Asurion, LLC (7)

Senior Secured First Lien Term Loan

S + 375

7.41%

02/2033

 

1,802

 

 

 

1,786

 

 

 

0.3

 

 

 

1,709

 

Bonterra LLC

Unitranche First Lien Delayed Draw Term Loan

S + 475, 75 Floor

8.48%

03/2032

 

1,343

 

 

 

1,338

 

 

 

0.2

 

 

 

1,317

 

Bonterra LLC (5)

Unitranche First Lien Revolver

S + 475, 75 Floor

8.49%

03/2032

 

269

 

 

 

264

 

 

 

0.0

 

 

 

243

 

Bonterra LLC

Unitranche First Lien Term Loan

S + 475, 75 Floor

8.48%

03/2032

 

12,333

 

 

 

12,284

 

 

 

2.2

 

 

 

12,093

 

Bonterra LLC (5)

Unitranche First Lien Delayed Draw Term Loan

S + 475, 75 Floor

8.48%

03/2032

 

2,709

 

 

 

2,672

 

 

 

0.5

 

 

 

2,605

 

C-4 Analytics

Senior Secured First Lien Term Loan

S + 500, 100 Floor

8.67%

05/2030

 

7,252

 

 

 

7,203

 

 

 

1.3

 

 

 

7,252

 

C-4 Analytics (5)

Senior Secured First Lien Revolver

S + 500, 100 Floor

8.67%

05/2030

 

225

 

 

 

220

 

 

 

0.0

 

 

 

225

 

CallRevu, LLC (4)(5)

Unitranche First Lien Revolver

 

10/2032

 

-

 

 

 

-

 

 

 

(0.0

)

 

 

(1

)

CallRevu, LLC

Unitranche First Lien Term Loan

S + 475, 75 Floor

8.48%

10/2032

 

175

 

 

 

173

 

 

 

0.0

 

 

 

171

 

Concord III, LLC (5)

Unitranche First Lien Revolver

S + 625, 100 Floor

9.98%

12/2028

 

244

 

 

 

242

 

 

 

0.0

 

 

 

244

 

Concord III, LLC

Unitranche First Lien Term Loan

S + 600, 100 Floor

9.73%

12/2028

 

5,547

 

 

 

5,517

 

 

 

1.0

 

 

 

5,547

 

Concord III, LLC

Unitranche First Lien Term Loan

S + 626, 100 Floor

9.99%

12/2028

 

295

 

 

 

292

 

 

 

0.1

 

 

 

295

 

Concord III, LLC

Unitranche First Lien Term Loan

S + 626, 100 Floor

9.99%

12/2028

 

1,687

 

 

 

1,687

 

 

 

0.3

 

 

 

1,687

 

DS Admiral (7)

Senior Secured First Lien Term Loan

S + 425

7.98%

06/2031

 

1,037

 

 

 

1,031

 

 

 

0.2

 

 

 

992

 

Evergreen IX Borrower 2023, LLC (4)(5)

Unitranche First Lien Revolver

 

09/2029

 

-

 

 

 

(7

)

 

 

-

 

 

 

-

 

Evergreen IX Borrower 2023, LLC

Unitranche First Lien Term Loan

S + 475, 75 Floor

8.48%

09/2030

 

4,388

 

 

 

4,311

 

 

 

0.8

 

 

 

4,388

 

Evergreen IX Borrower 2023, LLC

Unitranche First Lien Term Loan

S + 475, 75 Floor

8.48%

09/2030

 

4,913

 

 

 

4,877

 

 

 

0.9

 

 

 

4,913

 

Granicus, Inc.

Unitranche First Lien Delayed Draw Term Loan

S + 575 (225 PIK), 100 Floor

9.41%

01/2031

 

1,033

 

 

 

1,029

 

 

 

0.2

 

 

 

1,033

 

Granicus, Inc. (5)

Unitranche First Lien Revolver

P + 650 (225 PIK), 100 Floor

13.25%

01/2031

 

44

 

 

 

40

 

 

 

0.0

 

 

 

39

 

Granicus, Inc.

Unitranche First Lien Term Loan

S + 575 (225 PIK), 100 Floor

9.41%

01/2031

 

3,993

 

 

 

3,968

 

 

 

0.7

 

 

 

3,993

 

Granicus, Inc. (5)

Unitranche First Lien Delayed Draw Term Loan

 

01/2031

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Lightspeed Buyer, Inc. (5)

Unitranche First Lien Revolver

S + 475, 75 Floor

8.40%

02/2032

 

798

 

 

 

774

 

 

 

0.1

 

 

 

774

 

Lightspeed Buyer, Inc. (4)(5)

Unitranche First Lien Delayed Draw Term Loan

 

02/2032

 

-

 

 

 

(22

)

 

 

(0.0

)

 

 

(70

)

Lightspeed Buyer, Inc.

Unitranche First Lien Term Loan

S + 475, 75 Floor

8.48%

02/2032

 

16,698

 

 

 

16,635

 

 

 

3.0

 

 

 

16,542

 

Marlabs (4)(5)

Senior Secured First Lien Delayed Draw Term Loan

 

08/2030

 

-

 

 

 

(4

)

 

 

(0.0

)

 

 

(39

)

Marlabs (5)

Senior Secured First Lien Revolver

S + 500, 100 Floor

9.00%

08/2030

 

207

 

 

 

204

 

 

 

0.0

 

 

 

197

 

Marlabs

Senior Secured First Lien Term Loan

S + 500, 100 Floor

9.00%

08/2030

 

3,275

 

 

 

3,247

 

 

 

0.6

 

 

 

3,181

 

Medicus IT (4)(5)

Unitranche First Lien Delayed Draw Term Loan

 

07/2031

 

-

 

 

 

(11

)

 

 

-

 

 

 

-

 

Medicus IT (5)

Unitranche First Lien Revolver

P + 475, 75 Floor

11.50%

07/2031

 

138

 

 

 

129

 

 

 

0.0

 

 

 

138

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes

 

 

21


 

 

 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
June 30, 2026
(in thousands, except share and per share data) (Unaudited)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

 

Cost

 

 

Percentage
of Net
Assets ***

 

 

Fair
Value

 

Medicus IT

Unitranche First Lien Term Loan

S + 450, 75 Floor

8.23%

07/2031

 

6,070

 

 

$

6,023

 

 

 

1.1

 

%

$

6,070

 

Medicus IT (4)(5)

Unitranche First Lien Delayed Draw Term Loan

 

06/2032

 

-

 

 

 

(2

)

 

 

(0.1

)

 

 

-

 

Medicus IT (5)

Unitranche First Lien Revolver

P + 500, 75 Floor

11.75%

06/2032

 

110

 

 

 

105

 

 

 

0.0

 

 

 

110

 

Medicus IT

Unitranche First Lien Term Loan

S + 450, 75 Floor

8.23%

06/2032

 

11,387

 

 

 

11,311

 

 

 

2.1

 

 

 

11,387

 

Rightworks LLC (5)

Unitranche First Lien Revolver

S + 475, 100 Floor

8.39%

05/2029

 

300

 

 

 

300

 

 

 

0.0

 

 

 

300

 

Rightworks LLC

Unitranche First Lien Term Loan

S + 475, 100 Floor

8.39%

05/2029

 

11,384

 

 

 

11,384

 

 

 

2.1

 

 

 

11,384

 

Security Risk Advisors Intl, LLC (4)(5)

Unitranche First Lien Delayed Draw Term Loan

 

09/2031

 

-

 

 

 

(1

)

 

 

-

 

 

 

-

 

Security Risk Advisors Intl, LLC (5)

Unitranche First Lien Revolver

S + 450, 75 Floor

8.23%

09/2031

 

67

 

 

 

63

 

 

 

0.0

 

 

 

67

 

Security Risk Advisors Intl, LLC

Unitranche First Lien Term Loan

S + 450, 75 Floor

8.23%

09/2031

 

3,840

 

 

 

3,817

 

 

 

0.7

 

 

 

3,840

 

SMX Group, LLC (7)

Senior Secured First Lien Term Loan

S + 450

8.14%

02/2032

 

5,366

 

 

 

5,321

 

 

 

0.9

 

 

 

5,181

 

Trintech, Inc. (4)(5)

Senior Secured First Lien Revolver

 

01/2033

 

-

 

 

 

(9

)

 

 

(0.0

)

 

 

(12

)

Trintech, Inc. (4)(5)

Senior Secured First Lien Delayed Draw Term Loan

 

01/2033

 

-

 

 

 

(6

)

 

 

(0.0

)

 

 

(16

)

Trintech, Inc.

Senior Secured First Lien Revolver

S + 475, 75 Floor

8.39%

01/2033

 

7,742

 

 

 

7,670

 

 

 

1.4

 

 

 

7,644

 

 

 

 

 

 

 

117,663

 

 

 

116,847

 

 

 

21.0

 

 

 

116,407

 

Telecommunication Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CCI Buyer, Inc (4)(5)

Unitranche First Lien Revolver

 

05/2032

 

-

 

 

 

(14

)

 

 

0.0

 

 

 

6

 

CCI Buyer, Inc

Unitranche First Lien Term Loan

S + 500, 75 Floor

8.70%

05/2032

 

28,088

 

 

 

27,837

 

 

 

5.1

 

 

 

28,182

 

UPC (Sunrise Financing Partnership) (7)

Senior Secured First Lien Term Loan

S + 247

6.10%

03/2032

 

1,775

 

 

 

1,782

 

 

 

0.3

 

 

 

1,755

 

Windstream Services LLC (6)

Senior Secured First Lien Term Loan

S + 400

7.64%

09/2032

 

1,323

 

 

 

1,323

 

 

 

0.2

 

 

 

1,333

 

 

 

 

 

 

31,186

 

 

 

30,928

 

 

 

5.6

 

 

 

31,276

 

Transportation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Air Transport Services Group (Stonepeak Nile) (7)

Senior Secured First Lien Term Loan

S + 225

5.91%

04/2032

 

1,416

 

 

 

1,418

 

 

 

0.3

 

 

 

1,414

 

AIT Worldwide Logistics (7)

Senior Secured First Lien Term Loan

S + 425

7.91%

04/2033

 

1,155

 

 

 

1,144

 

 

 

0.2

 

 

 

1,157

 

American Airlines Inc (6)(7)

Senior Secured First Lien Term Loan

S + 225

5.91%

06/2029

 

1,542

 

 

 

1,542

 

 

 

0.3

 

 

 

1,518

 

American Airlines Inc (6)(7)

Senior Secured First Lien Term Loan

S + 300

6.67%

05/2033

 

317

 

 

 

314

 

 

 

0.1

 

 

 

314

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes

 

 

22


 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
June 30, 2026
(in thousands, except share and per share data) (Unaudited)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

 

Cost

 

 

Percentage
of Net
Assets ***

 

 

Fair
Value

 

American Axle & Manufacturing Inc (6)(7)

Senior Secured First Lien Term Loan

S + 325

6.92%

09/2032

 

1,416

 

 

$

1,416

 

 

 

0.3

 

%

$

1,419

 

Avis Budget Car Rental LLC (6)(7)

Senior Secured First Lien Term Loan

S + 250

6.14%

07/2032

 

1,607

 

 

 

1,610

 

 

 

0.3

 

 

 

1,604

 

 

 

 

 

 

 

7,453

 

 

 

7,444

 

 

 

1.5

 

 

 

7,426

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Debt Investments
United States

 

 

 

 

$

778,318

 

 

$

771,304

 

 

 

138.9

 

%

$

767,345

 

Equity Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial and Professional Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Iris Buyer, LLC

Common Stock

 

 

 

192

 

 

 

193

 

 

 

0.1

 

 

 

258

 

Iris Buyer, LLC

Common Stock

 

 

 

192,308

 

 

 

-

 

 

 

0.0

 

 

 

111

 

 

 

 

 

 

 

 

 

193

 

 

 

0.1

 

 

 

369

 

Consumer Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Landscape Workshop LLC

Common Stock

 

 

 

810,811

 

 

 

811

 

 

 

0.2

 

 

 

840

 

Landscape Workshop LLC

Common Stock

 

 

 

 

1,210,165

 

 

 

1,622

 

 

 

0.2

 

 

 

1,254

 

 

 

 

 

 

 

 

 

2,433

 

 

 

0.4

 

 

 

2,094

 

Diversified Financials

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Constellation Wealth Capital Fund II (5)(6)(9)(10)

Partnership Interest

 

 

 

 

2,311,716

 

 

 

2,312

 

 

 

0.4

 

 

 

2,147

 

WhiteHawk Evergreen Fund, LP (6)(9)(10)

Partnership Interest

 

 

 

10,000,000

 

 

 

10,000

 

 

 

1.9

 

 

 

10,518

 

 

 

 

 

 

 

 

 

12,312

 

 

 

2.3

 

 

 

12,665

 

Financial Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Schellman Holdings, LLC

Common Stock

 

 

 

 

2,286

 

 

 

2,286

 

 

 

0.4

 

 

 

2,286

 

 

 

 

 

 

 

 

 

2,286

 

 

 

0.4

 

 

 

2,286

 

Health Care Equipment and Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Arrow Management Acquisition, LLC

Common Stock

 

 

 

 

15,998

 

 

 

16

 

 

 

-

 

 

 

-

 

Arrow Management Acquisition, LLC

Common Stock

 

 

 

 

1,584

 

 

 

1,584

 

 

 

0.3

 

 

 

1,603

 

Buyer Cascade Acquiror, Inc.

Common Stock

 

 

 

 

2,439

 

 

 

2,439

 

 

 

0.4

 

 

 

2,439

 

BVI Medical Inc.

Common Stock

 

 

 

 

681

 

 

 

909

 

 

 

0.1

 

 

 

323

 

Headlands Buyer, Inc.

Common Stock

 

 

 

 

82,454

 

 

 

825

 

 

 

0.2

 

 

 

1,003

 

IVX Health Holdings, Inc.

Common Stock

 

 

 

880

 

 

 

880

 

 

 

0.4

 

 

 

2,122

 

Outcomes Group Holding Inc

Common Stock

 

 

 

 

2,247

 

 

 

2,251

 

 

 

0.4

 

 

 

2,247

 

Vital Care Buyer, LLC

Common Stock

 

 

 

64

 

 

 

64

 

 

 

0.0

 

 

 

64

 

Vital Care Buyer, LLC

Common Stock

 

 

 

649

 

 

 

1

 

 

 

0.0

 

 

 

29

 

 

 

 

 

 

 

 

 

8,969

 

 

 

1.8

 

 

 

9,830

 

Pharmaceuticals, Biotechnology and Life Sciences

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nephron Pharmaceuticals LLC

Common Stock Warrant

 

 

 

4

 

 

 

-

 

 

 

-

 

 

 

-

 

RN Enterprises, LLC

Common Stock

 

 

 

633

 

 

 

633

 

 

 

0.1

 

 

 

629

 

WCT Group Holdings, LLC

Common Stock

 

 

 

118

 

 

 

1,176

 

 

 

0.4

 

 

 

2,406

 

 

 

 

 

 

 

 

 

1,809

 

 

 

0.5

 

 

 

3,035

 

Total Equity Investments
United States

 

 

 

 

 

 

 

$

28,002

 

 

 

5.5

 

%

$

30,279

 

Total United States

 

 

 

 

 

 

 

$

799,306

 

 

 

144.4

 

%

$

797,624

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Switzerland

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pharmaceuticals, Biotechnology and Life Sciences

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Solvias AG LP (4)(5)(6)

Senior Secured First Lien Revolver

 

02/2032

 

CHF -

 

 

 

(25

)

 

 

-

 

 

 

-

 

Solvias AG LP (6)

Senior Secured First Lien Term Loan

SR + 550, 75 Floor

6.25%

02/2032

 

CHF 9,134

 

 

 

9,951

 

 

 

2.1

 

 

 

11,419

 

 

 

 

 

 

 

 

 

 

9,926

 

 

 

2.1

 

 

 

11,419

 

Total Debt Investments
Switzerland

 

 

 

 

 

 

 

$

9,926

 

 

 

2.1

 

%

$

11,419

 

Equity Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pharmaceuticals, Biotechnology and Life Sciences

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sequence Parent (6)

Common Stock

 

 

 

3,290

 

 

 

197

 

 

 

0.0

 

 

 

189

 

Sequence Parent (6)

Common Stock

 

 

 

48

 

 

 

48

 

 

 

0.0

 

 

 

56

 

 

 

 

 

 

 

 

 

245

 

 

 

0.0

 

%

 

245

 

Total Equity Investments
Switzerland

 

 

 

 

 

 

 

$

245

 

 

 

0.0

 

%

$

245

 

Total Switzerland

 

 

 

 

 

 

 

$

10,171

 

 

 

2.1

 

%

$

11,664

 

See accompanying notes

 

 

23


 

 

 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
June 30, 2026
(in thousands, except share and per share data) (Unaudited)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

 

Cost

 

 

Percentage
of Net
Assets ***

 

 

Fair
Value

 

Netherlands

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial and Professional Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Avidity Acquisition B.V. (5)(6)(12)

Unitranche First Lien - Last Out Delayed Draw Term Loan

E + 500

7.60%

03/2032

5

 

 

$

6

 

 

 

0.0

 

%

$

6

 

Avidity Acquisition B.V. (6)(12)

Unitranche First Lien - Last Out Term Loan

E + 712

9.72%

03/2032

123

 

 

 

128

 

 

 

0.0

 

 

 

141

 

Pitch MidCo B.V. (5)(6)

Unitranche First Lien Delayed Draw Term Loan

E + 625

8.48%

04/2031

432

 

 

 

479

 

 

 

0.1

 

 

 

494

 

Pitch MidCo B.V. (6)

Unitranche First Lien Term Loan

E + 625

8.54%

04/2031

2,864

 

 

 

2,999

 

 

 

0.6

 

 

 

3,273

 

Pitch MidCo B.V. (6)

Unitranche First Lien Term Loan

E + 625

8.35%

04/2031

1,607

 

 

 

1,807

 

 

 

0.3

 

 

 

1,836

 

Van Der Steen (6)

Unitranche First Lien Term Loan

E + 575

8.04%

05/2031

3,289

 

 

 

3,468

 

 

 

0.7

 

 

 

3,758

 

Van Der Steen (6)

Unitranche First Lien Delayed Draw Term Loan

E + 575

7.90%

05/2031

1,098

 

 

 

1,247

 

 

 

0.2

 

 

 

1,254

 

Van Der Steen (5)(6)

Unitranche First Lien Delayed Draw Term Loan

E + 550

7.75%

05/2031

2,241

 

 

 

2,611

 

 

 

0.5

 

 

 

2,560

 

 

 

 

 

 

 

 

 

12,745

 

 

 

2.4

 

 

 

13,322

 

Materials

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CLI Bidco B.V. (5)(6)

Unitranche First Lien Delayed Draw Term Loan

E + 475

7.13%

02/2033

53

 

 

 

60

 

 

 

0.0

 

 

 

61

 

CLI Bidco B.V. (6)

Unitranche First Lien Term Loan

E + 475

7.04%

02/2033

263

 

 

 

307

 

 

 

0.1

 

 

 

301

 

 

 

 

 

 

 

 

 

367

 

 

 

0.1

 

 

 

362

 

Total Debt Investments
Netherlands

 

 

 

 

 

 

 

$

13,112

 

 

 

2.5

 

%

$

13,684

 

Total Netherlands

 

 

 

 

 

 

 

$

13,112

 

 

 

2.5

 

%

$

13,684

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

United Kingdom

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial and Professional Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hamsard 3778 Limited (4)(5)(6)

Unitranche First Lien Delayed Draw Term Loan

 

10/2031

£

-

 

 

 

(6

)

 

 

-

 

 

 

-

 

Hamsard 3778 Limited (6)

Unitranche First Lien Term Loan

SN + 525

8.98%

10/2031

£

2,853

 

 

 

3,632

 

 

 

0.6

 

 

 

3,784

 

 

 

 

 

 

 

 

 

3,626

 

 

 

0.6

 

 

 

3,784

 

Diversified Financials

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Primrose Bidco Limited (6)

Unitranche First Lien Term Loan

SN + 550

9.23%

11/2031

£

1,971

 

 

 

2,433

 

 

 

0.5

 

 

 

2,615

 

 

 

 

 

 

 

 

 

2,433

 

 

 

0.5

 

 

 

2,615

 

Food, Beverage and Tobacco

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Froneri US Inc (6)(7)

Senior Secured First Lien Term Loan

S + 225

5.88%

08/2032

 

1,607

 

 

 

1,608

 

 

 

0.3

 

 

 

1,597

 

 

 

 

 

 

 

 

 

1,608

 

 

 

0.3

 

 

 

1,597

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Debt Investments
United Kingdom

 

 

 

 

 

 

 

$

7,667

 

 

 

1.4

 

%

$

7,996

 

Total United Kingdom

 

 

 

 

 

 

 

$

7,667

 

 

 

1.4

 

%

$

7,996

 

See accompanying notes

 

 

24


 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
June 30, 2026
(in thousands, except share and per share data) (Unaudited)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

Cost

 

Percentage
of Net
Assets ***

 

Fair
Value

 

Australia

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial and Professional Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ancora Bidco PTY LTD (6)

Unitranche First Lien Term Loan

B + 500, 50 Floor

9.35%

11/2030

 

AUD 5,191

 

 

$

3,371

 

 

 

0.6

 

%

$

3,601

 

Ancora Bidco PTY LTD (5)(6)

Unitranche First Lien Delayed Draw Term Loan

S + 500, 50 Floor

8.64%

11/2030

 

AUD 918

 

 

 

617

 

 

 

0.1

 

 

 

634

 

 

 

 

 

 

 

 

 

3,988

 

 

 

0.7

 

 

 

4,235

 

Total Debt Investments
Australia

 

 

 

 

 

 

 

$

3,988

 

 

 

0.7

 

%

$

4,235

 

Equity Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial and Professional Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ancora Bidco PTY LTD (6)

Common Stock

 

 

 

64,327,036

 

 

 

663

 

 

 

0.2

 

 

 

914

 

Ancora Bidco PTY LTD (6)

Common Stock

 

 

 

3,385,633

 

 

 

35

 

 

 

0.0

 

 

 

48

 

 

 

 

 

 

 

 

 

698

 

 

 

0.2

 

 

 

962

 

Total Equity Investments
Australia

 

 

 

 

 

 

 

$

698

 

 

 

0.2

 

%

$

962

 

Total Australia

 

 

 

 

 

 

 

$

4,686

 

 

 

0.9

 

%

$

5,197

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Canada

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial and Professional Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Garda World Security Corporation (6)(7)

Senior Secured First Lien Term Loan

S + 275

6.42%

02/2029

 

1,334

 

 

 

1,338

 

 

 

0.2

 

 

 

1,334

 

 

 

 

 

 

 

 

 

1,338

 

 

 

0.2

 

 

 

1,334

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diversified Financials

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dawson Logan 2025-L5 LP (5)(6)(8)

Unsecured Debt

12.65%

12.65%

10/2040

 

1,517

 

 

 

1,517

 

 

 

0.3

 

 

 

1,482

 

 

 

 

 

 

 

 

 

1,517

 

 

 

0.3

 

 

 

1,482

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Health Care Equipment and Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Klick Inc. (6)

Unitranche First Lien Delayed Draw Term Loan

S + 500, 75 Floor

8.64%

11/2032

 

3,516

 

 

 

3,509

 

 

 

0.6

 

 

 

3,499

 

Klick Inc. (4)(5)(6)

Unitranche First Lien Revolver

 

11/2032

 

-

 

 

 

(16

)

 

 

(0.0

)

 

 

(18

)

Klick Inc. (6)

Unitranche First Lien Term Loan

S + 500, 75 Floor

8.66%

11/2032

 

32,885

 

 

 

32,737

 

 

 

5.9

 

 

 

32,720

 

 

 

 

 

 

 

 

 

36,230

 

 

 

6.5

 

 

 

36,201

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pharmaceuticals, Biotechnology and Life Sciences

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Aryeh Bidco Investment Ltd. (6)

Unitranche First Lien Term Loan

C + 500, 75 Floor

7.29%

01/2033

 

CAD 35,000

 

 

 

24,976

 

 

 

4.5

 

 

 

24,811

 

Aryeh Bidco Investment Ltd. (5)(6)

Unitranche First Lien Delayed Draw Term Loan

C + 500, 75 Floor

7.29%

01/2033

 

CAD 931

 

 

 

658

 

 

 

0.1

 

 

 

680

 

Aryeh Bidco Investment Ltd. (5)(6)

Unitranche First Lien Revolver

C + 500, 75 Floor

7.29%

01/2033

 

CAD 559

 

 

 

374

 

 

 

0.1

 

 

 

394

 

 

 

 

 

 

 

 

 

26,008

 

 

 

4.7

 

 

 

25,885

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transportation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Westjet Loyalty LP (6)(7)

Senior Secured First Lien Term Loan

S + 275

6.48%

02/2031

 

948

 

 

 

949

 

 

 

0.2

 

 

 

921

 

 

 

 

 

 

 

 

 

949

 

 

 

0.2

 

 

 

921

 

Total Debt Investments
Canada

 

 

 

 

 

 

 

$

66,042

 

 

 

11.9

 

%

$

65,823

 

Equity Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pharmaceuticals, Biotechnology and Life Sciences

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Aryeh Bidco Investment Ltd. (6)

Common Stock

 

 

 

 

205,771

 

 

 

1,633

 

 

 

0.3

 

 

 

1,802

 

 

 

 

 

 

 

 

 

1,633

 

 

 

0.3

 

 

 

1,802

 

Total Equity Investments
Canada

 

 

 

 

 

 

 

$

1,633

 

 

 

0.3

 

%

$

1,802

 

Total Canada

 

 

 

 

 

 

 

$

67,675

 

 

 

12.2

 

%

$

67,625

 

See accompanying notes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

25


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
June 30, 2026
(in thousands, except share and per share data) (Unaudited)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

Cost

 

Percentage
of Net
Assets ***

 

Fair
Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

France

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diversified Financials

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

HSBC Continental Europe (6)

Unsecured Debt

E + 725

9.45%

02/2033

10,000

 

 

$

11,803

 

 

 

2.1

 

%

$

11,426

 

 

 

 

 

 

 

 

 

11,803

 

 

 

2.1

 

 

 

11,426

 

Pharmaceuticals, Biotechnology and Life Sciences

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Olyos Group (4)(5)(6)

Unitranche First Lien Delayed Draw Term Loan

 

06/2028

-

 

 

 

(30

)

 

 

-

 

 

 

-

 

Olyos Group (5)(6)

Unitranche First Lien Delayed Draw Term Loan

E + 600

8.13%

06/2028

3,624

 

 

 

4,101

 

 

 

0.7

 

 

 

4,141

 

Olyos Group (6)

Unitranche First Lien Term Loan

E + 600

8.13%

06/2032

2,209

 

 

 

2,521

 

 

 

0.5

 

 

 

2,524

 

 

 

 

 

 

 

 

 

6,592

 

 

 

1.2

 

 

 

6,665

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Debt Investments
France

 

 

 

 

 

 

 

$

18,395

 

 

 

3.3

 

%

$

18,091

 

Total France

 

 

 

 

 

 

 

$

18,395

 

 

 

3.3

 

%

$

18,091

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Spain

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diversified Financials

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Banco Santander, S.A. (6)

Unsecured Debt

E + 725

9.45%

09/2055

8,500

 

 

 

9,867

 

 

 

1.8

 

 

 

9,713

 

 

 

 

 

 

 

 

 

9,867

 

 

 

1.8

 

 

 

9,713

 

Total Debt Investments
Spain

 

 

 

 

 

 

 

$

9,867

 

 

 

1.8

 

%

$

9,713

 

Total Spain

 

 

 

 

 

 

 

$

9,867

 

 

 

1.8

 

%

$

9,713

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Israel

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital Goods

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Playtika (6)(7)

Senior Secured First Lien Term Loan

S + 275

6.39%

03/2028

 

828

 

 

 

810

 

 

 

0.1

 

 

 

805

 

 

 

 

 

 

 

 

 

810

 

 

 

0.1

 

 

 

805

 

Total Debt Investments
Israel

 

 

 

 

 

 

 

$

810

 

 

 

0.1

 

%

$

805

 

Total Israel

 

 

 

 

 

 

 

$

810

 

 

 

0.1

 

%

$

805

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gibraltar

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consumer Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Entain/GVC Holdings (6)(7)

Senior Secured First Lien Term Loan

S + 225

5.98%

07/2032

 

798

 

 

 

795

 

 

 

0.1

 

 

 

798

 

 

 

 

 

 

 

 

 

795

 

 

 

0.1

 

 

 

798

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Debt Investments
Gibraltar

 

 

 

 

 

 

 

$

795

 

 

 

0.1

 

%

$

798

 

Total Gibraltar

 

 

 

 

 

 

 

$

795

 

 

 

0.1

 

%

$

798

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes

 

26


 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
June 30, 2026
(in thousands, except share and per share data) (Unaudited)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

Cost

 

Percentage
of Net
Assets ***

 

Fair
Value

 

Germany

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Materials

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pipe Bidco GmbH (5)(6)

Unitranche First Lien Delayed Draw Term Loan

E + 450

7.05%

01/2033

2,290

 

 

$

2,599

 

 

 

0.5

 

%

$

2,616

 

Pipe Bidco GmbH (6)

Unitranche First Lien Term Loan

E + 450

6.79%

01/2033

7,659

 

 

 

8,805

 

 

 

1.6

 

 

 

8,752

 

 

 

 

 

 

 

 

 

11,404

 

 

 

2.1

 

 

 

11,368

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Debt Investments
Germany

 

 

 

 

 

 

 

$

11,404

 

 

 

2.1

 

%

$

11,368

 

Total Germany

 

 

 

 

 

 

 

$

11,404

 

 

 

2.1

 

%

$

11,368

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Finland

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Software and Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Saarni (6)

Unitranche First Lien Delayed Draw Term Loan

E + 525

7.58%

03/2032

4

 

 

 

5

 

 

 

0.0

 

 

 

5

 

Saarni (6)

Unitranche First Lien Term Loan

E + 525

7.58%

03/2032

101

 

 

 

107

 

 

 

0.1

 

 

 

115

 

 

 

 

 

 

 

 

 

112

 

 

 

0.1

 

 

 

120

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Debt Investments
Finland

 

 

 

 

 

 

 

$

112

 

 

 

0.1

 

%

$

120

 

Total Finland

 

 

 

 

 

 

 

$

112

 

 

 

0.1

 

%

$

120

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Investments

 

 

 

 

 

 

 

$

944,000

 

 

 

171.1

 

%

$

944,685

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and Cash Equivalents

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dreyfus Government Cash Management Institutional Fund

Cash Equivalents

 

3.55%

 

 

 

 

 

1,205

 

 

 

0.2

 

 

 

1,205

 

Goldman Sachs FS Government Fund

Cash Equivalents

 

3.54%

 

 

 

 

 

14,329

 

 

 

2.6

 

 

 

14,329

 

Other cash

 

 

 

 

 

 

 

 

13,805

 

 

 

2.5

 

 

 

13,994

 

Total cash and cash equivalents, including restricted cash

 

 

 

 

 

 

 

$

29,339

 

 

 

5.3

 

%

$

29,528

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investments and Cash and Cash Equivalents Total

 

 

 

 

 

 

 

$

973,339

 

 

 

176.4

 

%

$

974,213

 

 

*The majority of the investments bear interest at a rate that may be determined by reference to Secured Overnight Financing Rate (“SOFR” or “S”), Prime (“P”), EURIBOR (“E”), SONIA (“SN”), BBSY (“B”), SARON (“SR”) or CORRA (“C”) and which reset monthly, quarterly, semiannually, or annually. For each, the Company has provided the spread over the reference rate and the current interest rate in effect at the reporting date. The impact of a credit spread adjustment, if applicable, is included within the stated all-in interest rate. As of June 30, 2026, the reference rates for the Company’s variable rate loans are represented in the below table. Certain investments are subject to an interest rate floor. For fixed rate loans, a spread above a reference rate is not applicable.

**The total par amount is presented for debt investments, while the number of shares or units owned is presented for equity investments. Par amount is denominated in U.S. Dollars ($) unless otherwise noted.

***Percentage is based on net assets of $552,216 as of June 30, 2026.

 

 

 

 

Reference Rate

 

Overnight

 

 

1 Month

 

 

3 Month

 

 

6 Month

 

 

12 Month

 

Prime (“P”)

 

6.75%

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

SOFR (“S”)

 

 

-

 

 

3.63%

 

 

3.63%

 

 

3.67%

 

 

3.68%

 

EURIBOR (“E”)

 

 

-

 

 

2.20%

 

 

2.32%

 

 

2.57%

 

 

2.72%

 

SONIA (“SN”)

 

3.73%

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

BBSY (“B”)

 

 

-

 

 

 

-

 

 

4.47%

 

 

 

-

 

 

 

-

 

SARON (“SR”)

 

 

-

 

 

-0.04%

 

 

 

-

 

 

 

-

 

 

 

-

 

CORRA (“C”)

 

2.34%

 

 

2.28%

 

 

2.29%

 

 

 

-

 

 

 

-

 

 

(1)
All positions held are non-controlled/non-affiliated investments, unless otherwise noted, as defined by the Investment Company Act. Non-controlled/non-affiliated investments are investments that are neither controlled nor affiliated.

 

 

See accompanying notes

27


 

(2)
All debt investments are income-producing, unless otherwise noted. Equity and member interests are non-income-producing unless otherwise noted. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act. Its investments are therefore generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act.
(3)
The fair value of the investment was determined using significant unobservable inputs unless otherwise noted, as defined by the Investment Company Act. See Note 2 “Summary of Significant Accounting Policies.”
(4)
The negative cost, if applicable, is the result of the capitalized discount or unfunded commitment being greater than the principal amount outstanding on the loan. The negative fair value, if applicable, is the result of the capitalized discount or unfunded commitment on the loan.
(5)
Position or portion thereof is an unfunded commitment and no interest is being earned on the unfunded portion. The investment may be subject to an unused/letter of credit facility fee. See Note 8 “Commitments and Contingencies.”
(6)
Investment is not a qualifying asset as defined under section 55(a) of the Investment Company Act of 1940. Qualifying assets must represent at least 70% of total assets at the time of acquisition. The Company’s percentage of non-qualifying assets based on fair value was 19.2% as of June 30, 2026.
(7)
This investment is valued using observable inputs and is considered a Level 2 investment per Financial Accounting Standards Board (“FASB” ) guidance under ASC 820. See Note 5 “Fair Value of Financial Instruments” for further information related to investments at fair value.
(8)
Fixed rate investment.
(9)
This investment was valued using net asset value as a practical expedient for fair value. Consistent with “FASB” guidance under ASC 820, these investments are excluded from the hierarchical level.
(10)
Capital contributed to this investment is subject to restrictions on withdrawal.
(11)
Position or portion thereof unsettled as of June 30, 2026.
(12)
These loans are unitranche first lien/last-out term loans. In addition to the interest earned based on the effective interest rate of this loan, which is the amount reflected in this schedule, the Company is entitled to receive additional interest as a result of an agreement among lenders whereby the loan has been allocated to “first-out” and “last-out” tranches, whereby the “first-out” tranche will have priority as to the “last-out” tranche with respect to payments of principal, interest and any amounts due thereunder. The Company holds the “last-out” tranche.
(13)
The investment is on non-accrual status as of June 30, 2026.

 

 

Foreign Currency Exchange Contracts

 

 

 

 

 

Counterparty

Currency Purchased

Currency Sold

Settlement

Unrealized
Appreciation
(Depreciation)

 

NatWest Markets Plc

 USD 9,852

EUR 8,500

9/24/2026

$

104

 

NatWest Markets Plc

 USD 11,412

EUR 10,000

9/29/2026

$

(58

)

Total Foreign Currency Exchange Contracts

 

 

 

$

46

 

 

 

 

 

 

 

EUR Euro (“€”)

 

 

 

 

See accompanying notes

 

 

28


 

 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
December 31, 2025
(in thousands, except share and per share data)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

Cost

 

Percentage
of Net
Assets ***

 

Fair
Value

 

Investments (1)(2)(3)

 

 

United States

 

 

Debt Investments

 

 

Capital Goods

 

 

Accurate Finance Sub, LLC (4)(5)

Senior Secured First Lien Delayed Draw Term Loan

 

09/2032

$

-

 

$

(1

)

 

 

(0.0

)

%

$

(2

)

Accurate Finance Sub, LLC (4)(5)

Senior Secured First Lien Revolver

 

09/2032

 

-

 

 

(1

)

 

 

(0.0

)

 

 

(1

)

Accurate Finance Sub, LLC

Senior Secured First Lien Term Loan

S + 475, 75 Floor

8.42%

09/2032

 

550

 

 

546

 

 

 

0.1

 

 

 

546

 

Ahead DB Holdings LLC (7)

Senior Secured First Lien Term Loan

S + 250, 75 Floor

6.17%

02/2031

 

2,813

 

 

2,806

 

 

 

0.6

 

 

 

2,813

 

Altar Bidco, Inc. (7)

Senior Secured First Lien Term Loan

S + 310, 50 Floor

6.78%

02/2029

 

3,307

 

 

3,279

 

 

 

0.7

 

 

 

3,278

 

Ascend Learning, LLC (7)

Senior Secured First Lien Term Loan

S + 300, 50 Floor

6.72%

12/2028

 

767

 

 

767

 

 

 

0.2

 

 

 

771

 

Bingo Holdings I LLC (7)

Senior Secured First Lien Term Loan

S + 475

8.42%

06/2032

 

2,579

 

 

2,556

 

 

 

0.5

 

 

 

2,534

 

Boxer Parent Company Inc. (7)(11)

Senior Secured First Lien Term Loan

S + 300

6.82%

07/2031

 

3,750

 

 

3,741

 

 

 

0.8

 

 

 

3,745

 

Brand Industrial Services (7)

Senior Secured First Lien Term Loan

S + 450, 50 Floor

8.35%

08/2030

 

685

 

 

668

 

 

 

0.1

 

 

 

626

 

Chariot Buyer (7)

Senior Secured First Lien Term Loan

S + 300

6.72%

09/2032

 

2,237

 

 

2,234

 

 

 

0.5

 

 

 

2,244

 

Cloud Software Group, Inc. (7)

Senior Secured First Lien Term Loan

S + 325

6.92%

08/2032

 

512

 

 

512

 

 

 

0.1

 

 

 

513

 

Cloud Software Group, Inc. (7)

Senior Secured First Lien Term Loan

S + 325

6.92%

03/2031

 

2,552

 

 

2,552

 

 

 

0.6

 

 

 

2,558

 

Corelogic, Inc. (7)

Senior Secured First Lien Term Loan

S + 361.45, 50 Floor

7.33%

06/2028

 

2,238

 

 

2,240

 

 

 

0.5

 

 

 

2,243

 

Dayforce Inc (7)(11)

Senior Secured First Lien Term Loan

S + 300

6.69%

10/2032

 

3,375

 

 

3,368

 

 

 

0.7

 

 

 

3,369

 

GB Eagle Buyer, Inc.

Unitranche First Lien Delayed Draw Term Loan

S + 450, 100 Floor

8.35%

12/2030

 

1,282

 

 

1,277

 

 

 

0.3

 

 

 

1,269

 

GB Eagle Buyer, Inc. (4)(5)

Unitranche First Lien Revolver

 

12/2030

 

-

 

 

(4

)

 

 

(0.0

)

 

 

(5

)

GB Eagle Buyer, Inc.

Unitranche First Lien Term Loan

S + 450, 100 Floor

8.17%

12/2030

 

3,162

 

 

3,134

 

 

 

0.7

 

 

 

3,130

 

GB Eagle Buyer, Inc.

Unitranche First Lien Term Loan

S + 450, 100 Floor

8.35%

12/2030

 

20,403

 

 

20,202

 

 

 

4.3

 

 

 

20,199

 

GB Eagle Buyer, Inc. (4)(5)

Unitranche First Lien Delayed Draw Term Loan

 

12/2030

 

-

 

 

(51

)

 

 

(0.0

)

 

 

(104

)

GB Eagle Buyer, Inc. (4)(5)

Unitranche First Lien Revolver

 

12/2030

 

-

 

 

(40

)

 

 

(0.0

)

 

 

(41

)

Genesys Cloud Services Holdings II LLC (7)

Senior Secured First Lien Term Loan

S + 250

6.22%

12/2027

 

2,840

 

 

2,805

 

 

 

0.6

 

 

 

2,838

 

Iron Mountain Inc (6)(7)

Senior Secured First Lien Term Loan

S + 200

5.72%

01/2031

 

2,813

 

 

2,813

 

 

 

0.6

 

 

 

2,816

 

Mcafee Corp. (7)

Senior Secured First Lien Term Loan

S + 300, 50 Floor

6.72%

03/2029

 

2,000

 

 

1,908

 

 

 

0.4

 

 

 

1,852

 

Parts Town

Unitranche First Lien Term Loan

S + 500 (175 PIK), 75 Floor

8.67%

04/2030

 

5,447

 

 

5,419

 

 

 

1.2

 

 

 

5,433

 

Parts Town (4)(5)

Unitranche First Lien Delayed Draw Term Loan

 

04/2030

 

-

 

 

-

 

 

 

(0.0

)

 

 

(1

)

Ping Identity Corp (7)

Senior Secured First Lien Term Loan

S + 275

6.59%

11/2032

 

1,117

 

 

1,118

 

 

 

0.2

 

 

 

1,121

 

Pushpay USA Inc. (7)

Senior Secured First Lien Term Loan

S + 419.46

8.07%

08/2031

 

992

 

 

986

 

 

 

0.2

 

 

 

993

 

Qlik Technologies (7)(11)

Senior Secured First Lien Term Loan

S + 325, 50 Floor

6.94%

10/2030

 

2,803

 

 

2,810

 

 

 

0.6

 

 

 

2,802

 

Quartz Acquireco LLC (Qualtrics)

Senior Secured First Lien Term Loan

S + 225

5.92%

06/2030

 

2,808

 

 

2,805

 

 

 

0.6

 

 

 

2,808

 

Realpage, Inc. (7)

Senior Secured First Lien Term Loan

S + 326.16, 50 Floor

6.93%

04/2028

 

2,240

 

 

2,232

 

 

 

0.5

 

 

 

2,241

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes

 

 

29


 

 

 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
December 31, 2025
(in thousands, except share and per share data)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

Cost

 

 

Percentage
of Net
Assets ***

 

 

Fair
Value

 

Red Planet Borrower, LLC (7)

Senior Secured First Lien Term Loan

S + 400, 50 Floor

7.72%

09/2032

 

2,158

 

 

2,137

 

 

 

0.5

 

 

 

2,165

 

Sovos Compliance, LLC (7)

Senior Secured First Lien Term Loan

S + 325

6.97%

08/2029

 

1,586

 

 

1,584

 

 

 

0.3

 

 

 

1,593

 

TransDigm Inc (6)(7)

Senior Secured First Lien Term Loan

S + 250

6.22%

02/2031

 

2,793

 

 

2,803

 

 

 

0.6

 

 

 

2,807

 

Zayo Group Holdings, Inc. (7)

Senior Secured First Lien Term Loan

S + 350

7.22%

09/2032

 

1,751

 

 

1,680

 

 

 

0.4

 

 

 

1,667

 

Zelis Payments Buyer Inc (7)

Senior Secured First Lien Term Loan

S + 275

6.47%

09/2029

 

2,638

 

 

2,615

 

 

 

0.6

 

 

 

2,616

 

 

 

 

 

 

84,198

 

 

83,500

 

 

 

18.0

 

 

 

83,436

 

Commercial and Professional Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Access Records Management (7)

Senior Secured First Lien Term Loan

S + 400, 50 Floor

7.72%

08/2030

 

3,059

 

 

3,049

 

 

 

0.6

 

 

 

2,960

 

AlixPartners, LLP (7)(11)

Senior Secured First Lien Term Loan

S + 200

5.69%

08/2032

 

2,810

 

 

2,814

 

 

 

0.6

 

 

 

2,818

 

Allied Universal Holdco LLC (7)

Senior Secured First Lien Term Loan

S + 335

7.07%

08/2032

 

2,419

 

 

2,417

 

 

 

0.5

 

 

 

2,434

 

Career Certified LLC (5)

Senior Secured First Lien Delayed Draw Term Loan

S + 500, 100 Floor

8.67%

02/2031

 

99

 

 

99

 

 

 

0.0

 

 

 

99

 

Career Certified LLC (4)(5)

Senior Secured First Lien Revolver

 

02/2031

 

-

 

 

(1

)

 

 

-

 

 

 

-

 

Career Certified LLC

Senior Secured First Lien Term Loan

S + 500, 100 Floor

8.67%

02/2031

 

746

 

 

741

 

 

 

0.2

 

 

 

746

 

CMG Holdco

Unitranche First Lien Delayed Draw Term Loan

S + 450, 100 Floor

8.20%

10/2028

 

413

 

 

410

 

 

 

0.1

 

 

 

408

 

CMG Holdco

Unitranche First Lien Delayed Draw Term Loan

S + 450, 100 Floor

8.20%

10/2028

 

1,038

 

 

1,030

 

 

 

0.2

 

 

 

1,026

 

CMG Holdco (5)

Unitranche First Lien Delayed Draw Term Loan

S + 450, 100 Floor

8.78%

10/2028

 

1,071

 

 

1,059

 

 

 

0.2

 

 

 

1,054

 

CMG Holdco (4)(5)

Unitranche First Lien Delayed Draw Term Loan

 

10/2028

 

-

 

 

(4

)

 

 

(0.0

)

 

 

(7

)

CMG Holdco (4)(5)

Unitranche First Lien Revolver

 

10/2028

 

-

 

 

(4

)

 

 

(0.0

)

 

 

(6

)

CMG Holdco

Unitranche First Lien Term Loan

S + 450, 100 Floor

8.20%

10/2028

 

700

 

 

695

 

 

 

0.1

 

 

 

691

 

CMG Holdco (4)(5)

Unitranche First Lien Delayed Draw Term Loan

 

11/2030

 

-

 

 

(20

)

 

 

(0.0

)

 

 

(51

)

CMG Holdco (4)(5)

Unitranche First Lien Revolver

 

11/2030

 

-

 

 

(6

)

 

 

(0.0

)

 

 

(8

)

Crisis Prevention Institute, Inc. (7)

Senior Secured First Lien Term Loan

S + 400, 50 Floor

7.67%

04/2031

 

2,040

 

 

2,036

 

 

 

0.4

 

 

 

2,032

 

Dispatch Acquisition Holdings, LLC (5)

Unitranche First Lien Revolver

S + 475, 75 Floor

8.42%

11/2032

 

1,673

 

 

1,627

 

 

 

0.3

 

 

 

1,627

 

Dispatch Acquisition Holdings, LLC

Unitranche First Lien Term Loan

S + 475, 75 Floor

8.42%

11/2032

 

25,385

 

 

25,131

 

 

 

5.4

 

 

 

25,131

 

Duraserv LLC (5)

Senior Secured First Lien Delayed Draw Term Loan

S + 475, 75 Floor

8.48%

06/2031

 

1,048

 

 

1,040

 

 

 

0.2

 

 

 

1,030

 

Duraserv LLC

Senior Secured First Lien Delayed Draw Term Loan

S + 475, 75 Floor

8.48%

06/2031

 

1,766

 

 

1,754

 

 

 

0.4

 

 

 

1,748

 

Duraserv LLC (5)

Senior Secured First Lien Revolver

S + 475, 75 Floor

8.57%

06/2030

 

119

 

 

112

 

 

 

0.0

 

 

 

110

 

Duraserv LLC

Senior Secured First Lien Term Loan

S + 475, 75 Floor

8.48%

06/2031

 

4,761

 

 

4,725

 

 

 

1.0

 

 

 

4,714

 

Duraserv LLC (4)(5)

Senior Secured First Lien Delayed Draw Term Loan

 

06/2031

 

-

 

 

(17

)

 

 

(0.0

)

 

 

(36

)

 

 

See accompanying notes

 

 

30


 

 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
December 31, 2025
(in thousands, except share and per share data)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

Cost

 

 

Percentage
of Net
Assets ***

 

 

Fair
Value

 

Fairbanks Morse Defense (7)

Senior Secured First Lien Term Loan

S + 275

6.42%

06/2030

 

1,173

 

 

1,163

 

 

 

0.3

 

 

 

1,179

 

FS Investments (Franklin Sq.)

Senior Secured First Lien Term Loan

S + 225

6.17%

04/2031

 

2,833

 

 

2,805

 

 

 

0.6

 

 

 

2,762

 

Galway Borrower, LLC (5)

Unitranche First Lien Revolver

S + 450, 75 Floor

8.19%

09/2028

 

121

 

 

117

 

 

 

0.0

 

 

 

117

 

Galway Borrower, LLC (5)

Unitranche First Lien Delayed Draw Term Loan

S + 450, 75 Floor

8.17%

09/2028

 

1,121

 

 

1,088

 

 

 

0.2

 

 

 

1,135

 

GN Loanco, LLC (7)

Senior Secured First Lien Term Loan

S + 450, 75 Floor

8.34%

12/2030

 

3,080

 

 

3,034

 

 

 

0.7

 

 

 

3,065

 

Halo Buyer Inc (5)

Unitranche First Lien Revolver

S + 600, 100 Floor

9.72%

08/2029

 

187

 

 

178

 

 

 

0.0

 

 

 

194

 

Halo Buyer Inc

Unitranche First Lien Term Loan

S + 600, 100 Floor

9.72%

08/2029

 

3,452

 

 

3,394

 

 

 

0.8

 

 

 

3,499

 

Iris Buyer, LLC

Unitranche First Lien Delayed Draw Term Loan

S + 525, 100 Floor

8.92%

10/2030

 

326

 

 

320

 

 

 

0.1

 

 

 

323

 

Iris Buyer, LLC (4)(5)

Unitranche First Lien Revolver

 

10/2029

 

-

 

 

(9

)

 

 

(0.0

)

 

 

(5

)

Iris Buyer, LLC

Unitranche First Lien Term Loan

S + 525, 100 Floor

9.09%

10/2030

 

3,461

 

 

3,387

 

 

 

0.7

 

 

 

3,426

 

Iris Buyer, LLC (5)

Unitranche First Lien Delayed Draw Term Loan

S + 525, 100 Floor

8.92%

10/2030

 

521

 

 

518

 

 

 

0.1

 

 

 

514

 

Iris Buyer, LLC

Unitranche First Lien Term Loan

S + 525, 100 Floor

8.92%

10/2030

 

101

 

 

100

 

 

 

0.0

 

 

 

100

 

Lawn Star Buyer, LLC (4)(5)

Senior Secured First Lien Revolver

 

06/2031

 

-

 

 

(6

)

 

 

-

 

 

 

-

 

Lawn Star Buyer, LLC

Senior Secured First Lien Term Loan

S + 475, 100 Floor

8.42%

06/2031

 

1,800

 

 

1,784

 

 

 

0.4

 

 

 

1,799

 

McKissock Investment Holdings LLC (Colibri) (7)

Senior Secured First Lien Term Loan

S + 500, 75 Floor

8.87%

03/2029

 

2,940

 

 

2,894

 

 

 

0.6

 

 

 

2,769

 

Midwest Physician Administrative Services, LLC (7)

Senior Secured First Lien Term Loan

S + 326.16, 75 Floor

6.93%

03/2028

 

1,675

 

 

1,575

 

 

 

0.3

 

 

 

1,528

 

Neptune Bidco US Inc. (6)(7)

Senior Secured First Lien Term Loan

S + 510, 50 Floor

9.01%

04/2029

 

2,619

 

 

2,545

 

 

 

0.6

 

 

 

2,596

 

Northstar (7)

Senior Secured First Lien Term Loan

S + 475, 50 Floor

8.59%

05/2030

 

572

 

 

570

 

 

 

0.1

 

 

 

578

 

Pre-paid Legal Services, Inc. (7)

Senior Secured First Lien Term Loan

S + 325, 50 Floor

6.97%

12/2028

 

1,635

 

 

1,632

 

 

 

0.3

 

 

 

1,585

 

Prime Security Services Borrower, LLC (P1/ADT) (6)(7)

Senior Secured First Lien Term Loan

S + 200

6.13%

10/2030

 

2,812

 

 

2,816

 

 

 

0.6

 

 

 

2,820

 

Quidelortho Corp (6)(7)

Senior Secured First Lien Term Loan

S + 400

7.72%

08/2032

 

3,072

 

 

3,056

 

 

 

0.7

 

 

 

3,075

 

Southern Veterinary Partners LLC (7)

Senior Secured First Lien Term Loan

S + 250

6.37%

12/2031

 

1,494

 

 

1,486

 

 

 

0.3

 

 

 

1,493

 

Trace3 (Escape Velocity Holdings) (5)(7)(11)

Senior Secured First Lien Delayed Draw Term Loan

 

10/2032

 

-

 

 

-

 

 

 

0.0

 

 

 

1

 

Trace3 (Escape Velocity Holdings) (7)(11)

Senior Secured First Lien Term Loan

S + 400

7.69%

10/2032

 

1,692

 

 

1,695

 

 

 

0.4

 

 

 

1,698

 

Trugreen (7)

Senior Secured First Lien Term Loan

S + 410, 75 Floor

7.82%

11/2027

 

2,084

 

 

2,023

 

 

 

0.4

 

 

 

2,047

 

Unosquare, LLC (4)(5)

Senior Secured First Lien Delayed Draw Term Loan

 

06/2031

 

-

 

 

-

 

 

 

(0.0

)

 

 

(10

)

Unosquare, LLC (4)(5)

Senior Secured First Lien Revolver

 

06/2031

 

-

 

 

-

 

 

 

(0.0

)

 

 

(4

)

Unosquare, LLC

Senior Secured First Lien Term Loan

S + 475, 75 Floor

8.47%

06/2031

 

3,042

 

 

3,014

 

 

 

0.6

 

 

 

3,022

 

Vaco Holdings, LLC (7)

Senior Secured First Lien Term Loan

S + 500, 75 Floor

8.67%

01/2029

 

1,424

 

 

1,314

 

 

 

0.3

 

 

 

1,166

 

DecisionHR Holdings, Inc (4)(5)

Senior Secured First Lien Delayed Draw Term Loan

 

12/2031

 

-

 

 

(0

)

 

 

(0.0

)

 

 

(1

)

DecisionHR Holdings, Inc

Senior Secured First Lien Term Loan

S + 450, 100 Floor

8.28%

12/2031

 

700

 

 

695

 

 

 

0.1

 

 

 

695

 

 

 

See accompanying notes

 

 

31


 

 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
December 31, 2025
(in thousands, except share and per share data)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

Cost

 

 

Percentage
of Net
Assets ***

 

 

Fair
Value

 

DecisionHR Holdings, Inc (4)(5)

Senior Secured First Lien Revolver

 

12/2031

 

-

 

 

(1

)

 

 

(0.0

)

 

 

(1

)

 

 

 

 

 

93,084

 

 

91,874

 

 

 

19.5

 

 

 

91,685

 

Consumer Discretionary Distribution and Retail

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bass Pro - Great American Outdoors Group LLC (7)

Senior Secured First Lien Term Loan

S + 325, 75 Floor

6.97%

01/2032

 

2,985

 

 

2,974

 

 

 

0.6

 

 

 

3,007

 

Family Dollar

Senior Secured Second Lien Term Loan

S + 650, 100 Floor

10.37%

07/2030

 

10,000

 

 

9,912

 

 

 

2.2

 

 

 

10,300

 

Gloves Buyers, Inc. (7)

Senior Secured First Lien Term Loan

S + 400, 50 Floor

7.72%

01/2032

 

2,280

 

 

2,230

 

 

 

0.5

 

 

 

2,273

 

Harbor Freight Tools USA, Inc (7)(11)

Senior Secured First Lien Term Loan

S + 225

5.94%

06/2031

 

2,845

 

 

2,813

 

 

 

0.6

 

 

 

2,822

 

Inspire Brands, Inc. (Arby’s & Buffalo Wild Wings) (7)

Senior Secured First Lien Term Loan

S + 250, 75 Floor

6.22%

12/2030

 

2,798

 

 

2,801

 

 

 

0.6

 

 

 

2,808

 

Mavis Tire Express (7)

Senior Secured First Lien Term Loan

S + 300, 75 Floor

6.72%

05/2028

 

1,860

 

 

1,859

 

 

 

0.4

 

 

 

1,868

 

PetSmart (7)

Senior Secured First Lien Term Loan

S + 400

7.73%

08/2032

 

3,034

 

 

3,010

 

 

 

0.7

 

 

 

3,026

 

 

 

 

 

 

25,802

 

 

25,599

 

 

 

5.6

 

 

 

26,104

 

Consumer Durables and Apparel

 

 

 

 

 

 

 

 

 

 

 

 

 

 

HP PHRG Borrower, LLC (7)(11)

Senior Secured First Lien Term Loan

S + 400

7.67%

02/2032

 

3,007

 

 

2,952

 

 

 

0.6

 

 

 

2,994

 

Hunter Douglas Holdings UK Limited (6)(7)

Senior Secured First Lien Term Loan

S + 325

6.92%

01/2032

 

1,738

 

 

1,715

 

 

 

0.4

 

 

 

1,749

 

Varsity Brands (7)

Senior Secured First Lien Term Loan

S + 300

6.67%

08/2031

 

2,608

 

 

2,580

 

 

 

0.6

 

 

 

2,621

 

 

 

 

 

 

7,353

 

 

7,247

 

 

 

1.6

 

 

 

7,364

 

Consumer Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Astro Acquisition LLC (7)

Senior Secured First Lien Term Loan

S + 325, 50 Floor

7.12%

08/2032

 

1,298

 

 

1,298

 

 

 

0.3

 

 

 

1,310

 

Caesars Entertainment Inc (6)(7)

Senior Secured First Lien Term Loan

S + 225, 50 Floor

5.97%

02/2030

 

3,205

 

 

3,182

 

 

 

0.7

 

 

 

3,188

 

CPM Holdings, Inc. (7)

Senior Secured First Lien Term Loan

S + 450, 50 Floor

8.34%

09/2028

 

1,532

 

 

1,512

 

 

 

0.3

 

 

 

1,527

 

Dave & Buster’s, Inc. (6)(7)

Senior Secured First Lien Term Loan

S + 325

7.13%

11/2031

 

1,350

 

 

1,294

 

 

 

0.3

 

 

 

1,211

 

Essential Services Holding Corporation (4)(5)

Unitranche First Lien Delayed Draw Term Loan

 

06/2031

 

-

 

 

(3

)

 

 

-

 

 

 

-

 

Essential Services Holding Corporation (5)

Unitranche First Lien Revolver

S + 500, 75 Floor

8.88%

06/2030

 

186

 

 

182

 

 

 

0.0

 

 

 

186

 

Essential Services Holding Corporation

Unitranche First Lien Term Loan

S + 500, 75 Floor

8.88%

06/2031

 

3,792

 

 

3,760

 

 

 

0.8

 

 

 

3,792

 

Golden Nugget Inc (Landry’s) (7)

Senior Secured First Lien Term Loan

S + 325, 50 Floor

6.97%

01/2029

 

2,804

 

 

2,795

 

 

 

0.6

 

 

 

2,806

 

J&J Ventures Gaming (7)

Senior Secured First Lien Term Loan

S + 350, 75 Floor

7.22%

04/2030

 

3,072

 

 

3,026

 

 

 

0.7

 

 

 

3,055

 

Landscape Workshop LLC (5)

Unitranche First Lien Delayed Draw Term Loan

S + 500, 75 Floor

8.67%

05/2032

 

2,492

 

 

2,463

 

 

 

0.6

 

 

 

2,619

 

Landscape Workshop LLC (5)

Unitranche First Lien Revolver

S + 500, 75 Floor

8.67%

05/2031

 

564

 

 

534

 

 

 

0.1

 

 

 

564

 

Landscape Workshop LLC

Unitranche First Lien Term Loan

S + 500, 75 Floor

8.67%

05/2032

 

19,411

 

 

19,223

 

 

 

4.3

 

 

 

19,799

 

Learning Care Group (US) No. 2 Inc. (7)

Senior Secured First Lien Term Loan

S + 400, 50 Floor

7.86%

08/2028

 

2,194

 

 

2,177

 

 

 

0.4

 

 

 

1,838

 

Marriott Ownership Resorts, Inc. (6)(7)

Senior Secured First Lien Term Loan

S + 225

5.97%

03/2031

 

2,813

 

 

2,799

 

 

 

0.6

 

 

 

2,820

 

Scientific Games Holdings LP (7)

Senior Secured First Lien Term Loan

S + 300, 50 Floor

6.93%

04/2029

 

3,038

 

 

3,018

 

 

 

0.6

 

 

 

2,988

 

Voyager Parent LLC (6)(7)

Senior Secured First Lien Term Loan

S + 475

8.42%

07/2032

 

2,993

 

 

2,965

 

 

 

0.6

 

 

 

2,998

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes

 

 

 

 

32


 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
December 31, 2025
(in thousands, except share and per share data)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

Cost

 

 

Percentage
of Net
Assets ***

 

 

Fair
Value

 

CRS TH Holdings, Corp. (4)(5)

Senior Secured First Lien Delayed Draw Term Loan

 

12/2032

 

-

 

 

(2

)

 

 

(0.0

)

 

 

(3

)

CRS TH Holdings, Corp. (4)(5)

Senior Secured First Lien Revolver

 

12/2032

 

-

 

 

(2

)

 

 

(0.0

)

 

 

(2

)

CRS TH Holdings, Corp.

Senior Secured First Lien Term Loan

S + 475, 75 Floor

8.42%

12/2032

 

1,375

 

 

1,365

 

 

 

0.3

 

 

 

1,365

 

 

 

 

 

 

52,119

 

 

51,586

 

 

 

11.2

 

 

 

52,061

 

Diversified Financials

 

 

 

 

 

 

 

 

 

 

 

 

 

 

RWA Wealth Partners, LLC.

Unitranche First Lien Term Loan

S + 475, 75 Floor

8.63%

11/2030

 

1,687

 

 

1,676

 

 

 

0.4

 

 

 

1,687

 

RWA Wealth Partners, LLC. (5)

Unitranche First Lien Delayed Draw Term Loan

S + 475, 75 Floor

8.49%

11/2030

 

330

 

 

327

 

 

 

0.1

 

 

 

330

 

RWA Wealth Partners, LLC. (4)(5)

Unitranche First Lien Revolver

 

11/2030

 

-

 

 

(2

)

 

 

-

 

 

 

-

 

 

 

 

 

 

2,017

 

 

2,001

 

 

 

0.5

 

 

 

2,017

 

Energy

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Brazos (7)

Senior Secured First Lien Term Loan

S + 250, 50 Floor

6.27%

02/2030

 

1,865

 

 

1,866

 

 

 

0.4

 

 

 

1,870

 

Cornerstone Generation, LLC (7)

Senior Secured First Lien Term Loan

S + 325

7.09%

10/2031

 

364

 

 

363

 

 

 

0.1

 

 

 

368

 

Delek US Holdings, Inc. (6)(7)

Senior Secured First Lien Term Loan

S + 350, 50 Floor

7.22%

11/2029

 

1,796

 

 

1,795

 

 

 

0.4

 

 

 

1,800

 

Vistra Zero Operating Company, LLC (7)(11)

Senior Secured First Lien Term Loan

S + 200

5.69%

04/2031

 

3,210

 

 

3,182

 

 

 

0.7

 

 

 

3,184

 

 

 

 

 

 

7,235

 

 

7,206

 

 

 

1.6

 

 

 

7,222

 

Financial Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Americana Partners LLC (4)(5)

Unitranche First Lien Delayed Draw Term Loan

 

05/2031

 

-

 

 

(4

)

 

 

-

 

 

 

-

 

Americana Partners LLC (4)(5)

Unitranche First Lien Revolver

 

05/2031

 

-

 

 

(3

)

 

 

-

 

 

 

-

 

Americana Partners LLC

Unitranche First Lien Term Loan

S + 425, 75 Floor

7.92%

05/2031

 

650

 

 

645

 

 

 

0.1

 

 

 

650

 

Aretec Group (Cetera) (7)

Senior Secured First Lien Term Loan

S + 300

6.72%

08/2030

 

1,500

 

 

1,502

 

 

 

0.3

 

 

 

1,508

 

Blackhawk Network Holdings, Inc. (7)(11)

Senior Secured First Lien Term Loan

S + 400, 100 Floor

7.67%

03/2029

 

2,234

 

 

2,231

 

 

 

0.5

 

 

 

2,247

 

Camelot US (6)(7)

Senior Secured First Lien Term Loan

S + 325

6.97%

01/2031

 

2,810

 

 

2,801

 

 

 

0.6

 

 

 

2,818

 

Cary Street Partners (5)

Senior Secured First Lien Delayed Draw Term Loan

S + 475, 100 Floor

8.42%

05/2031

 

178

 

 

165

 

 

 

0.0

 

 

 

178

 

Cary Street Partners (4)(5)

Senior Secured First Lien Revolver

 

05/2031

 

-

 

 

(4

)

 

 

-

 

 

 

-

 

Cary Street Partners

Senior Secured First Lien Term Loan

S + 475, 100 Floor

8.42%

05/2031

 

1,791

 

 

1,770

 

 

 

0.4

 

 

 

1,791

 

Coral-Us Co-Borrower LLC (7)

Senior Secured First Lien Term Loan

S + 325

7.15%

01/2032

 

3,860

 

 

3,805

 

 

 

0.8

 

 

 

3,794

 

Fortress Intermediate 3 Inc (7)

Senior Secured First Lien Term Loan

S + 300

6.78%

06/2031

 

1,869

 

 

1,849

 

 

 

0.4

 

 

 

1,873

 

HPOne (4)(5)

Senior Secured First Lien Delayed Draw Term Loan

 

08/2031

 

-

 

 

(6

)

 

 

(0.0

)

 

 

(8

)

HPOne (4)(5)

Senior Secured First Lien Revolver

 

08/2031

 

-

 

 

(21

)

 

 

(0.0

)

 

 

(21

)

HPOne

Senior Secured First Lien Term Loan

S + 475, 75 Floor

8.42%

08/2031

 

10,800

 

 

10,720

 

 

 

2.3

 

 

 

10,724

 

Jane Street Group / JSG Finance Inc (7)

Senior Secured First Lien Term Loan

S + 200

5.82%

12/2031

 

3,755

 

 

3,729

 

 

 

0.8

 

 

 

3,742

 

Jump Financial LLC

Senior Secured First Lien Term Loan

S + 350

7.17%

02/2032

 

475

 

 

474

 

 

 

0.1

 

 

 

470

 

Kestra Advisor Services Holdings A, Inc. (7)

Senior Secured First Lien Term Loan

S + 300

6.72%

03/2031

 

2,436

 

 

2,432

 

 

 

0.5

 

 

 

2,444

 

 

 

See accompanying notes

 

 

 

 

33


 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
December 31, 2025
(in thousands, except share and per share data)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

Cost

 

 

Percentage
of Net
Assets ***

 

 

Fair
Value

 

LBM Acquisition (7)

Senior Secured First Lien Term Loan

S + 385, 75 Floor

7.58%

05/2034

 

2,534

 

 

2,436

 

 

 

0.5

 

 

 

2,383

 

Modena Buyer LLC (7)

Senior Secured First Lien Term Loan

S + 450

8.34%

07/2031

 

2,594

 

 

2,548

 

 

 

0.6

 

 

 

2,586

 

Nexus (7)

Senior Secured First Lien Term Loan

S + 350

7.22%

07/2031

 

793

 

 

787

 

 

 

0.2

 

 

 

783

 

Nexus (7)

Senior Secured First Lien Term Loan

S + 400

7.72%

07/2031

 

1,986

 

 

1,989

 

 

 

0.4

 

 

 

1,974

 

Numera (4)(5)

Unitranche First Lien Delayed Draw Term Loan

 

08/2032

 

-

 

 

(1

)

 

 

(0.0

)

 

 

(2

)

Numera (4)(5)

Unitranche First Lien Revolver

 

08/2032

 

-

 

 

(1

)

 

 

(0.0

)

 

 

(1

)

Numera

Unitranche First Lien Term Loan

S + 500, 75 Floor

8.72%

08/2032

 

600

 

 

596

 

 

 

0.1

 

 

 

596

 

Plano Holdco, Inc.

Senior Secured First Lien Term Loan

S + 350

7.17%

10/2031

 

2,291

 

 

2,245

 

 

 

0.5

 

 

 

2,228

 

Rand Parent, LLC (7)

Senior Secured First Lien Term Loan

S + 300

6.67%

03/2030

 

2,810

 

 

2,788

 

 

 

0.6

 

 

 

2,822

 

Savers (7)(11)

Senior Secured First Lien Term Loan

S + 300

6.70%

09/2032

 

2,545

 

 

2,538

 

 

 

0.6

 

 

 

2,561

 

Star Parents, Inc. (7)

Senior Secured First Lien Term Loan

S + 400

7.67%

09/2030

 

3,048

 

 

2,986

 

 

 

0.7

 

 

 

3,055

 

Summit Acquisition Inc

Senior Secured First Lien Term Loan

S + 350

7.22%

10/2031

 

846

 

 

844

 

 

 

0.2

 

 

 

853

 

UHY Advisors , Inc.

Unitranche First Lien Term Loan

S + 475, 75 Floor

8.57%

11/2031

 

1,762

 

 

1,751

 

 

 

0.4

 

 

 

1,762

 

UHY Advisors , Inc. (5)

Unitranche First Lien Delayed Draw Term Loan

S + 475, 75 Floor

8.42%

11/2031

 

212

 

 

208

 

 

 

0.0

 

 

 

212

 

UHY Advisors , Inc. (5)

Unitranche First Lien Revolver

S + 475, 75 Floor

8.42%

11/2031

 

130

 

 

127

 

 

 

0.0

 

 

 

130

 

Vrs Buyer Inc (5)(7)

Senior Secured First Lien Delayed Draw Term Loan

 

10/2032

 

-

 

 

-

 

 

 

-

 

 

 

-

 

Vrs Buyer Inc (7)

Senior Secured First Lien Term Loan

S + 350

7.24%

10/2032

 

604

 

 

601

 

 

 

0.1

 

 

 

607

 

White Cap Supply Holdings, LLC (7)

Senior Secured First Lien Term Loan

S + 325

6.97%

10/2029

 

2,798

 

 

2,755

 

 

 

0.6

 

 

 

2,813

 

Chicago US Midco III LP (5)

Senior Secured First Lien Delayed Draw Term Loan

 

10/2032

 

-

 

 

1

 

 

 

0.0

 

 

 

1

 

Chicago US Midco III LP

Senior Secured First Lien Term Loan

S + 250

6.22%

10/2032

 

2,438

 

 

2,447

 

 

 

0.5

 

 

 

2,446

 

Jefferies Finance LLC (6)(7)(11)

Senior Secured First Lien Term Loan

S + 275

6.50%

10/2031

 

3,205

 

 

3,182

 

 

 

0.7

 

 

 

3,188

 

 

 

 

 

 

63,554

 

 

62,912

 

 

 

13.6

 

 

 

63,207

 

Food, Beverage and Tobacco

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Aspire Bakeries Holdings LLC (7)

Senior Secured First Lien Term Loan

S + 350

7.22%

12/2030

 

447

 

 

445

 

 

 

0.1

 

 

 

450

 

Primary Products (7)

Senior Secured First Lien Term Loan

S + 325, 50 Floor

7.19%

04/2029

 

1,576

 

 

1,572

 

 

 

0.3

 

 

 

1,559

 

 

 

 

 

 

2,023

 

 

2,017

 

 

 

0.4

 

 

 

2,009

 

Health Care Equipment and Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1-800 Contacts (CNT Holdings I Corp) (7)

Senior Secured First Lien Term Loan

S + 225, 75 Floor

6.09%

11/2032

 

2,793

 

 

2,800

 

 

 

0.6

 

 

 

2,803

 

Admi Corp. (7)

Senior Secured First Lien Term Loan

S + 386.45, 50 Floor

7.58%

12/2027

 

1,583

 

 

1,550

 

 

 

0.3

 

 

 

1,505

 

Admi Corp. (7)

Senior Secured First Lien Term Loan

S + 575

9.47%

12/2027

 

517

 

 

506

 

 

 

0.1

 

 

 

497

 

Agiliti Health, Inc. (7)

Senior Secured First Lien Term Loan

S + 300

6.86%

05/2030

 

2,006

 

 

1,954

 

 

 

0.4

 

 

 

1,970

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes

 

 

 

34


 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
December 31, 2025
(in thousands, except share and per share data)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

Cost

 

 

Percentage
of Net
Assets ***

 

 

Fair
Value

 

Amneal Pharmaceuticals LLC (6)(7)

Senior Secured First Lien Term Loan

S + 350, 50 Floor

7.22%

08/2032

 

998

 

 

995

 

 

 

0.2

 

 

 

1,007

 

Angels of Care

Senior Secured First Lien Term Loan

S + 550, 100 Floor

9.22%

02/2030

 

3,684

 

 

3,656

 

 

 

0.8

 

 

 

3,684

 

Angels of Care (4)(5)

Senior Secured First Lien Revolver

 

02/2030

 

-

 

 

(3

)

 

 

-

 

 

 

-

 

Angels of Care (5)

Senior Secured First Lien Delayed Draw Term Loan

S + 550, 100 Floor

9.43%

02/2030

 

273

 

 

271

 

 

 

0.1

 

 

 

273

 

Arrow Management Acquisition, LLC (4)(5)

Unitranche First Lien Delayed Draw Term Loan

 

07/2032

 

-

 

 

(32

)

 

 

0.0

 

 

 

89

 

Arrow Management Acquisition, LLC (5)

Unitranche First Lien Revolver

S + 500, 75 Floor

8.67%

07/2032

 

779

 

 

757

 

 

 

0.2

 

 

 

779

 

Arrow Management Acquisition, LLC

Unitranche First Lien Term Loan

S + 500, 75 Floor

8.67%

07/2032

 

19,239

 

 

19,048

 

 

 

4.2

 

 

 

19,488

 

Avalign Technologies, Inc. (5)

Unitranche First Lien Revolver

S + 650, 75 Floor

10.22%

12/2028

 

461

 

 

449

 

 

 

0.1

 

 

 

380

 

Avalign Technologies, Inc.

Unitranche First Lien Term Loan

S + 725 (362.5 PIK), 75 Floor

11.07%

12/2028

 

7,394

 

 

7,303

 

 

 

1.5

 

 

 

6,746

 

Bristol Hospice (4)(5)

Unitranche First Lien Revolver

 

08/2032

 

-

 

 

(22

)

 

 

-

 

 

 

-

 

Bristol Hospice

Unitranche First Lien Term Loan

S + 500, 75 Floor

8.62%

08/2032

 

24,239

 

 

24,003

 

 

 

5.3

 

 

 

24,724

 

BVI Medical Inc. (5)

Unitranche First Lien Delayed Draw Term Loan

S + 625 (500 PIK), 75 Floor

10.13%

03/2032

 

126

 

 

124

 

 

 

0.0

 

 

 

124

 

BVI Medical Inc. (4)(5)

Unitranche First Lien Revolver

 

03/2032

 

-

 

 

(9

)

 

 

(0.0

)

 

 

(9

)

BVI Medical Inc.

Unitranche First Lien Term Loan

S + 625 (500 PIK), 75 Floor

9.97%

03/2032

 

8,423

 

 

8,311

 

 

 

1.8

 

 

 

8,375

 

Cvet Midco 2, L.P. (7)

Senior Secured First Lien Term Loan

S + 500, 50 Floor

8.67%

10/2029

 

2,095

 

 

1,977

 

 

 

0.4

 

 

 

1,889

 

Embecta Corp. (6)(7)(11)

Senior Secured First Lien Term Loan

S + 300, 50 Floor

6.72%

03/2029

 

2,414

 

 

2,413

 

 

 

0.5

 

 

 

2,422

 

Global Medical Response Inc (7)

Senior Secured First Lien Term Loan

S + 350

7.38%

10/2032

 

1,996

 

 

1,990

 

 

 

0.4

 

 

 

2,011

 

HAH Group Holding Company (7)

Senior Secured First Lien Term Loan

S + 500

8.72%

09/2031

 

2,313

 

 

2,248

 

 

 

0.4

 

 

 

2,038

 

Hanger, Inc. (7)(11)

Senior Secured First Lien Term Loan

S + 350

7.22%

10/2031

 

1,753

 

 

1,751

 

 

 

0.4

 

 

 

1,761

 

Hanger, Inc. (5)(7)(11)

Senior Secured First Lien Delayed Draw Term Loan

S + 350

7.22%

10/2031

 

134

 

 

133

 

 

 

0.0

 

 

 

135

 

Headlands Buyer, Inc. (4)(5)

Unitranche First Lien Delayed Draw Term Loan

 

09/2032

 

-

 

 

(13

)

 

 

0.0

 

 

 

4

 

Headlands Buyer, Inc. (4)(5)

Unitranche First Lien Revolver

 

09/2032

 

-

 

 

(12

)

 

 

-

 

 

 

-

 

Headlands Buyer, Inc.

Unitranche First Lien Term Loan

S + 475, 100 Floor

8.74%

09/2032

 

6,780

 

 

6,713

 

 

 

1.5

 

 

 

6,789

 

Heartland Dental LLC (7)

Senior Secured First Lien Term Loan

S + 375

7.47%

08/2032

 

1,407

 

 

1,405

 

 

 

0.3

 

 

 

1,414

 

IVX Health Merger Sub, Inc. (8)

Unsecured Debt

13.50 PIK

13.50%

06/2031

 

3,528

 

 

3,468

 

 

 

0.8

 

 

 

3,633

 

IVX Health Merger Sub, Inc. (4)(5)

Unitranche First Lien Revolver

 

06/2030

 

-

 

 

(21

)

 

 

-

 

 

 

-

 

IVX Health Merger Sub, Inc.

Unitranche First Lien Term Loan

S + 500, 100 Floor

8.67%

06/2030

 

6,759

 

 

6,651

 

 

 

1.5

 

 

 

6,827

 

Laseraway Intermediate Holdings II, LLC (7)

Senior Secured First Lien Term Loan

S + 601.16, 75 Floor

9.89%

10/2027

 

5,195

 

 

5,171

 

 

 

1.1

 

 

 

5,176

 

LifePoint Health Inc (7)

Senior Secured First Lien Term Loan

S + 375

7.65%

11/2028

 

2,985

 

 

2,979

 

 

 

0.6

 

 

 

2,998

 

LifePoint Health Inc (7)(11)

Senior Secured First Lien Term Loan

S + 350

7.19%

05/2031

 

1,865

 

 

1,870

 

 

 

0.4

 

 

 

1,870

 

LTC Ally Inc (4)(5)

Senior Secured First Lien Revolver

 

04/2031

 

-

 

 

(1

)

 

 

-

 

 

 

-

 

LTC Ally Inc

Senior Secured First Lien Term Loan

S + 475, 100 Floor

8.73%

04/2031

 

2,786

 

 

2,766

 

 

 

0.6

 

 

 

2,786

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes

 

 

35


 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
December 31, 2025
(in thousands, except share and per share data)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

Cost

 

 

Percentage
of Net
Assets ***

 

 

Fair
Value

 

MB2 Dental

Unitranche First Lien Term Loan

S + 550, 75 Floor

9.22%

02/2031

 

5,447

 

 

5,405

 

 

 

1.2

 

 

 

5,502

 

MB2 Dental (5)

Unitranche First Lien Revolver

S + 550, 75 Floor

9.22%

02/2031

 

69

 

 

66

 

 

 

0.0

 

 

 

69

 

MB2 Dental

Unitranche First Lien Delayed Draw Term Loan

S + 550, 75 Floor

9.22%

02/2031

 

993

 

 

986

 

 

 

0.2

 

 

 

1,003

 

MB2 Dental

Unitranche First Lien Delayed Draw Term Loan

S + 550, 75 Floor

9.22%

02/2031

 

789

 

 

776

 

 

 

0.2

 

 

 

797

 

Medical Review Institute of America (5)

Unitranche First Lien Revolver

P + 400, 100 Floor

10.75%

07/2030

 

64

 

 

58

 

 

 

0.0

 

 

 

48

 

Medical Review Institute of America

Unitranche First Lien Term Loan

S + 500, 100 Floor

8.67%

07/2030

 

5,629

 

 

5,582

 

 

 

1.2

 

 

 

5,515

 

Net Health Acquisition Corp. (4)(5)

Unitranche First Lien Revolver

 

07/2031

 

-

 

 

(9

)

 

 

(0.0

)

 

 

(3

)

Net Health Acquisition Corp.

Unitranche First Lien Term Loan

S + 475, 75 Floor

8.47%

07/2031

 

8,775

 

 

8,704

 

 

 

1.9

 

 

 

8,754

 

Net Health Acquisition Corp.

Unitranche First Lien Term Loan

S + 475, 75 Floor

8.47%

07/2031

 

2,940

 

 

2,912

 

 

 

0.6

 

 

 

2,933

 

Organon & Co (6)(7)

Senior Secured First Lien Term Loan

S + 225, 50 Floor

5.97%

05/2031

 

2,920

 

 

2,826

 

 

 

0.6

 

 

 

2,821

 

Outcomes Group Holding Inc (7)

Senior Secured First Lien Term Loan

S + 300

6.72%

05/2031

 

1,990

 

 

1,983

 

 

 

0.4

 

 

 

2,005

 

Owens & Minor, Inc. (6)(7)

Senior Secured First Lien Term Loan

S + 375, 50 Floor

7.47%

03/2029

 

2,025

 

 

2,009

 

 

 

0.4

 

 

 

1,959

 

Premier Care Dental Management, LLC (5)

Unitranche First Lien Delayed Draw Term Loan

S + 500, 75 Floor

8.72%

08/2028

 

5,064

 

 

5,019

 

 

 

1.1

 

 

 

4,981

 

Team Health Holdings Inc (7)

Senior Secured First Lien Term Loan

S + 450

8.34%

06/2028

 

726

 

 

726

 

 

 

0.2

 

 

 

730

 

Viant Medical Holdings, Inc. (7)

Senior Secured First Lien Term Loan

S + 400

7.72%

10/2031

 

1,439

 

 

1,432

 

 

 

0.3

 

 

 

1,427

 

National Mentor Holdings, Inc. (5)(7)

Senior Secured First Lien Delayed Draw Term Loan

 

12/2030

 

-

 

 

-

 

 

 

0.0

 

 

 

1

 

National Mentor Holdings, Inc. (7)

Senior Secured First Lien Term Loan

S + 600

9.72%

12/2030

 

860

 

 

835

 

 

 

0.2

 

 

 

863

 

 

 

 

 

 

154,255

 

 

152,459

 

 

 

33.0

 

 

 

153,593

 

Insurance

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Acrisure, LLC (7)

Senior Secured First Lien Term Loan

S + 300

6.72%

11/2030

 

2,798

 

 

2,805

 

 

 

0.6

 

 

 

2,799

 

Alliant Holdings Intermediate LLC (7)

Senior Secured First Lien Term Loan

S + 250

6.22%

09/2031

 

2,798

 

 

2,801

 

 

 

0.6

 

 

 

2,807

 

AmWINS Group, Inc. (7)

Senior Secured First Lien Term Loan

S + 225, 75 Floor

5.97%

01/2032

 

2,992

 

 

3,004

 

 

 

0.6

 

 

 

3,004

 

King Risk Partners LLC

Unitranche First Lien Term Loan

S + 450, 100 Floor

8.22%

04/2031

 

2,264

 

 

2,248

 

 

 

0.5

 

 

 

2,264

 

King Risk Partners LLC (5)

Unitranche First Lien Delayed Draw Term Loan

S + 450, 100 Floor

8.22%

04/2031

 

1,243

 

 

1,238

 

 

 

0.3

 

 

 

1,243

 

King Risk Partners LLC (4)(5)

Unitranche First Lien Revolver

 

04/2031

 

-

 

 

(3

)

 

 

-

 

 

 

-

 

Onedigital Borrower LLC (7)

Senior Secured First Lien Term Loan

S + 300, 50 Floor

6.72%

07/2031

 

1,592

 

 

1,592

 

 

 

0.3

 

 

 

1,598

 

The Hilb Group, LLC (5)

Unitranche First Lien Delayed Draw Term Loan

S + 475, 75 Floor

8.47%

10/2031

 

388

 

 

382

 

 

 

0.1

 

 

 

374

 

 

 

See accompanying notes

 

 

 

 

 

 

 

 

 

36


 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
December 31, 2025
(in thousands, except share and per share data)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

Cost

 

 

Percentage
of Net
Assets ***

 

 

Fair
Value

 

The Hilb Group, LLC (5)

Unitranche First Lien Revolver

S + 475, 75 Floor

8.47%

10/2031

 

88

 

 

82

 

 

 

0.0

 

 

 

81

 

The Hilb Group, LLC

Unitranche First Lien Term Loan

S + 475, 75 Floor

8.47%

10/2031

 

5,950

 

 

5,900

 

 

 

1.3

 

 

 

5,891

 

Tropolis Holdings LLC

Senior Secured First Lien Delayed Draw Term Loan

S + 450, 100 Floor

8.17%

02/2031

 

549

 

 

546

 

 

 

0.1

 

 

 

549

 

Tropolis Holdings LLC (4)(5)

Senior Secured First Lien Revolver

 

02/2031

 

-

 

 

(1

)

 

 

-

 

 

 

-

 

Tropolis Holdings LLC

Senior Secured First Lien Term Loan

S + 450, 100 Floor

8.17%

02/2031

 

347

 

 

344

 

 

 

0.1

 

 

 

347

 

Tropolis Holdings LLC (5)

Senior Secured First Lien Delayed Draw Term Loan

S + 475, 100 Floor

8.54%

02/2031

 

179

 

 

179

 

 

 

0.0

 

 

 

179

 

Verscend Holding Corp (Cotiviti) (7)

Senior Secured First Lien Term Loan

S + 275

6.62%

05/2031

 

2,893

 

 

2,792

 

 

 

0.6

 

 

 

2,787

 

 

 

 

 

 

24,081

 

 

23,909

 

 

 

5.1

 

 

 

23,923

 

Materials

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Berlin Packaging L.L.C. (7)

Senior Secured First Lien Term Loan

S + 325

7.12%

06/2031

 

1,746

 

 

1,734

 

 

 

0.4

 

 

 

1,752

 

Chemours (6)(7)

Senior Secured First Lien Term Loan

S + 350

7.22%

10/2032

 

2,904

 

 

2,857

 

 

 

0.6

 

 

 

2,879

 

Clydesdale Acquisition Holdings, Inc. (7)(11)

Senior Secured First Lien Term Loan

S + 325

6.97%

04/2032

 

2,598

 

 

2,590

 

 

 

0.6

 

 

 

2,599

 

Cornerstone (7)

Senior Secured First Lien Term Loan

S + 450, 50 Floor

8.25%

05/2031

 

2,305

 

 

2,079

 

 

 

0.4

 

 

 

1,646

 

Discovery Purchaser Corporation (7)

Senior Secured First Lien Term Loan

S + 375, 50 Floor

7.61%

10/2029

 

2,259

 

 

2,239

 

 

 

0.5

 

 

 

2,177

 

Hexion Holdings Corporation (7)

Senior Secured First Lien Term Loan

S + 400, 50 Floor

7.73%

03/2029

 

1,797

 

 

1,781

 

 

 

0.4

 

 

 

1,738

 

Kodiak BP, LLC (7)

Senior Secured First Lien Term Loan

S + 375

7.47%

12/2031

 

2,113

 

 

2,053

 

 

 

0.4

 

 

 

2,067

 

LTI Holdings, Inc. (7)

Senior Secured First Lien Term Loan

S + 375

7.47%

07/2029

 

1,315

 

 

1,283

 

 

 

0.3

 

 

 

1,325

 

Lummus Technology Holdings V LLC (7)

Senior Secured First Lien Term Loan

S + 250

6.22%

12/2029

 

2,808

 

 

2,808

 

 

 

0.6

 

 

 

2,814

 

Mauser Packaging Solutions Holding Co (BWAY) (7)(11)

Senior Secured First Lien Term Loan

S + 350

7.19%

04/2030

 

2,830

 

 

2,802

 

 

 

0.6

 

 

 

2,781

 

MI Windows & Doors (Miter) (7)

Senior Secured First Lien Term Loan

S + 275

6.47%

03/2031

 

1,870

 

 

1,870

 

 

 

0.4

 

 

 

1,874

 

Olympus Water US Holding Corp (7)

Senior Secured First Lien Term Loan

S + 325

6.92%

07/2032

 

1,690

 

 

1,690

 

 

 

0.4

 

 

 

1,682

 

Online Labels Group, LLC (4)(5)

Senior Secured First Lien Revolver

 

12/2029

 

-

 

 

(1

)

 

 

-

 

 

 

-

 

Online Labels Group, LLC (5)

Senior Secured First Lien Delayed Draw Term Loan

S + 525, 100 Floor

8.92%

12/2029

 

87

 

 

86

 

 

 

0.0

 

 

 

87

 

Online Labels Group, LLC (4)(5)

Senior Secured First Lien Delayed Draw Term Loan

 

12/2029

 

-

 

 

(1

)

 

 

-

 

 

 

-

 

Online Labels Group, LLC

Senior Secured First Lien Term Loan

S + 525, 100 Floor

8.92%

12/2029

 

1,421

 

 

1,411

 

 

 

0.3

 

 

 

1,421

 

Oscar Acquisitionco, LLC (7)

Senior Secured First Lien Term Loan

S + 425, 50 Floor

7.92%

04/2029

 

1,847

 

 

1,705

 

 

 

0.3

 

 

 

1,335

 

Pegasus Steel

Senior Secured First Lien Term Loan

S + 475, 75 Floor

8.75%

01/2031

 

1,537

 

 

1,521

 

 

 

0.3

 

 

 

1,529

 

Pegasus Steel

Senior Secured First Lien Term Loan

S + 475, 75 Floor

8.42%

01/2031

 

884

 

 

884

 

 

 

0.2

 

 

 

879

 

Pegasus Steel (4)(5)

Senior Secured First Lien Delayed Draw Term Loan

 

01/2031

 

-

 

 

(2

)

 

 

(0.0

)

 

 

(2

)

Pegasus Steel (4)(5)

Senior Secured First Lien Delayed Draw Term Loan

 

01/2031

 

-

 

 

-

 

 

 

(0.0

)

 

 

(1

)

Pegasus Steel (4)(5)

Senior Secured First Lien Delayed Draw Term Loan

 

01/2031

 

-

 

 

-

 

 

 

(0.0

)

 

 

(2

)

Plastipak Packaging Inc (7)(11)

Senior Secured First Lien Term Loan

S + 250

6.19%

09/2032

 

2,808

 

 

2,808

 

 

 

0.6

 

 

 

2,818

 

See accompanying notes

 

37


 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
December 31, 2025
(in thousands, except share and per share data)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

Cost

 

 

Percentage
of Net
Assets ***

 

 

Fair
Value

 

Plaze Inc (7)

Senior Secured First Lien Term Loan

S + 350

7.22%

08/2026

 

731

 

 

726

 

 

 

0.1

 

 

 

678

 

Quikrete Holdings, Inc (7)(11)

Senior Secured First Lien Term Loan

S + 225

5.94%

03/2029

 

2,793

 

 

2,803

 

 

 

0.6

 

 

 

2,806

 

Tiger Acquisition LLC (7)

Senior Secured First Lien Term Loan

S + 250

6.23%

08/2032

 

560

 

 

560

 

 

 

0.1

 

 

 

563

 

Univar / Windsor Holdings III, LLC (7)

Senior Secured First Lien Term Loan

S + 275

6.47%

08/2030

 

1,396

 

 

1,403

 

 

 

0.3

 

 

 

1,401

 

USALCO (7)

Senior Secured First Lien Term Loan

S + 350, 50 Floor

7.22%

09/2031

 

1,698

 

 

1,698

 

 

 

0.4

 

 

 

1,708

 

USALCO (5)(7)

Senior Secured First Lien Delayed Draw Term Loan

 

09/2031

 

-

 

 

-

 

 

 

0.0

 

 

 

1

 

Wilsonart International Holdings LLC (7)(11)

Senior Secured First Lien Term Loan

S + 425

7.92%

08/2031

 

2,912

 

 

2,861

 

 

 

0.6

 

 

 

2,828

 

 

 

 

 

 

44,909

 

 

44,248

 

 

 

9.4

 

 

 

43,383

 

Media and Entertainment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Arches Buyer Inc. (7)

Senior Secured First Lien Term Loan

S + 335

7.07%

12/2027

 

1,984

 

 

1,963

 

 

 

0.4

 

 

 

1,991

 

Cengage Learning , Inc. (6)(7)(11)

Senior Secured First Lien Term Loan

S + 350, 100 Floor

7.19%

03/2031

 

2,254

 

 

2,244

 

 

 

0.5

 

 

 

2,266

 

GoodRx (6)(7)

Senior Secured First Lien Term Loan

S + 375

7.47%

07/2029

 

509

 

 

505

 

 

 

0.1

 

 

 

510

 

Kingpin Intermediate Holdings LLC (7)

Senior Secured First Lien Term Loan

S + 325

6.97%

09/2032

 

2,910

 

 

2,862

 

 

 

0.6

 

 

 

2,859

 

Knot Worldwide Inc. (7)

Senior Secured First Lien Term Loan

S + 375

7.47%

01/2028

 

1,489

 

 

1,468

 

 

 

0.3

 

 

 

1,252

 

Recess Holdings, Inc. (7)

Senior Secured First Lien Term Loan

S + 375, 100 Floor

7.62%

02/2030

 

1,858

 

 

1,848

 

 

 

0.4

 

 

 

1,872

 

Univision Communications Inc. (7)

Senior Secured First Lien Term Loan

S + 425, 50 Floor

7.92%

06/2029

 

2,035

 

 

2,009

 

 

 

0.4

 

 

 

2,041

 

Versant Media Group Inc (7)(11)

Senior Secured First Lien Term Loan

S + 350

7.19%

10/2030

 

2,800

 

 

2,786

 

 

 

0.6

 

 

 

2,804

 

Virgin Media Bristol LLC (6)(7)

Senior Secured First Lien Term Loan

S + 327.5

7.05%

03/2031

 

4,360

 

 

4,308

 

 

 

0.9

 

 

 

4,327

 

 

 

 

 

 

20,199

 

 

19,993

 

 

 

4.2

 

 

 

19,922

 

Pharmaceuticals, Biotechnology and Life Sciences

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Endo Finance Holdings, Inc. (6)(7)

Senior Secured First Lien Term Loan

S + 400, 50 Floor

7.72%

04/2031

 

2,578

 

 

2,539

 

 

 

0.6

 

 

 

2,561

 

Nephron Pharmaceuticals LLC

Unitranche First Lien - Last Out Term Loan

S + 920

13.19%

12/2027

 

2,462

 

 

2,432

 

 

 

0.5

 

 

 

2,462

 

RN Enterprises, LLC (5)

Unitranche First Lien Delayed Draw Term Loan

S + 500, 75 Floor

8.97%

10/2031

 

174

 

 

165

 

 

 

0.0

 

 

 

174

 

RN Enterprises, LLC (5)

Unitranche First Lien Revolver

S + 500, 75 Floor

8.81%

10/2031

 

116

 

 

105

 

 

 

0.0

 

 

 

116

 

RN Enterprises, LLC

Unitranche First Lien Term Loan

S + 525, 75 Floor

9.02%

10/2031

 

5,432

 

 

5,373

 

 

 

1.2

 

 

 

5,432

 

RN Enterprises, LLC

Unitranche First Lien Term Loan

S + 500, 75 Floor

8.77%

10/2031

 

693

 

 

688

 

 

 

0.1

 

 

 

692

 

WCG Intermediate Corp. (7)

Senior Secured First Lien Term Loan

S + 300

6.72%

02/2032

 

1,990

 

 

1,974

 

 

 

0.4

 

 

 

1,997

 

WCT Group Holdings, LLC (4)(5)

Unitranche First Lien Revolver

 

12/2029

 

-

 

 

(8

)

 

 

(0.0

)

 

 

(2

)

WCT Group Holdings, LLC

Unitranche First Lien Term Loan

S + 475, 75 Floor

8.47%

12/2029

 

3,308

 

 

3,248

 

 

 

0.7

 

 

 

3,291

 

WCT Group Holdings, LLC (5)

Unitranche First Lien Delayed Draw Term Loan

S + 475, 100 Floor

8.47%

12/2029

 

1,900

 

 

1,891

 

 

 

0.4

 

 

 

1,890

 

WCT Group Holdings, LLC (4)(5)

Unitranche First Lien Revolver

 

12/2029

 

-

 

 

(2

)

 

 

(0.0

)

 

 

(1

)

Parexel International Corp (7)

Senior Secured First Lien Term Loan

S + 275, 50 Floor

6.47%

12/2031

 

2,270

 

 

2,265

 

 

 

0.5

 

 

 

2,281

 

 

 

 

 

 

20,923

 

 

20,670

 

 

 

4.5

 

 

 

20,893

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes

 

 

 

38


 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
December 31, 2025
(in thousands, except share and per share data)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

Cost

 

 

Percentage
of Net
Assets ***

 

 

Fair
Value

 

Real Estate Management and Development

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CP Atlas Buyer Inc (7)

Senior Secured First Lien Term Loan

S + 525

8.97%

07/2030

 

2,334

 

 

2,257

 

 

 

0.5

 

 

 

2,264

 

Cushman & Wakefield US Borrower LLC (7)

Senior Secured First Lien Term Loan

S + 275, 50 Floor

6.47%

01/2030

 

743

 

 

746

 

 

 

0.2

 

 

 

749

 

Deep Blue Operating I LLC (6)(7)

Senior Secured First Lien Term Loan

S + 275

6.59%

10/2032

 

748

 

 

749

 

 

 

0.2

 

 

 

752

 

 

 

 

 

 

3,825

 

 

3,752

 

 

 

0.9

 

 

 

3,765

 

Software and Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asurion, LLC (7)

Senior Secured First Lien Term Loan

S + 435

8.07%

08/2028

 

2,537

 

 

2,505

 

 

 

0.5

 

 

 

2,544

 

Asurion, LLC (7)

Senior Secured First Lien Term Loan

S + 536.45

9.08%

01/2029

 

538

 

 

514

 

 

 

0.1

 

 

 

530

 

Bonterra LLC

Unitranche First Lien Delayed Draw Term Loan

S + 500, 75 Floor

8.94%

03/2032

 

1,347

 

 

1,344

 

 

 

0.3

 

 

 

1,340

 

Bonterra LLC (5)

Unitranche First Lien Revolver

S + 500, 75 Floor

8.69%

03/2032

 

202

 

 

197

 

 

 

0.0

 

 

 

194

 

Bonterra LLC

Unitranche First Lien Term Loan

S + 500, 75 Floor

8.67%

03/2032

 

12,396

 

 

12,344

 

 

 

2.7

 

 

 

12,334

 

Bonterra LLC (5)

Unitranche First Lien Delayed Draw Term Loan

S + 475, 75 Floor

8.69%

03/2032

 

1,384

 

 

1,359

 

 

 

0.3

 

 

 

1,358

 

C-4 Analytics

Senior Secured First Lien Term Loan

S + 500, 100 Floor

8.82%

05/2030

 

7,289

 

 

7,233

 

 

 

1.6

 

 

 

7,289

 

C-4 Analytics (5)

Senior Secured First Lien Revolver

S + 500, 100 Floor

8.82%

05/2030

 

225

 

 

219

 

 

 

0.0

 

 

 

225

 

C-4 Analytics (4)(5)

Senior Secured First Lien Delayed Draw Term Loan

 

05/2030

 

-

 

 

(7

)

 

 

-

 

 

 

-

 

CallRevu, LLC (5)

Unitranche First Lien Revolver

 

10/2032

 

-

 

 

-

 

 

 

-

 

 

 

-

 

CallRevu, LLC

Unitranche First Lien Term Loan

S + 475, 75 Floor

8.42%

10/2032

 

175

 

 

174

 

 

 

0.0

 

 

 

174

 

Concord III, LLC (5)

Unitranche First Lien Revolver

S + 625, 100 Floor

9.92%

12/2028

 

244

 

 

242

 

 

 

0.1

 

 

 

244

 

Concord III, LLC

Unitranche First Lien Term Loan

S + 600, 100 Floor

9.67%

12/2028

 

5,576

 

 

5,541

 

 

 

1.2

 

 

 

5,576

 

Concord III, LLC

Unitranche First Lien Term Loan

S + 625, 100 Floor

9.92%

12/2028

 

297

 

 

293

 

 

 

0.1

 

 

 

297

 

Concord III, LLC

Unitranche First Lien Term Loan

S + 625, 100 Floor

10.25%

12/2028

 

1,696

 

 

1,696

 

 

 

0.4

 

 

 

1,696

 

DS Admiral

Senior Secured First Lien Term Loan

S + 425

7.92%

06/2031

 

2,048

 

 

2,029

 

 

 

0.4

 

 

 

2,017

 

Ensono (7)

Senior Secured First Lien Term Loan

S + 411.45, 75 Floor

7.83%

05/2028

 

1,595

 

 

1,568

 

 

 

0.3

 

 

 

1,597

 

Evergreen IX Borrower 2023, LLC (4)(5)

Unitranche First Lien Revolver

 

09/2029

 

-

 

 

(8

)

 

 

-

 

 

 

-

 

Evergreen IX Borrower 2023, LLC

Unitranche First Lien Term Loan

S + 475, 75 Floor

8.42%

09/2030

 

4,410

 

 

4,326

 

 

 

0.9

 

 

 

4,410

 

Evergreen IX Borrower 2023, LLC

Unitranche First Lien Term Loan

S + 475, 75 Floor

8.42%

09/2030

 

4,938

 

 

4,896

 

 

 

1.1

 

 

 

4,938

 

Granicus, Inc.

Unitranche First Lien Delayed Draw Term Loan

S + 575 (225 PIK), 100 Floor

9.59%

01/2031

 

1,026

 

 

1,021

 

 

 

0.2

 

 

 

1,026

 

Granicus, Inc. (4)(5)

Unitranche First Lien Revolver

 

01/2031

 

-

 

 

(4

)

 

 

(0.0

)

 

 

(22

)

Granicus, Inc.

Unitranche First Lien Term Loan

S + 575 (225 PIK), 100 Floor

9.59%

01/2031

 

3,972

 

 

3,944

 

 

 

0.9

 

 

 

3,972

 

Granicus, Inc. (5)

Unitranche First Lien Delayed Draw Term Loan

S + 575 (225 PIK), 75 Floor

9.56%

01/2031

 

2

 

 

2

 

 

 

0.0

 

 

 

2

 

Imagine Learning LLC (7)

Senior Secured First Lien Term Loan

S + 350, 50 Floor

7.22%

12/2029

 

1,172

 

 

1,151

 

 

 

0.2

 

 

 

1,134

 

Marlabs (4)(5)

Senior Secured First Lien Delayed Draw Term Loan

 

08/2030

 

-

 

 

(5

)

 

 

-

 

 

 

-

 

Marlabs (5)

Senior Secured First Lien Revolver

S + 475, 100 Floor

8.57%

08/2030

 

67

 

 

64

 

 

 

0.0

 

 

 

67

 

See accompanying notes

 

 

39


 

 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
December 31, 2025
(in thousands, except share and per share data)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

Cost

 

 

Percentage
of Net
Assets ***

 

 

Fair
Value

 

Marlabs

Senior Secured First Lien Term Loan

S + 475, 100 Floor

8.42%

08/2030

 

3,292

 

 

3,260

 

 

 

0.7

 

 

 

3,292

 

Medicus IT (4)(5)

Unitranche First Lien Delayed Draw Term Loan

 

07/2031

 

-

 

 

(11

)

 

 

-

 

 

 

-

 

Medicus IT (5)

Unitranche First Lien Revolver

P + 475, 75 Floor

11.50%

07/2031

 

83

 

 

75

 

 

 

0.0

 

 

 

83

 

Medicus IT

Unitranche First Lien Term Loan

S + 500, 75 Floor

8.67%

07/2031

 

6,070

 

 

6,019

 

 

 

1.3

 

 

 

6,070

 

Medicus IT (4)(5)

Unitranche First Lien Delayed Draw Term Loan

 

06/2032

 

-

 

 

(2

)

 

 

-

 

 

 

-

 

Medicus IT (5)

Unitranche First Lien Revolver

P + 500, 75 Floor

11.75%

06/2032

 

66

 

 

60

 

 

 

0.0

 

 

 

66

 

Medicus IT

Unitranche First Lien Term Loan

S + 500, 75 Floor

8.67%

06/2032

 

11,387

 

 

11,302

 

 

 

2.4

 

 

 

11,387

 

Mermaid Bidco Inc. (7)

Senior Secured First Lien Term Loan

S + 325

7.15%

07/2031

 

749

 

 

749

 

 

 

0.2

 

 

 

752

 

Milano Acquisition Corp (Gainwell) (7)

Senior Secured First Lien Term Loan

S + 410, 75 Floor

7.77%

10/2027

 

2,477

 

 

2,426

 

 

 

0.5

 

 

 

2,438

 

Planview Parents, Inc. (7)

Senior Secured First Lien Term Loan

S + 350

7.17%

12/2027

 

2,562

 

 

2,503

 

 

 

0.5

 

 

 

2,465

 

Rightworks LLC (5)

Unitranche First Lien Revolver

S + 500, 100 Floor

8.72%

05/2029

 

165

 

 

165

 

 

 

0.0

 

 

 

165

 

Rightworks LLC

Unitranche First Lien Term Loan

S + 500, 100 Floor

8.72%

05/2029

 

11,440

 

 

11,440

 

 

 

2.5

 

 

 

11,440

 

Rocket Software (7)

Senior Secured First Lien Term Loan

S + 375, 50 Floor

7.47%

11/2028

 

2,803

 

 

2,793

 

 

 

0.6

 

 

 

2,806

 

Security Risk Advisors Intl, LLC (4)(5)

Unitranche First Lien Delayed Draw Term Loan

 

09/2031

 

-

 

 

(2

)

 

 

(0.0

)

 

 

(5

)

Security Risk Advisors Intl, LLC (5)

Unitranche First Lien Revolver

S + 450, 75 Floor

8.49%

09/2031

 

67

 

 

63

 

 

 

0.0

 

 

 

63

 

Security Risk Advisors Intl, LLC

Unitranche First Lien Term Loan

S + 450, 75 Floor

8.49%

09/2031

 

3,850

 

 

3,822

 

 

 

0.8

 

 

 

3,822

 

Skopima Consilio Parent LLC (7)

Senior Secured First Lien Term Loan

S + 375, 50 Floor

7.47%

05/2028

 

2,274

 

 

2,210

 

 

 

0.4

 

 

 

2,084

 

SMX Group, LLC (7)

Senior Secured First Lien Term Loan

S + 450

8.22%

02/2032

 

5,393

 

 

5,343

 

 

 

1.1

 

 

 

5,344

 

Asurion, LLC (7)(11)

Senior Secured First Lien Term Loan

S + 425

7.94%

09/2030

 

997

 

 

997

 

 

 

0.2

 

 

 

998

 

 

 

 

 

 

 

106,811

 

 

105,850

 

 

 

22.6

 

 

 

106,212

 

Telecommunication Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CCI Buyer, Inc (4)(5)

Unitranche First Lien Revolver

 

05/2032

 

-

 

 

(15

)

 

 

0.0

 

 

 

5

 

CCI Buyer, Inc

Unitranche First Lien Term Loan

S + 500, 75 Floor

9.00%

05/2032

 

28,229

 

 

27,951

 

 

 

6.1

 

 

 

28,323

 

UPC (Sunrise Financing Partnership) (7)(11)

Senior Secured First Lien Term Loan

S + 250

6.19%

03/2032

 

2,805

 

 

2,816

 

 

 

0.6

 

 

 

2,818

 

Windstream Services LLC (6)

Senior Secured First Lien Term Loan

S + 400

7.72%

09/2032

 

3,070

 

 

3,059

 

 

 

0.7

 

 

 

3,085

 

 

 

 

 

 

34,104

 

 

33,811

 

 

 

7.4

 

 

 

34,231

 

Transportation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Air Transport Services Group (Stonepeak Nile) (7)

Senior Secured First Lien Term Loan

S + 225

6.16%

04/2032

 

2,805

 

 

2,809

 

 

 

0.6

 

 

 

2,809

 

AIT Worldwide Logistics Holdings, Inc. (7)(11)

Senior Secured First Lien Term Loan

S + 400, 75 Floor

7.89%

04/2030

 

1,860

 

 

1,852

 

 

 

0.4

 

 

 

1,874

 

American Airlines Inc (6)(7)(11)

Senior Secured First Lien Term Loan

S + 225

5.94%

06/2029

 

2,782

 

 

2,782

 

 

 

0.6

 

 

 

2,789

 

American Axle & Manufacturing Inc (6)(7)(11)

Senior Secured First Lien Term Loan

S + 325

6.94%

09/2032

 

1,535

 

 

1,535

 

 

 

0.3

 

 

 

1,538

 

Jetblue Airways Corporation (6)(7)

Senior Secured First Lien Term Loan

S + 475, 50 Floor

8.44%

08/2029

 

2,411

 

 

2,300

 

 

 

0.5

 

 

 

2,320

 

Les Schwab Tire (LS Group Opco Acquisition, LLC) (7)

Senior Secured First Lien Term Loan

S + 250

6.32%

04/2031

 

2,798

 

 

2,808

 

 

 

0.6

 

 

 

2,805

 

Tenneco Inc. (7)

Senior Secured First Lien Term Loan

S + 485, 50 Floor

8.74%

11/2028

 

1,522

 

 

1,501

 

 

 

0.3

 

 

 

1,495

 

Avis Budget Car Rental LLC (6)(7)

Senior Secured First Lien Term Loan

S + 250

6.22%

07/2032

 

1,870

 

 

1,875

 

 

 

0.4

 

 

 

1,866

 

 

 

 

 

 

 

17,583

 

 

17,462

 

 

 

3.7

 

 

 

17,496

 

See accompanying notes

 

 

40


 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
December 31, 2025
(in thousands, except share and per share data)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

Cost

 

 

Percentage
of Net
Assets ***

 

 

Fair
Value

 

Total Debt Investments
United States

 

 

 

 

$

764,075

 

$

756,096

 

 

 

162.8

 

%

$

758,523

 

Equity Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial and Professional Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Iris Buyer, LLC

Common Stock

 

 

 

192

 

 

193

 

 

 

0.0

 

 

 

227

 

Iris Buyer, LLC

Common Stock

 

 

 

192,308

 

 

-

 

 

 

0.0

 

 

 

83

 

 

 

 

 

 

 

 

193

 

 

 

0.1

 

 

 

310

 

Consumer Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Landscape Workshop LLC

Common Stock

 

 

 

810,811

 

 

811

 

 

 

0.2

 

 

 

906

 

 

 

 

 

 

 

 

811

 

 

 

0.2

 

 

 

906

 

Diversified Financials

 

 

 

 

 

 

 

 

 

 

 

 

 

 

WhiteHawk Evergreen Fund, LP (2)(6)(9)(10)

Partnership Interest

 

 

 

10,000,000

 

 

10,000

 

 

 

2.2

 

 

 

10,459

 

 

 

 

 

 

 

 

10,000

 

 

 

2.2

 

 

 

10,459

 

Health Care Equipment and Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Arrow Management Acquisition, LLC

Common Stock

 

 

 

 

15,998

 

 

16

 

 

 

0.0

 

 

 

16

 

Arrow Management Acquisition, LLC

Common Stock

 

 

 

 

1,584

 

 

1,584

 

 

 

0.3

 

 

 

1,584

 

BVI Medical Inc.

Common Stock

 

 

 

 

681

 

 

909

 

 

 

0.2

 

 

 

703

 

Headlands Buyer, Inc.

Common Stock

 

 

 

 

82,454

 

 

825

 

 

 

0.2

 

 

 

825

 

IVX Health Merger Sub, Inc.

Common Stock

 

 

 

880

 

 

880

 

 

 

0.4

 

 

 

1,801

 

Vital Care Buyer, LLC

Common Stock

 

 

 

649

 

 

1

 

 

 

0.0

 

 

 

37

 

Vital Care Buyer, LLC

Common Stock

 

 

 

64

 

 

64

 

 

 

0.0

 

 

 

61

 

 

 

 

 

 

 

 

4,279

 

 

 

1.1

 

 

 

5,027

 

Pharmaceuticals, Biotechnology and Life Sciences

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nephron Pharmaceuticals LLC

Common Stock Warrant

 

 

 

4

 

 

-

 

 

 

0.0

 

 

 

39

 

RN Enterprises, LLC

Common Stock

 

 

 

633

 

 

633

 

 

 

0.2

 

 

 

749

 

WCT Group Holdings, LLC

Common Stock

 

 

 

118

 

 

1,176

 

 

 

0.5

 

 

 

2,543

 

 

 

 

 

 

 

 

1,809

 

 

 

0.7

 

 

 

3,331

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Equity Investments
United States

 

 

 

 

 

 

$

17,092

 

 

 

4.3

 

%

$

20,033

 

Switzerland

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pharmaceuticals, Biotechnology and Life Sciences

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Solvias AG LP (4)(5)(6)

Senior Secured First Lien Revolver

 

02/2032

 

CHF 0

 

 

(28

)

 

 

-

 

 

 

-

 

Solvias AG LP (6)

Senior Secured First Lien Term Loan

SR + 525, 75 Floor

6.00%

02/2032

 

CHF 11,588

 

 

9,981

 

 

 

2.5

 

 

 

11,617

 

Total Debt Investments
Switzerland

 

 

 

 

 

 

$

9,953

 

 

 

2.5

 

%

$

11,617

 

Equity Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pharmaceuticals, Biotechnology and Life Sciences

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sequence Parent (6)

Common Stock

 

 

 

3,290

 

 

197

 

 

 

0.0

 

 

 

227

 

Sequence Parent (6)

Common Stock

 

 

 

48

 

 

48

 

 

 

0.0

 

 

 

54

 

 

 

 

 

 

 

 

245

 

 

 

0.1

 

%

 

281

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Equity Investments
Switzerland

 

 

 

 

 

 

$

245

 

 

 

0.1

 

%

$

281

 

Netherlands

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial and Professional Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Avidity Acquisition B.V. (5)(6)

Unitranche First Lien - Last Out Delayed Draw Term Loan

E + 525

7.37%

03/2032

6

 

 

6

 

 

 

0.0

 

 

 

6

 

Avidity Acquisition B.V. (6)

Unitranche First Lien - Last Out Term Loan

E + 525

7.37%

03/2032

145

 

 

128

 

 

 

0.0

 

 

 

145

 

Van Der Steen (6)

Unitranche First Lien Term Loan

E + 550

7.52%

05/2031

3,862

 

 

3,462

 

 

 

0.8

 

 

 

3,862

 

Van Der Steen (6)

Unitranche First Lien Delayed Draw Term Loan

E + 550

7.57%

05/2031

1,289

 

 

1,246

 

 

 

0.3

 

 

 

1,289

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes

 

 

41


 

 

 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
December 31, 2025
(in thousands, except share and per share data)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

Cost

 

 

Percentage
of Net
Assets ***

 

 

Fair
Value

 

Pitch MidCo B.V. (5)(6)

Unitranche First Lien Delayed Draw Term Loan

E + 550

7.55%

04/2031

507

 

 

477

 

 

 

0.1

 

 

 

507

 

Pitch MidCo B.V. (6)

Unitranche First Lien Term Loan

E + 550

7.52%

04/2031

3,363

 

 

2,992

 

 

 

0.7

 

 

 

3,363

 

Pitch MidCo B.V. (6)

Unitranche First Lien Delayed Draw Term Loan

E + 625

8.28%

04/2031

1,887

 

 

1,803

 

 

 

0.4

 

 

 

1,887

 

 

 

 

 

 

 

 

10,114

 

 

 

2.3

 

 

 

11,059

 

Software and Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fugue Finance BV (6)(7)(11)

Senior Secured First Lien Term Loan

S + 275, 50 Floor

6.57%

01/2032

 

2,276

 

 

2,259

 

 

 

0.5

 

 

 

2,287

 

 

 

 

 

 

 

 

2,259

 

 

 

0.5

 

 

 

2,287

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Debt Investments
Netherlands

 

 

 

 

 

 

$

12,373

 

 

 

2.8

 

%

$

13,346

 

United Kingdom

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial and Professional Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hamsard 3778 Limited (4)(5)(6)

Unitranche First Lien Delayed Draw Term Loan

 

10/2031

£

-

 

 

(6

)

 

 

-

 

 

 

-

 

Hamsard 3778 Limited (6)

Unitranche First Lien Term Loan

SN + 550

9.22%

10/2031

£

3,837

 

 

3,626

 

 

 

0.8

 

 

 

3,837

 

 

 

 

 

 

 

 

3,620

 

 

 

0.8

 

 

 

3,837

 

Diversified Financials

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Primrose Bidco Limited (6)

Unitranche First Lien Term Loan

SN + 550

9.47%

11/2031

£

2,651

 

 

2,429

 

 

 

0.6

 

 

 

2,651

 

 

 

 

 

 

 

 

2,429

 

 

 

0.6

 

 

 

2,651

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Boots Group Finco LP (6)(7)

Senior Secured First Lien Term Loan

S + 350

7.21%

08/2032

 

1,301

 

 

1,303

 

 

 

0.3

 

 

 

1,310

 

 

 

 

 

 

 

 

1,303

 

 

 

0.3

 

 

 

1,310

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Food, Beverage and Tobacco

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Froneri US Inc (6)(7)

Senior Secured First Lien Term Loan

S + 250

6.37%

08/2032

 

3,745

 

 

3,742

 

 

 

0.8

 

 

 

3,750

 

 

 

 

 

 

 

 

3,742

 

 

 

0.8

 

 

 

3,750

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Software and Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sophos Holdings (6)(7)

Senior Secured First Lien Term Loan

S + 361.45

7.33%

03/2027

 

526

 

 

526

 

 

 

0.1

 

 

 

527

 

 

 

 

 

 

 

 

526

 

 

 

0.1

 

 

 

527

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Debt Investments
United Kingdom

 

 

 

 

 

 

$

11,620

 

 

 

2.6

 

%

$

12,075

 

Australia

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial and Professional Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ancora Bidco PTY LTD (6)

Unitranche First Lien Term Loan

B + 500, 50 Floor

8.60%

11/2030

 

AUD 3,462

 

 

3,366

 

 

 

0.8

 

 

 

3,497

 

Ancora Bidco PTY LTD (4)(5)(6)

Unitranche First Lien Delayed Draw Term Loan

 

11/2030

 

AUD 0

 

 

(11

)

 

 

0.0

 

 

 

7

 

 

 

 

 

 

 

 

3,355

 

 

 

0.8

 

 

 

3,504

 

Total Debt Investments
Australia

 

 

 

 

 

 

$

3,355

 

 

 

0.8

 

%

$

3,504

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes

 

 

 

42


 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
December 31, 2025
(in thousands, except share and per share data)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

Cost

 

Percentage
of Net
Assets ***

 

Fair
Value

 

Equity Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial and Professional Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ancora Bidco PTY LTD (6)

Common Stock

 

 

 

64,327,036

 

 

663

 

 

 

0.2

 

 

 

889

 

Ancora Bidco PTY LTD (6)

Common Stock

 

 

 

3,385,633

 

 

35

 

 

 

0.0

 

 

 

47

 

 

 

 

 

 

 

 

698

 

 

 

0.2

 

 

 

936

 

Total Equity Investments
Australia

 

 

 

 

 

 

$

698

 

 

 

0.2

 

%

$

936

 

Canada

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial and Professional Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Garda World Security Corporation (6)(7)

Senior Secured First Lien Term Loan

S + 300

6.75%

02/2029

 

2,800

 

 

2,810

 

 

 

0.6

 

 

 

2,815

 

 

 

 

 

 

 

 

2,810

 

 

 

0.6

 

 

 

2,815

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consumer Discretionary Distribution and Retail

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restaurant Brands Int’l (1011778 B.C. Unlimited) (6)(7)

Senior Secured First Lien Term Loan

S + 175

5.47%

09/2030

 

3,735

 

 

3,739

 

 

 

0.8

 

 

 

3,744

 

 

 

 

 

 

 

 

3,739

 

 

 

0.8

 

 

 

3,744

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consumer Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Husky Holding LLC (5)(6)(7)

Senior Secured First Lien Delayed Draw Term Loan

 

02/2029

 

-

 

 

-

 

 

 

0.0

 

 

 

1

 

 

 

 

 

 

 

 

-

 

 

 

0.0

 

 

 

1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Energy

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Rockpoint Gas Storage Partners (6)(7)

Senior Secured First Lien Term Loan

S + 250

6.17%

09/2031

 

928

 

 

928

 

 

 

0.2

 

 

 

934

 

 

 

 

 

 

 

 

928

 

 

 

0.2

 

 

 

934

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Health Care Equipment and Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

KLICK INC. (4)(5)(6)

Unitranche First Lien Delayed Draw Term Loan

 

11/2032

 

-

 

 

(9

)

 

 

(0.0

)

 

 

(18

)

KLICK INC. (4)(5)(6)

Unitranche First Lien Revolver

 

11/2032

 

-

 

 

(17

)

 

 

(0.0

)

 

 

(18

)

KLICK INC. (6)

Unitranche First Lien Term Loan

S + 500, 75 Floor

8.72%

11/2032

 

32,967

 

 

32,802

 

 

 

7.1

 

 

 

32,802

 

 

 

 

 

 

 

 

32,776

 

 

 

7.1

 

 

 

32,766

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Media and Entertainment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ontario Gaming GTA (One Toronto) (6)(7)

Senior Secured First Lien Term Loan

S + 425, 50 Floor

7.92%

08/2030

 

1,995

 

 

1,877

 

 

 

0.4

 

 

 

1,851

 

 

 

 

 

 

 

 

1,877

 

 

 

0.4

 

 

 

1,851

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transportation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Westjet Loyalty LP (6)(7)(11)

Senior Secured First Lien Term Loan

S + 325

6.92%

02/2031

 

1,858

 

 

1,809

 

 

 

0.4

 

 

 

1,869

 

 

 

 

 

 

 

 

1,809

 

 

 

0.4

 

 

 

1,869

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Debt Investments
Canada

 

 

 

 

 

 

$

43,939

 

 

 

9.5

 

%

$

43,980

 

France

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pharmaceuticals, Biotechnology and Life Sciences

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Olyos (5)(6)

Unitranche First Lien Delayed Draw Term Loan

E + 600

7.91%

06/2028

1,273

 

 

1,263

 

 

 

0.3

 

 

 

1,273

 

Olyos (6)

Unitranche First Lien Term Loan

E + 600

8.00%

06/2032

2,594

 

 

2,518

 

 

 

0.6

 

 

 

2,594

 

 

 

 

 

 

 

 

3,781

 

 

 

0.9

 

 

 

3,867

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Debt Investments
France

 

 

 

 

 

 

$

3,781

 

 

 

0.9

 

%

$

3,867

 

 

 

See accompanying notes

 

 

43


 

 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
December 31, 2025
(in thousands, except share and per share data)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

Cost

 

Percentage
of Net
Assets ***

 

Fair
Value

 

Ireland

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial and Professional Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ion Platform Finance US Inc (6)(7)

Senior Secured First Lien Term Loan

S + 385

7.52%

10/2032

 

2,935

 

 

2,877

 

 

 

0.6

 

 

 

2,763

 

 

 

 

 

 

 

 

2,877

 

 

 

0.6

 

 

 

2,763

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Debt Investments
Ireland

 

 

 

 

 

 

$

2,877

 

 

 

0.6

 

%

$

2,763

 

Denmark

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial and Professional Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Genmab A/S/Genmab Finance LLC (6)(7)

Senior Secured First Lien Term Loan

S + 300

6.73%

11/2032

 

1,100

 

 

1,100

 

 

 

0.2

 

 

 

1,107

 

 

 

 

 

 

 

 

1,100

 

 

 

0.2

 

 

 

1,107

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Debt Investments
Denmark

 

 

 

 

 

 

$

1,100

 

 

 

0.2

 

%

$

1,107

 

Gibraltar

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial and Professional Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Entain/GVC Holdings (6)(7)(11)

Senior Secured First Lien Term Loan

S + 225

5.94%

07/2032

 

2,808

 

 

2,797

 

 

 

0.6

 

 

 

2,791

 

 

 

 

 

 

 

 

2,797

 

 

 

0.6

 

 

 

2,791

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Debt Investments
Gibraltar

 

 

 

 

 

 

$

2,797

 

 

 

0.6

 

%

$

2,791

 

Israel

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial and Professional Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Playtika (6)(7)

Senior Secured First Lien Term Loan

S + 275

6.47%

03/2028

 

2,867

 

 

2,790

 

 

 

0.6

 

 

 

2,777

 

 

 

 

 

 

 

 

2,790

 

 

 

0.6

 

 

 

2,777

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Debt Investments
Isreal

 

 

 

 

 

 

$

2,790

 

 

 

0.6

 

%

$

2,777

 

Germany

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial and Professional Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TK Elevator Midco (6)(7)

Senior Secured First Lien Term Loan

S + 300, 50 Floor

7.20%

04/2030

 

1,855

 

 

1,847

 

 

 

0.4

 

 

 

1,869

 

 

 

 

 

 

 

 

1,847

 

 

 

0.4

 

 

 

1,869

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Debt Investments
Germany

 

 

 

 

 

 

$

1,847

 

 

 

0.4

 

%

$

1,869

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes

 

 

 

 

 

 

 

44


 

Crescent Private Credit Income Corp.
Consolidated Schedule of Investments
December 31, 2025
(in thousands, except share and per share data)

 

Country/Security/Industry/Company

Investment Type

Interest
Term *

Interest
Rate

Maturity/
Dissolution
Date

Principal
Amount,
Par Value
or Shares **

 

Cost

 

Percentage
of Net
Assets ***

 

Fair
Value

 

Finland

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial and Professional Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Saarni (5)(6)

Unitranche First Lien Delayed Draw Term Loan

E + 525

7.33%

03/2032

5

 

 

4

 

 

 

0.0

 

 

 

5

 

Saarni (6)

Unitranche First Lien Term Loan

E + 525

7.67%

03/2032

118

 

 

108

 

 

 

0.0

 

 

 

118

 

 

 

 

 

 

 

 

112

 

 

 

0.0

 

 

 

123

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Debt Investments
Finland

 

 

 

 

 

 

$

112

 

 

 

0.0

 

%

$

123

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Investments

 

 

 

 

 

 

$

870,675

 

 

 

188.9

 

%

$

879,592

 

Cash and Cash Equivalents

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dreyfus Government Cash Management Institutional Fund

Cash Equivalents

 

 

 

 

2,659

 

 

2,659

 

 

 

0.6

 

 

 

2,659

 

Goldman Sachs FS Government Fund

Cash Equivalents

 

 

 

 

31,907

 

 

31,907

 

 

 

6.9

 

 

 

31,907

 

Other cash

 

 

 

 

 

 

 

63,400

 

 

 

13.6

 

 

 

63,400

 

Total cash and cash equivalents, including restricted cash

 

 

 

 

 

 

$

97,966

 

 

 

21.1

 

 %

$

97,966

 

Investments and Cash and Cash Equivalents Total

 

 

 

 

 

 

$

968,641

 

 

 

210.0

 

%

$

977,558

 

 

*The majority of the investments bear interest at a rate that may be determined by reference to Secured Overnight Financing Rate (“SOFR” or “S”), Prime (“P”), EURIBOR (“E”), SONIA (“SN”), BBSY (“B”) or SARON (“SR”) and which reset monthly, quarterly, semiannually, or annually. For each, the Company has provided the spread over the reference rate and the current interest rate in effect at the reporting date. The impact of a credit spread adjustment, if applicable, is included within the stated all-in interest rate. As of December 31, 2025, the reference rates for the Company’s variable rate loans are represented in the below table. Certain investments are subject to an interest rate floor. For fixed rate loans, a spread above a reference rate is not applicable.

**The total par amount is presented for debt investments, while the number of shares or units owned is presented for equity investments. Par amount is denominated in U.S. Dollars ($) unless otherwise noted.

***Percentage is based on net assets of $465,069 as of December 31, 2025.

 

 

 

 

 

Reference Rate

 

Overnight

 

 

1 Month

 

 

3 Month

 

 

6 Month

 

 

12 Month

 

Prime (“P”)

 

6.75%

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

SOFR (“S”)

 

 

-

 

 

3.69%

 

 

3.65%

 

 

3.57%

 

 

3.14%

 

EURIBOR (“E”)

 

 

-

 

 

1.96%

 

 

2.06%

 

 

2.12%

 

 

2.22%

 

SONIA (“SN”)

 

3.73%

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

BBSY (“B”)

 

 

-

 

 

 

-

 

 

3.60%

 

 

 

-

 

 

 

-

 

SARON (“SR”)

 

 

-

 

 

-0.04%

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(1)
All positions held are non-controlled/non-affiliated investments, unless otherwise noted, as defined by the Investment Company Act. Non-controlled/non-affiliated investments are investments that are neither controlled nor affiliated.
(2)
All debt investments are income-producing, unless otherwise noted. Equity and member interests are non-income-producing unless otherwise noted. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act. Its investments are therefore generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act.
(3)
The fair value of the investment was determined using significant unobservable inputs unless otherwise noted, as defined by the Investment Company Act. See Note 2 “Summary of Significant Accounting Policies.”
(4)
The negative cost, if applicable, is the result of the capitalized discount or unfunded commitment being greater than the principal amount outstanding on the loan. The negative fair value, if applicable, is the result of the capitalized discount or unfunded commitment on the loan.
(5)
Position or portion thereof is an unfunded loan commitment and no interest is being earned on the unfunded portion. The investment may be subject to an unused/letter of credit facility fee. See Note 8 “Commitments and Contingencies.”
(6)
Investment is not a qualifying asset as defined under section 55(a) of the Investment Company Act of 1940. Qualifying assets must represent at least 70% of total assets at the time of acquisition. The Company’s percentage of non-qualifying assets based on fair value was 18.3% as of December 31, 2025.
(7)
This investment is valued using observable inputs and is considered a Level 2 investment per FASB guidance under ASC 820. See Note 5 “Fair Value of Financial Instruments” for further information related to investments at fair value.
(8)
Fixed rate investment.
(9)
This investment was valued using net asset value as a practical expedient for fair value. Consistent with FASB guidance under ASC 820, these investments are excluded from the hierarchical level.

45


 

(10)
Capital contributed to this investment is subject to restrictions on withdrawal.
(11)
Position or portion thereof unsettled as of December 31, 2025.

 

 

 

 

46


 

 

Crescent Private Credit Income Corp.

Notes to Consolidated Financial Statements

(in thousands, except share and per share amounts)

June 30, 2026
(Unaudited)

Note 1. Organization and Basis of Presentation

Crescent Private Credit Income Corp. (the “Company”) was formed on November 10, 2022 as a Maryland corporation structured as a non-diversified, closed-end management investment company. The Company elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “Investment Company Act”). The Company is externally managed by its adviser, Crescent Cap NT Advisors, LLC (the “Adviser”), an investment adviser registered with the Securities and Exchange Commission (the “SEC”) under the Investment Advisers Act of 1940. In addition, the Company has elected to be treated, and intends to qualify annually, as a regulated investment company (a “RIC”) under Subchapter M of the Internal Revenue Code of 1986 (the “Code”). As a RIC, the Company will not be taxed on its income to the extent that it distributes such income each year and satisfies other applicable income tax requirements. The Company has authorized three classes of its common stock, par value $0.01 per share, Class S Common Stock (“Class S shares”), Class D Common Stock (“Class D shares”) and Class I Common Stock (“Class I shares” and, together with Class S shares and Class D shares, “Common Shares”).

The Company’s investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation. The Company invests primarily in directly originated assets, including debt securities and related equity investments, made to or issued by U.S. middle-market companies. The Company may also make investments in syndicated loans and other liquid credit opportunities, including in publicly traded debt instruments, for cash management purposes and to generate attractive risk adjusted returns.

CCAP Administration LLC (the “Administrator”) provides certain administrative services necessary for the Company to operate. Company management consists of investment and administrative professionals from the Adviser and Administrator, along with the Company’s Board of Directors (the “Board”). The Adviser directs and executes the investment operations and capital raising activities of the Company subject to oversight from the Board, which sets the broad policies of the Company. The Board has delegated investment management of the Company’s portfolio assets to the Adviser. The Board consists of five directors, three of whom are independent.

From time to time, the Company may form wholly owned subsidiaries to facilitate the normal course of business if the Adviser determines that for legal, tax, regulatory, accounting or other similar reasons it is in the best interest of the Company to do so. The Company has also formed special purpose vehicles that hold certain investments in connection with the Company’s credit facilities.

On May 3, 2023, Crescent Capital Group LP, an affiliate of the Adviser (“Crescent”), purchased 1,000 Common Shares for $25, or $25.00 per share.

In addition, the Company has sold Class I shares to certain private placement investors (“Private Placement Investors”) including affiliates of Sun Life Financial Inc. (together with its subsidiaries and joint ventures, “Sun Life”), Crescent’s parent company, in transactions (each, a “Private Placement”) exempt from the registration provisions of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to Section 4(a)(2) thereof and/or Regulation S promulgated thereunder.

On August 1, 2024, the Company began to publicly offer on a continuous basis of up to $2.5 billion in Common Shares, including Class I shares, Class S shares and Class D shares, pursuant to a registered offering (the “Offering”). On April 29, 2026, the Company filed a registration statement on Form N-2 increasing the size of the Offering to up to $3.0 billion in Common Shares.

 

Note 2. Summary of Significant Accounting Policies

Basis of Presentation

The Company’s functional currency is the United States dollar and these consolidated financial statements have been prepared in that currency. The Company’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to Regulation S-X. The Company is treated as an investment company and, therefore, applies the specialized accounting and reporting guidance in Accounting Standards Codification (“ASC”) 946, Financial Services – Investment Companies.

The accompanying consolidated financial statements of the Company and related financial information have been prepared pursuant to the requirements for reporting on Form 10-Q and Regulation S-X. In the opinion of management, the consolidated financial statements reflect all adjustments and reclassifications consisting solely of normal accruals that are necessary for the fair presentation of financial results as of and for the periods presented. The Company consolidates all entities in which it holds a controlling financial interest. All intercompany balances and transactions have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the current period presentation.

47


 

Use of Estimates

The preparation of the consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions that may affect the amounts reported in the consolidated financial statements and accompanying notes. The consolidated financial statements reflect all adjustments that in the opinion of management are necessary for the fair statement of the Company’s results of the period presented. Although management believes that the estimates and assumptions are reasonable, changes in the economic environment, financial markets and any other parameters used in determining these estimates could cause actual results to differ materially.

Cash and Cash Equivalents and Restricted Cash and Restricted Cash Equivalents

Cash and cash equivalents consist of demand deposits and may include highly liquid investments (e.g., money market funds, U.S. Treasury notes, and similar type instruments) with original maturities of three months or less. The Company deposits its cash and cash equivalents with highly rated banking corporations and, at times, cash deposits may exceed the insured limits under applicable law. Cash equivalents held by the Company are deemed to be a Level 1 asset per ASC 820 Fair Value hierarchy, as defined below. Restricted cash and cash equivalents consists of deposits and cash collateral held at U.S. Bank N.A. related to the Company’s credit facilities.

Investment Transactions

Loan originations are recorded on the date of the binding commitment. Investments purchased on a secondary market are recorded on the trade date. Realized gains or losses are recorded using the specific identification method as the difference between the net proceeds received (excluding prepayment fees, if any) and the amortized cost basis of the investment without regard to unrealized gains or losses previously recognized, and include investments written off during the period, net of recoveries. The net change in unrealized gains or losses primarily reflects the change in investment fair values as of the last day of the reporting period and also includes the reversal of previously recorded unrealized gains or losses with respect to investments realized during the period.

Investment Valuation

The Company applies Financial Accounting Standards Board ASC 820, Fair Value Measurement (ASC 820), as amended, which establishes a framework for measuring fair value in accordance with GAAP and required disclosures of fair value measurements. ASC 820 determines fair value to be the price that would be received for an investment in a current sale, which assumes an orderly transaction between market participants on the measurement date. Market participants are defined as buyers and sellers in the principal or most advantageous market (which may be a hypothetical market) that are independent, knowledgeable, and willing and able to transact. In accordance with ASC 820, the Company considers its principal market to be the market that has the greatest volume and level of activity. ASC 820 specifies a fair value hierarchy that prioritizes and ranks the level of observability of inputs used in the determination of fair value. In accordance with ASC 820, these levels are summarized below:

Level 1—Valuations based on quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access.
Level 2—Valuations based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.
Level 3—Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

Investments for which market quotations are readily available are typically valued at those market quotations. To validate market quotations, the Adviser utilizes a number of factors to determine if the quotations are representative of fair value, including the source and number of the quotations. With respect to investments for which market quotations are not readily available, or for which market quotations are deemed not reflective of the fair value, the Adviser, as the Board’s valuation designee, determines the fair value of the investments in good faith, based on, among other things, the fair valuation recommendations from investment professionals, the oversight of the Company’s Audit Committee and independent third-party valuation firms.

The Adviser, as the valuation designee, undertakes a multi-step valuation process under the supervision of the Board, which includes, among other procedures, the following:

Each investment is initially valued by the investment professionals responsible for monitoring that investment.
The Adviser has established pricing and valuation committees, which are responsible for reviewing and approving the fair valuation recommendations from the investment professionals.
The valuations of certain portfolio investments are independently corroborated by third-party valuation firms based on certain criteria including investment size and risk profile.
Final valuation determinations and supporting materials are provided to the Board quarterly as part of the Boards oversight of the Adviser as the valuation designee.

Investments in investment companies are valued at fair value. Fair values are generally determined utilizing the net asset value (“NAV”) supplied by, or on behalf of, management of each investment company, which is net of management and incentive fees or allocations charged by the investment company and is in accordance with the “practical expedient”, as defined by ASC 820. NAVs

48


 

received by, or on behalf of, management of each investment company are based on the fair value of the investment company’s underlying investments in accordance with policies established by management of each investment company, as described in each of their financial statements and offering memorandum. Investments which are valued using NAV as a practical expedient are excluded from the above hierarchy.

The Company applies the valuation policy approved by the Board that is consistent with ASC 820. Consistent with the valuation policy, the Adviser, in its capacity as the Board’s valuation designee, evaluates the source of inputs, including any markets in which its investments are trading (or any markets in which securities with similar attributes are trading), in determining fair value. When a security is valued based on prices provided by reputable dealers or pricing services (that is, broker quotes), the Company subjects those prices to various criteria in making the determination as to whether a particular investment would qualify for classification as a Level 2 or Level 3 investment. For example, the Company reviews pricing methodologies provided by dealers or pricing services in order to determine if observable market information is being used, versus unobservable inputs. Some additional factors considered include the number of prices obtained as well as an assessment as to their quality. Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur.

Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Additionally, the fair value of such investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values that may ultimately be realized. Further, such investments are generally less liquid than publicly traded securities and may be subject to contractual and other restrictions on resale. If the Company were required to liquidate a portfolio investment in a forced or liquidation sale, it could realize amounts that are different from the amounts presented and such differences could be material. In addition, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses ultimately realized on these investments to be different from the unrealized gains or losses reflected herein.

Foreign Currency

Foreign currency amounts are translated into U.S. dollars on the following basis:

 

• cash and cash equivalents, fair value of investments, outstanding debt on revolving credit facilities, other assets and liabilities: at the spot exchange rate on the last business day of the period; and

 

• purchases and sales of investments, borrowings and repayments of such borrowings, income and expenses: at the rates of exchange prevailing on the respective dates of such transactions.

 

Although net assets and fair values are presented based on the applicable foreign exchange rates described above, the Company does not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in fair values of investments held. Gains or losses on foreign currency transactions are included within net realized gain (loss) on foreign currency transactions on the Consolidated Statements of Operations. Fluctuations arising from the translation of foreign currency on cash, investments and borrowings are included within net change in unrealized appreciation (depreciation) on investments and foreign currency translation on the Consolidated Statements of Operations.

 

The Company’s approach to hedging the foreign currency exposure in its non-U.S. dollar denominated investments is to borrow local currency under the Company’s credit facilities or to enter into foreign currency forward contracts.

 

Foreign Currency Forward Contracts

 

The Company may enter into foreign currency forward contracts to reduce the Company’s exposure to foreign currency exchange rate fluctuations in the value of foreign currencies. In a foreign currency forward contract, the Company agrees to receive or deliver a fixed quantity of one currency for another, at a pre-determined price at a future date. Forward foreign currency contracts are marked-to-market at the applicable forward rate. Unrealized appreciation (depreciation) on foreign currency forward contracts are recorded on the Consolidated Statements of Assets and Liabilities on a gross basis, not taking into account collateral posted which is recorded separately, if applicable. All foreign currency forward contracts are currently held with a single counterparty. Notional amounts and the gross fair value of foreign currency forward contract assets and liabilities are presented separately on the Consolidated Schedule of Investments. Purchases and sales of foreign currency forward contracts having the same notional value, settlement date and counterparty are generally settled net (which results in a net foreign currency position of zero with the counterparty) and any realized gains or losses are recognized on the settlement date. The Company does not utilize hedge accounting and as such, the Company recognizes its derivatives at fair value with changes in the net unrealized appreciation (depreciation) on foreign currency forward contracts recorded on the Consolidated Statements of Operations.

49


 

Debt Issuance Costs

The Company records costs related to the issuance of debt obligations as deferred financing costs. These costs are amortized over the life of the related debt instrument using the straight-line method which approximates the effective interest method. See Note 6 “Debt” for details.

Interest and Dividend Income Recognition

Interest income is recorded on an accrual basis and includes the amortization of purchase discounts and premiums. Discounts and premiums to par value are accreted or amortized into interest income over the contractual life of the respective security using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion and amortization of discounts and premiums, if any. Upon prepayment of a loan or debt security, any prepayment premiums, unamortized upfront loan origination fees and unamortized discounts are recorded as interest income.

Dividend income from common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly traded portfolio companies. Dividend income from preferred equity securities is recorded on an accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected. Each distribution received from an equity investment is evaluated to determine if the distribution should be recorded as dividend income or a return of capital to the stockholders. Generally, the Company will not record distributions from equity investments as dividend income unless there is sufficient current or accumulated earnings prior to the distribution. Distributions that are classified as a return of capital to stockholders are recorded as a reduction in the cost basis of the investment.

Certain investments have contractual payment-in-kind (“PIK”) interest or dividends. PIK represents accrued interest or accumulated dividends that are added to the loan principal or cost basis of the investment on the respective interest or dividend payment dates rather than being paid in cash and generally becomes due at maturity or upon being called by the issuer. PIK is recorded as interest income, as applicable. If at any point the Company believes PIK is not expected to be realized, the investment generating PIK will be placed on non-accrual status. Accrued PIK interest or dividends are generally reversed through interest or dividend income, respectively, when an investment is placed on non-accrual status.

Loans are generally placed on non-accrual status when principal or interest payments are past due 30 days or more or when there is reasonable doubt that principal or interest will be collected in full. Accrued and unpaid interest is generally reversed when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as income or applied to principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid current and, in management’s judgment, are likely to remain current. Management may determine to not place a loan on non-accrual status if the loan has sufficient collateral value and is in the process of collection. As of June 30, 2026, the Company had investments in one portfolio company on non-accrual status, which represented 0.9% and 0.5% of the total debt investments at cost and fair value, respectively. As of December 31, 2025, the Company had no investments on non-accrual status.

Other Income

Other income may include income such as consent, waiver, amendment, agency, underwriting and arranger fees associated with the Company’s investment activities. Such fees are recognized as income when earned or the services are rendered.

Offering Expenses

The Company’s offering expenses include, among other things, legal fees, registration fees and other costs pertaining to the preparation of the Company’s registration statement (and any amendments or supplements thereto) relating to the Offering and associated marketing materials. Any offering expenses incurred by the Company, including reimbursements to the Adviser, are recorded as deferred offering costs on the Consolidated Statements of Assets and Liabilities and subsequently amortized to expenses on the Company’s Consolidated Statements of Operations over 12 months. The Company’s reimbursement of offering expenses paid on its behalf will be in accordance with the terms of the Expense Support and Conditional Reimbursement Agreement. As of June 30, 2026 and December 31, 2025, the Company had $488 and $366 of offering expenses, respectively, capitalized on the Consolidated Statements of Assets and Liabilities. For the three and six months ended June 30, 2026, the Company amortized $205 and $416 of offering expenses, respectively. For the three and six months ended June 30, 2025, the Company amortized $1,061 and $2,021 of offering expenses, respectively.

Income Taxes

The Company elected to be regulated as a BDC under the Investment Company Act. The Company also intends to qualify annually as a RIC under the Code. So long as the Company maintains its status as a RIC, it will generally not pay corporate-level U.S. federal income or excise taxes on any ordinary income or capital gains that it distributes at least annually to its stockholders as dividends. As a result, any tax liability related to income earned and distributed by the Company represents obligations of the Company’s stockholders and will not be reflected in the consolidated financial statements of the Company.

The Company evaluates tax positions taken or expected to be taken in the course of preparing its consolidated financial statements to determine whether the tax positions are “more-likely-than-not” to be sustained by the applicable tax authority. Tax positions not

50


 

deemed to meet the “more-likely-than-not” threshold are reserved and recorded as a tax benefit or expense in the current year. All penalties and interest associated with income taxes are included in income tax expense. Conclusions regarding tax positions are subject to review and may be adjusted at a later date based on factors including, but not limited to, on-going analyses of tax laws, regulations and interpretations thereof. The Company accounts for income taxes in conformity with ASC 740 - Income Taxes (“ASC 740”). ASC 740 provides guidelines for how uncertain tax positions should be recognized, measured, presented and disclosed in the consolidated financial statements. The Company intends to make the requisite distributions to its stockholders, which will generally relieve the Company from corporate-level income taxes.

The Company intends to comply with the applicable provisions of the Code, pertaining to regulated investment companies and to make distributions of taxable income sufficient to relieve it from substantially all federal income taxes. As of June 30, 2026, the Company is subject to potential examination by U.S. federal tax authorities and state tax authorities for returns filed since the Company’s inception in 2023.

In order for the Company not to be subject to federal excise taxes, it must distribute annually an amount at least equal to the sum of (i) 98% of its ordinary income (taking into account certain deferrals and elections) for the calendar year, (ii) 98.2% of its net capital gains for the current one-year period ending October 31 in that calendar year and (iii) any undistributed ordinary income and net capital gains from preceding years. The Company, at its discretion, may carry forward taxable income in excess of calendar year dividends and pay a 4% excise tax on this income. If the Company chooses to do so, this generally would increase expenses and reduce the amount available to be distributed to stockholders. The Company accrues excise tax on estimated undistributed taxable income as required on a quarterly basis. See Note 11 “Income Taxes” for details.

Allocation of Income, Expenses, Gains and Losses

Income, expenses (other than those attributable to a specific class), gains and losses are allocated to each class of shares based upon the aggregate NAV of that class in relation to the aggregate NAV of the Company. Expenses that are specific to a class of shares are allocated to such class directly.

Distributions

To the extent that the Company has taxable income available, the Company intends to make monthly distributions to its stockholders. Distributions to stockholders are recorded on the record date. All distributions will be paid at the discretion of the Board and will depend on the Company’s earnings, financial condition, maintenance of the tax treatment as a RIC, compliance with applicable BDC regulations and such other factors as the Board may deem relevant from time to time. Although the gross distribution per share is generally equivalent for each share class, the net distribution for each share class is reduced for any class specific expenses, including stockholder servicing and/or distribution fees, if any.

The Company has adopted a distribution reinvestment plan pursuant to which stockholders will have their cash distributions automatically reinvested in additional shares of the Company’s same class of common stock to which the distribution relates unless they elect to receive their distributions in cash.

Segment Reporting

Since its commencement, the Company has operated and been managed as a single reportable segment deriving returns mainly in the form of interest income, dividend income and other fees from the investments made in pursuit of its single stated investment objective. The accounting policies of the Company are consistent with those described in these Notes to Consolidated Financial Statements. The chief operating decision maker (“CODM”) is represented by an executive committee comprised of a chief executive officer, a chief financial officer and other executive officers of the Company. The CODM considers net investment income, leverage and increase (decrease) in net assets resulting from operations in deciding how to deploy capital and/or make distributions to stockholders. Detailed financial information for the Company is disclosed within these financial statements with total assets and liabilities disclosed on the Consolidated Statements of Assets and Liabilities, investments held on the Consolidated Schedule of Investments, results of operations and significant segment expenses on the Consolidated Statements of Operations and other information about the Companys performance, including total return, portfolio turnover and ratios within the Financial Highlights in Note 10.

 

Note 3. Agreements and Related Party Transactions

Administration Agreement

On May 3, 2023, the Company entered into an administration agreement with the Administrator and on August 27, 2024 amended and restated such administration agreement (as amended and restated, the “Administration Agreement”). The Board, including a majority of the Company’s independent directors, also approved the renewal of the Administration Agreement at a board meeting held on February 11, 2026. Under the terms of the Administration Agreement, the Administrator provides administrative services to the Company. These services include providing office facilities, equipment, clerical bookkeeping and record keeping services, maintaining financial and other records, preparing reports to stockholders and reports and other materials filed with the SEC or any other regulatory authority, and generally overseeing the payment of expenses and the performance of administrative and professional services rendered

51


 

by others. The Administrator also will provide on the Company’s behalf significant managerial assistance to those portfolio companies to which the Company is required to provide such assistance. Certain of these services are reimbursable to the Administrator under the terms of the Administration Agreement. In addition, the Administrator is permitted to delegate its duties under the Administration Agreement to affiliates or third parties. To the extent the Administrator outsources any of its functions, the Company will pay the fees associated with such functions on a direct basis, without incremental profit to the Administrator. The Administration Agreement may be terminated by either party without penalty on 60 days’ written notice to the other party.

For the three and six months ended June 30, 2026, the Company incurred administrative services expenses of $382 and $764, respectively, which are included in administrative services expenses on the Consolidated Statements of Operations. For the three and six months ended June 30, 2025, the Company incurred administrative services expenses of $336 and $670, respectively, which are included in administrative services expenses on the Consolidated Statements of Operations. As of June 30, 2026 and December 31, 2025, $269 and $223, respectively, were payable to the Administrator, which were included in accrued expenses and other liabilities on the Consolidated Statements of Assets and Liabilities. In addition to administrative services expenses, the payable balances may include other operating expenses paid by the Administrator on behalf of the Company.

No person who is an officer, director or employee of the Administrator or its affiliates and who serves as a director of the Company receives any compensation for his or her services as a director. However, the Company reimburses the Administrator (or its affiliates) for an allocable portion of the costs, expenses, compensation and benefits paid by the Administrator or its affiliates to the Company’s chief compliance officer, chief financial officer, general counsel and secretary, their respective staffs and operations staff who provide services to the Company; provided that such reimbursement does not conflict with Section 7.8 of the Company’s charter. The allocable portion of the compensation for these officers and other professionals are included in the administration expenses paid to the Administrator. Directors who are not affiliated with the Administrator or its affiliates receive compensation for their services and reimbursement of expenses incurred to attend meetings.

Investment Advisory and Management Agreement

On May 3, 2023, the Company entered into an investment advisory and management agreement with the Adviser and on September 5, 2023 and August 27, 2024 amended and restated such investment advisory and management agreement (as amended and restated, the “Investment Advisory and Management Agreement”). The Board, including a majority of the Company’s independent directors, most recently approved the renewal of the Company’s Investment Advisory and Management Agreement at a board meeting held on February 11, 2026. Under the terms of the Investment Advisory and Management Agreement, the Adviser provides investment advisory services to the Company and its portfolio investments. The Adviser’s services under the Investment Advisory and Management Agreement are not exclusive, and the Adviser is free to furnish similar or other services to others so long as its services to the Company are not impaired. From time to time the Adviser may voluntarily agree to defer or waive all or portion of the fees (including incentive fees) and/or rights to be reimbursed for expenses that would otherwise have been earned by the Adviser during any period. Any such waiver is made at the sole discretion of the Adviser and is not required by any contractual or regulatory obligation.

Under the terms of the Investment Advisory and Management Agreement, the Adviser is entitled to receive a base management fee and may also receive incentive fees, as discussed below. The Adviser waived its base management fee from inception through April 30, 2024 and began charging its base management fee on the value of the Company’s net assets as of May 1, 2024 on the terms set forth in the Investment Advisory and Management Agreement. The Adviser voluntarily agreed to waive incentive fees from the Company’s inception through June 30, 2026. In addition, the Adviser has also voluntarily waived its right to receive management and incentive fees related to the Company’s investments in WhiteHawk Evergreen Fund LP and Constellation Wealth Capital Fund II for any period in which these investments remain in the investment portfolio.

Base Management Fee

The management fee is payable monthly in arrears at an annual rate of 1.25% of the value of the Company’s net assets as of the beginning of the first calendar day of the applicable month. For purposes of calculating the management fee under the Investment Advisory and Management Agreement, net assets means the Company’s total net assets, determined on a consolidated basis in accordance with GAAP, and appropriately adjusted for any share issuances or repurchases during the current calendar month. For example, assuming there were 30 days in a calendar month, if we sold shares on the first day of the month, our net asset value for such month would give effect to the net proceeds of the issuance for the 30 days of the month during which the additional shares were outstanding. If we repurchased shares on the 25th day of the month, our net asset value for such month would give effect to the repurchase for the five days of the month during which such shares were no longer outstanding. For the first calendar month in which the Company had operations, May 2023, net assets were measured as the beginning net assets as of the effective date of the initial Investment Advisory and Management Agreement.

For the three and six months ended June 30, 2026, the Company incurred management fees of $1,705 and $3,273, respectively, of which $20 and $38, respectively, were voluntarily waived by the Adviser.

For the three and six months ended June 30, 2025, the Company incurred management fees of $804 and $1,386, respectively, of which $15 and $24, respectively, were voluntarily waived by the Adviser. As of June 30, 2026 and December 31, 2025, $1,685 and $1,313 management fees, respectively, were unpaid.

52


 

Incentive Fee per Investment Advisory and Management Agreement

Under the Investment Advisory and Management Agreement, the incentive fee consists of two parts:

The first part, the income incentive fee, is calculated and payable quarterly in arrears and is paid with respect to the Company’s pre-incentive fee net investment income (as defined below) in each calendar quarter as follows: (a) no incentive fee based on pre-incentive fee net investment income in any calendar quarter in which the Company’s pre-incentive fee net investment income does not exceed a hurdle rate of 1.25% per quarter (5.0% annualized) (the “Hurdle”), (b) 100% of the dollar amount of the Company’s pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income, if any, that exceeds the Hurdle rate but is less than a rate of return of 1.4286% (5.714% annualized), and (c) 12.5% of the dollar amount of the Company’s pre-incentive fee net investment income, if any, that exceeds a rate of return of 1.4286% (5.714% annualized).

The second part, the capital gains incentive fee, is determined and payable in arrears as of the end of each calendar year at a rate of 12.5% of the Company’s realized capital gains, if any, on a cumulative basis from the Company’s commencement of operations through the end of such calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees. In the event that the Investment Advisory and Management Agreement shall terminate as of a date that is not a calendar year end, the termination date shall be treated as though it were a calendar year end for purposes of calculating and paying a capital gains incentive fee.

Pre-incentive fee net investment income means, as the context requires, either the dollar value of, or percentage rate of return on the value of the Company’s net assets in accordance with GAAP at the end of the immediately preceding quarter from, interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that the Company receives from portfolio companies) accrued during each calendar quarter, minus the Company’s operating expenses accrued for such quarter (including the base management fee, expenses payable under the Administration Agreement entered into between us and the Administrator and any interest expense or fees on any credit facilities or outstanding debt and dividends paid on any issued and outstanding preferred stock, but excluding the incentive fee and any stockholder and/or distribution servicing fees). Pre-incentive fee net investment income returns include, in the case of investments with a deferred interest feature (such as market or original issue discount, debt investments with PIK interest and zero coupon securities), accrued income that the Company has not yet received in cash. Pre-incentive fee net investment income returns do not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. The impact of expense support payments and recoupments is also excluded from pre-incentive fee net investment income. Fees payable under the Investment Advisory and Management Agreement for any partial period will be appropriately prorated and adjusted for any share issuances or repurchases during the relevant quarter.

 

For the purposes of calculating the incentive fee under the Investment Advisory and Management Agreement, these calculations are appropriately prorated and adjusted for any share issuances or repurchases during the relevant quarter, if applicable. For example, assuming there were 90 days in a calendar quarter, if we sold shares on the 31st day of the quarter, our pre-incentive fee net investment income returns, expressed as a rate of return on the value of our net assets at the end of the immediately preceding quarter, for such quarter would give effect to the net proceeds of the issuance for the 60 days of the quarter during which the additional shares were outstanding. If we repurchased shares on the 85th day of the quarter, our pre-incentive fee net investment income returns, expressed as a rate of return on the value of our net assets at the end of the immediately preceding quarter, for such quarter would give effect to the repurchase for the five days of the month during which such shares were no longer outstanding.

 

For the three and six months ended June 30, 2026, the Company incurred income incentive fees of $1,410 and $2,753, respectively, all of which were voluntarily waived by the Adviser. For the three and six months ended June 30, 2025, the Company incurred income incentive fees of $482 and $842, respectively, all of which were voluntarily waived by the Adviser. As of June 30, 2026 and December 31, 2025, no income incentive fees were unpaid.

Capital Gains Based Incentive Fee on Cumulative Unrealized Capital Appreciation

The Company accrues, but does not pay, a portion of the incentive fee based on capital gains with respect to net unrealized appreciation. Under GAAP, the Company is required to accrue an incentive fee based on capital gains that includes net realized capital gains and losses and net unrealized capital appreciation and depreciation on investments held at the end of each period. In calculating the accrual for the incentive fee based on capital gains, the Company considers the cumulative aggregate unrealized capital appreciation in the calculation, since an incentive fee based on capital gains would be payable if such unrealized capital appreciation were realized, even though such unrealized capital appreciation is not permitted to be considered in calculating the fee payable under the Investment Advisory and Management Agreement. This accrual is calculated using the aggregate cumulative realized capital gains and losses and aggregate cumulative unrealized capital appreciation or depreciation. If such amount is positive at the end of a period, then the Company records a capital gains incentive fee equal to 12.5% of such amount, minus the aggregate amount of actual incentive fees based on capital gains paid in all prior periods. If such amount is negative, then there is no accrual for such period. There can be no assurance that such unrealized capital appreciation will be realized in the future.

53


 

For the three and six months ended June 30, 2026, the Company recorded (reversed) capital gains incentive fees of $0 and $(462), respectively. For the three and six months ended June 30, 2025, the Company recorded capital gains incentive fees of $373 and $185, respectively. Because the Adviser has agreed to voluntarily waive all incentive fees from inception through June 30, 2026, for the three and six months ended June 30, 2026, the Company recorded (reversed) a corresponding waiver of capital gains incentive fees of $0 and $462, respectively, and for the three and six months ended June 30, 2025, the Company recorded (reversed) a corresponding waiver of capital gains incentive fees of $(373) and $(185), respectively. As of June 30, 2026 and December 31, 2025, no capital gains based incentive fees remain outstanding.

Intermediary Manager Agreement

On July 17, 2023, the Company entered into an Intermediary Manager agreement (the “Intermediary Manager Agreement”) with Emerson Equity LLC (the “Intermediary Manager”). Our Board, including a majority of our independent directors, approved the continuation of the Intermediary Manager Agreement, at a board meeting held on February 11, 2026. Under the terms of the Intermediary Manager Agreement, the Intermediary Manager agreed to, among other things, manage the Company’s relationships with third-party brokers engaged by the Intermediary Manager to participate in the distribution of common shares and financial advisors. The Intermediary Manager will be entitled to receive stockholder servicing and/or distribution fees monthly in arrears at an annual rate of 0.85% of the Company’s aggregate NAV attributable to Class S shares as of the beginning of the first calendar day of the month. The Intermediary Manager is entitled to receive stockholder servicing and/or distribution fees monthly in arrears at an annual rate of 0.25% of the Company’s aggregate NAV attributable to Class D shares as of the beginning of the first calendar day of the month. No stockholder servicing and/or distribution fees will be paid with respect to Class I shares. The stockholder servicing and/or distribution fees will be payable to the Intermediary Manager, but the Intermediary Manager anticipates that all or a portion of the stockholder servicing and/or distribution fees will be retained by, or re-allowed (paid) to, participating broker-dealers.

The Company will cease paying the stockholder servicing and/or distribution fees on the Class S shares and Class D shares on the earlier to occur of the following: (i) a listing of Class I shares, (ii) a merger or consolidation with or into another entity, or the sale or other disposition of all or substantially all of the Company’s assets or (iii) the date following the completion of the primary portion of the Offering on which, in the aggregate, underwriting compensation from all sources in connection with the Offering, including the stockholder servicing and/or distribution fees and other underwriting compensation, is equal to 10% of the gross proceeds from the Offering.

In addition, at the end of the month in which the Intermediary Manager in conjunction with the transfer agent determines that total transaction or other fees, including upfront placement fees or brokerage commissions, and stockholder servicing and/or distribution fees paid with respect to any single share held in a stockholder’s account would exceed, in the aggregate, 10% of the gross proceeds from the sale of such Common Shares (or a lower limit as determined by the Intermediary Manager or the applicable selling agent), the Company will cease paying the stockholder servicing and/or distribution fee on either (i) each such share that would exceed such limit or (ii) all Class S shares and Class D shares in such stockholder’s account. At the end of such month, the applicable Class S shares or Class D shares in such common stockholder’s account will convert into a number of Class I shares (including any fractional shares), with an equivalent aggregate NAV as such Class S shares or Class D shares.

The Intermediary Manager is a broker-dealer registered with the SEC and is a member of the Financial Industry Regulatory Authority.

The Intermediary Manager Agreement may be terminated at any time, without the payment of any penalty, by vote of a majority of the Company’s board of directors who are not “interested persons”, as defined in the Investment Company Act, of the Company and who have no direct or indirect financial interest in the operation of the Company’s distribution plan or the Intermediary Manager Agreement or by vote of a majority of the outstanding voting securities of the Company, on not more than 60 days’ written notice to the Intermediary Manager.

The Intermediary Manager may terminate the Intermediary Manager Agreement, without the payment of penalty, on at least 120 days’ written notice to the Company. Either party may terminate the Intermediary Manager Agreement immediately upon notice to the other party in the event that such other party shall have failed to comply with any material provision of the Intermediary Manager Agreement. The Intermediary Manager Agreement will automatically terminate in the event of its assignment, as defined in the Investment Company Act. The Company’s obligations under the Intermediary Manager Agreement to pay the stockholder servicing and/or distribution fees with respect to the Class S shares and Class D shares distributed shall survive termination of the agreement until such shares are no longer outstanding (including such shares that have been converted into Class I shares, as described above).

Distribution and Servicing Plan

The Board has approved a distribution and servicing plan (the “Distribution and Servicing Plan”). The following table shows the stockholder servicing and/or distribution fees the Company pays the Intermediary Manager with respect to the Class S shares and Class D shares on an annualized basis as a percentage of the Company’s NAV for such class.

 

54


 

Class of Common Shares

 

Stockholder Servicing and/or Distribution Fee as a % of NAV

Class S Shares

 

0.85%

Class D Shares

 

0.25%

Class I Shares

 

-

The stockholder servicing and/or distribution fees are paid monthly in arrears, calculated using the NAV of the applicable class as of the beginning of the first calendar day of the month and subject to FINRA and other limitations on underwriting compensation.

The Intermediary Manager will reallow (pay) all or a portion of the stockholder servicing and/or distribution fees to participating brokers and servicing brokers for ongoing stockholder services performed by such brokers. Because the stockholder servicing and/or distribution fees with respect to Class S or Class D shares are calculated based on the aggregate NAV for all of the outstanding shares of each such class, it reduces the NAV with respect to all shares of each such class, including shares issued under the Company’s distribution reinvestment plan.

Eligibility to receive the stockholder servicing and/or distribution fee is conditioned on a broker providing the following ongoing services with respect to the Class S or Class D shares: assistance with recordkeeping, answering investor inquiries regarding the Company, including regarding distribution payments and reinvestments, helping investors understand their investments upon their request, and assistance with share repurchase requests. The stockholder servicing and/or distribution fees are ongoing fees that are not paid at the time of purchase.

For the three and six months ended June 30, 2026, the Company incurred stockholder servicing and/or distribution fees of $0.4 and $0.7, respectively, which were attributable to Class S and Class D shares, and were included in Other general and administrative expenses on the Consolidated Statements of Operations. For the three and six months ended June 30, 2025, the Company incurred stockholder servicing and/or distribution fees of $0.1, which were attributable to Class S shares. As of June 30, 2026 and December 31, 2025, there were $0.2 and $0.1 stockholder servicing and/or distribution fees payable to the Intermediary Manager, respectively, which were included in Accrued expenses and other liabilities on the Consolidated Statements of Assets and Liabilities.

Expense Support and Conditional Reimbursement Agreement

The Company has entered into an Expense Support and Conditional Reimbursement Agreement on May 3, 2023 (the “Expense Support Agreement”) with the Adviser. The Adviser may elect to pay certain expenses of the Company on the Company’s behalf (each, an “Expense Payment”), provided that no portion of an Expense Payment will be used to pay any interest expense or stockholder servicing and/or distribution fees of the Company. Any Expense Payment that the Adviser has committed to pay must be paid by the Adviser to the Company or on behalf of the Company in any combination of cash or other immediately available funds no later than forty-five days after such election was made in writing by the Adviser, and/or offset against amounts due from the Company to the Adviser or its affiliates.

Following any calendar month in which Available Operating Funds (as defined below) exceed the cumulative distributions accrued to the Company’s stockholders based on distributions declared with respect to record dates occurring in such calendar month (the amount of such excess being hereinafter referred to as “Excess Operating Funds”), the Company shall pay such Excess Operating Funds, or a portion thereof, to the Adviser until such time as all Expense Payments made by the Adviser to or on behalf of the Company within three years prior to the last business day of such calendar month have been reimbursed. Any payments required to be made by the Company shall be referred to herein as a “Reimbursement Payment.” As described below, reimbursement payments are conditioned on (i) an expense ratio (excluding any management or incentive fee) that, after giving effect to the recoupment, is lower than the expense ratio (excluding any management or incentive fee) at the time of the fee waiver or expense reimbursement and (ii) a distribution level (exclusive of return of capital to stockholders, if any), equal to, or greater than, the rate at the time of the waiver or reimbursement. “Available Operating Funds” means the sum of (i) the Company’s net investment company taxable income (including net short-term capital gains reduced by net long-term capital losses), (ii) the Company’s net capital gains (including the excess of net long-term capital gains over net short-term capital losses) and (iii) dividends and other distributions paid to the Company on account of investments in portfolio companies (to the extent such amounts listed in clause (iii) are not included under clauses (i) and (ii) above).

The Company’s obligation to make a Reimbursement Payment shall automatically become a liability of the Company on the last business day of the applicable calendar month, except to the extent the Adviser has waived its right to receive such payment for the applicable month. Reimbursement Payments for a given Expense Payment must be made within three years prior to the last business day of the applicable calendar month. The expense support is measured on a per share class basis.

The Expense Support Agreement provides that no Reimbursement Payment will be made for any calendar month if: (1) the annualized rate (based on a 365-day year) of regular cash distributions per share of common stock declared by the Company exclusive of returns of capital, distribution rate reductions due to distribution and stockholder fees, and any declared special dividends or distributions (the “Effective Rate of Distributions Per Share”) declared by the Company at the time of such Reimbursement Payment is less than the Effective Rate of Distributions Per Share at the time the Expense Payment was made to which such Reimbursement Payment relates, or (2) the Operating Expense Ratio (as defined below) at the time of such Reimbursement Payment is greater than the Operating Expense Ratio at the time the Expense Payment was made to which such Reimbursement Payment relates. The “Operating

55


 

Expense Ratio” is calculated by dividing Operating Expenses (as defined below), less organizational and offering expenses, base management and incentive fees owed to the Adviser, and interest expense, by the Company’s net assets. “Operating Expenses” means all of the operating costs and expenses incurred, as determined in accordance with GAAP.

For the three and six months ended June 30, 2026, the Company accrued expense support reimbursement payments to the Adviser totaling $618. As of June 30, 2026 and December 31, 2025, $425 and $0 of expense support reimbursement payments to the Adviser, respectively, were included as part of the net payable balance due to the Adviser in Accrued expenses and other liabilities on the Company’s Consolidated Statements of Assets and Liabilities.

 

For the three and six months ended June 30, 2026, there was no expense support provided by the Adviser. For the three and six months ended June 30, 2025, there was $2,022 and $3,994, respectively, of expense support provided by the Adviser. As of June 30, 2026, no expense support payments remained payable to the Company. As of December 31, 2025, $130 of expense support payments receivable from the Adviser was included net of the payable to the Adviser in Accrued expenses and other liabilities on the Company’s Consolidated Statements of Assets and Liabilities.

 

The following table presents a summary of all expenses supported, and recouped, by the Adviser.

 

For the Month Ended

 

Expense Support from the Adviser

 

 

Expense Support Reimbursed to the Adviser

 

 

Expense Support No Longer Eligible for Reimbursement

 

 

Unreimbursed Expense Support

 

 

Ratio of Operating Expenses to Average Net Assets for the Period(1)

 

 

Effective Rate of Distribution per Share(2)

 

 

Eligible for Reimbursement through

May 31, 2024

 

$

217

 

 

$

217

 

 

$

-

 

 

$

-

 

 

 

1.66

%

 

 

7.17

%

 

5/31/2027

June 30, 2024

 

 

197

 

 

 

197

 

 

 

-

 

 

 

-

 

 

 

1.45

%

 

 

7.09

%

 

6/30/2027

July 31, 2024

 

 

223

 

 

 

204

 

 

 

-

 

 

 

19

 

 

 

1.67

%

 

 

7.12

%

 

7/31/2027

August 31, 2024

 

 

2,077

 

 

 

-

 

 

 

-

 

 

 

2,077

 

 

 

1.77

%

 

 

7.14

%

 

8/31/2027

September 30, 2024

 

 

520

 

 

 

-

 

 

 

-

 

 

 

520

 

 

 

1.55

%

 

 

7.15

%

 

9/30/2027

October 31, 2024

 

 

643

 

 

 

-

 

 

 

-

 

 

 

643

 

 

 

2.40

%

 

 

7.12

%

 

10/31/2027

November 30, 2024

 

 

606

 

 

 

-

 

 

 

-

 

 

 

606

 

 

 

2.11

%

 

 

7.11

%

 

11/30/2027

December 31, 2024

 

 

551

 

 

 

-

 

 

 

-

 

 

 

551

 

 

 

1.60

%

 

 

7.11

%

 

12/31/2027

January 31, 2025

 

 

717

 

 

 

-

 

 

 

-

 

 

 

717

 

 

 

2.69

%

 

 

7.09

%

 

1/31/2028

February 28, 2025

 

 

645

 

 

 

-

 

 

 

-

 

 

 

645

 

 

 

2.09

%

 

 

7.10

%

 

2/29/2028

March 31, 2025

 

 

610

 

 

 

-

 

 

 

-

 

 

 

610

 

 

 

1.77

%

 

 

7.11

%

 

3/31/2028

April 30, 2025

 

 

714

 

 

 

-

 

 

 

-

 

 

 

714

 

 

 

2.34

%

 

 

7.14

%

 

4/30/2028

May 31, 2025

 

 

610

 

 

 

-

 

 

 

-

 

 

 

610

 

 

 

1.22

%

 

 

7.18

%

 

5/31/2028

June 30, 2025

 

 

698

 

 

 

-

 

 

 

-

 

 

 

698

 

 

 

1.55

%

 

 

7.13

%

 

6/30/2028

July 31, 2025

 

 

460

 

 

 

-

 

 

 

-

 

 

 

460

 

 

 

1.27

%

 

 

7.07

%

 

7/31/2028

August 31, 2025

 

 

320

 

 

 

-

 

 

 

-

 

 

 

320

 

 

 

1.27

%

 

 

7.08

%

 

8/31/2028

September 30, 2025

 

 

334

 

 

 

-

 

 

 

-

 

 

 

334

 

 

 

0.97

%

 

 

7.06

%

 

9/30/2028

October 31, 2025

 

 

206

 

 

 

-

 

 

 

-

 

 

 

206

 

 

 

1.19

%

 

 

7.10

%

 

10/31/2028

November 30, 2025

 

 

105

 

 

 

-

 

 

 

-

 

 

 

105

 

 

 

0.71

%

 

 

7.14

%

 

11/30/2028

 

(1) In accordance with the Expense Support and Conditional Reimbursement Agreement, the ratio of operating expenses excludes organization and offering expenses, stated interest expense, any base management fee and any incentive fee.


(2) The effective rate of distribution per share is the (a) annualized regular cash distributions per share, exclusive of returns of capital, distribution rate reductions due to distribution and stockholder fees, and declared special dividends or special distributions, if any, (b) divided by the prior month’s NAV per share.

 

 

Other Related Party Transactions

 

56


 

As previously disclosed, on January 5, 2021, Sun Life acquired a majority interest in Crescent and on March 30, 2026, acquired the remaining equity interest in Crescent (collectively, the “Sun Life Transaction”). There were no changes to the Company’s investment objective, strategies and processes or to the Crescent team responsible for the investment operations of the Adviser as a result of the Sun Life Transaction.

Note 4. Investments

The information in the following tables is presented on an aggregate portfolio basis, without regard to whether they are non-controlled, non-affiliated, non-controlled, affiliated or controlled affiliated, investments.

Investments at fair value consisted of the following (in thousands):

 

 

 

As of June 30, 2026

 

 

As of December 31, 2025

 

Investment Type

 

Cost

 

 

Fair Value

 

 

Unrealized Appreciation/ (Depreciation)

 

 

Cost

 

 

Fair Value

 

 

Unrealized Appreciation/ (Depreciation)

 

 Senior Secured First Lien

 

$

297,705

 

 

$

296,604

 

 

$

(1,101

)

 

$

457,925

 

 

$

458,450

 

 

$

525

 

 Unitranche First Lien

 

 

564,957

 

 

 

564,417

 

 

 

(540

)

 

 

378,769

 

 

 

383,346

 

 

 

4,577

 

 Unitranche First Lien - Last Out

 

 

2,464

 

 

 

2,369

 

 

 

(95

)

 

 

2,566

 

 

 

2,613

 

 

 

47

 

 Senior Secured Second Lien

 

 

25,109

 

 

 

25,386

 

 

 

277

 

 

 

9,912

 

 

 

10,300

 

 

 

388

 

 Unsecured Debt

 

 

23,187

 

 

 

22,621

 

 

 

(566

)

 

 

3,468

 

 

 

3,633

 

 

 

165

 

 Equity

 

 

18,266

 

 

 

20,623

 

 

 

2,357

 

 

 

8,035

 

 

 

10,791

 

 

 

2,756

 

 LLC/LP Equity Interests

 

 

12,312

 

 

 

12,665

 

 

 

353

 

 

 

10,000

 

 

 

10,459

 

 

 

459

 

Total Investments

 

$

944,000

 

 

$

944,685

 

 

$

685

 

 

$

870,675

 

 

$

879,592

 

 

$

8,917

 

The industry composition of investments at fair value is as follows (in thousands):

 

Industry

 

Fair Value as of
June 30, 2026

 

 

Percentage of Fair Value

 

 

 

Fair Value as of
December 31, 2025

 

 

Percentage of Fair Value

 

 

Health Care Equipment and Services

 

$

275,962

 

 

 

29.3

 

%

 

$

191,386

 

 

 

21.9

 

%

Commercial and Professional Services

 

 

129,647

 

 

 

13.7

 

 

 

 

115,253

 

 

 

13.2

 

 

Software and Services

 

 

116,527

 

 

 

12.3

 

 

 

 

109,149

 

 

 

12.4

 

 

Financial Services

 

 

73,069

 

 

 

7.7

 

 

 

 

66,386

 

 

 

7.5

 

 

Pharmaceuticals, Biotechnology and Life Sciences

 

 

68,475

 

 

 

7.2

 

 

 

 

39,989

 

 

 

4.5

 

 

Materials

 

 

60,029

 

 

 

6.4

 

 

 

 

43,383

 

 

 

4.9

 

 

Consumer Services

 

 

43,961

 

 

 

4.7

 

 

 

 

55,759

 

 

 

6.3

 

 

Diversified Financials

 

 

42,181

 

 

 

4.5

 

 

 

 

15,127

 

 

 

1.7

 

 

Telecommunication Services

 

 

31,276

 

 

 

3.3

 

 

 

 

34,231

 

 

 

3.9

 

 

Capital Goods

 

 

26,575

 

 

 

2.8

 

 

 

 

88,976

 

 

 

10.1

 

 

Insurance

 

 

25,928

 

 

 

2.7

 

 

 

 

23,923

 

 

 

2.7

 

 

Energy

 

 

17,343

 

 

 

1.8

 

 

 

 

8,156

 

 

 

0.9

 

 

Consumer Discretionary Distribution and Retail

 

 

12,127

 

 

 

1.3

 

 

 

 

29,848

 

 

 

3.4

 

 

Transportation

 

 

8,347

 

 

 

0.9

 

 

 

 

19,365

 

 

 

2.2

 

 

Media and Entertainment

 

 

8,267

 

 

 

0.9

 

 

 

 

21,773

 

 

 

2.5

 

 

Food, Beverage and Tobacco

 

 

3,021

 

 

 

0.3

 

 

 

 

5,759

 

 

 

0.7

 

 

Consumer Durables and Apparel

 

 

1,950

 

 

 

0.2

 

 

 

 

7,364

 

 

 

0.8

 

 

Real Estate Management and Development

 

 

-

 

 

 

-

 

 

 

 

3,765

 

 

 

0.4

 

 

Total Investments

 

$

944,685

 

 

 

100.0

 

%

 

$

879,592

 

 

 

100.0

 

%

 

57


 

The geographic composition of investments at fair value is as follows (in thousands):

 

Geographic Region

 

Fair Value as of
June 30, 2026

 

 

Percentage of Fair Value

 

 

 

Fair Value as of
December 31, 2025

 

 

Percentage of Fair Value

 

 

United States

 

$

797,624

 

 

 

84.4

 

 %

 

$

778,554

 

 

 

88.5

 

%

Canada

 

 

67,625

 

 

 

7.2

 

 

 

 

43,981

 

 

 

5.1

 

 

France

 

 

18,091

 

 

 

1.9

 

 

 

 

3,867

 

 

 

0.4

 

 

Netherlands

 

 

13,684

 

 

 

1.4

 

 

 

 

13,347

 

 

 

1.5

 

 

Switzerland

 

 

11,664

 

 

 

1.2

 

 

 

 

11,898

 

 

 

1.4

 

 

Germany

 

 

11,368

 

 

 

1.2

 

 

 

 

1,869

 

 

 

0.2

 

 

Spain

 

 

9,713

 

 

 

1.0

 

 

 

 

-

 

 

 

-

 

 

United Kingdom

 

 

7,996

 

 

 

0.8

 

 

 

 

12,075

 

 

 

1.4

 

 

Australia

 

 

5,197

 

 

 

0.6

 

 

 

 

4,440

 

 

 

0.5

 

 

Israel

 

 

805

 

 

 

0.1

 

 

 

 

2,777

 

 

 

0.3

 

 

Gibraltar

 

 

798

 

 

 

0.1

 

 

 

 

2,791

 

 

 

0.3

 

 

Finland

 

 

120

 

 

 

0.1

 

 

 

 

123

 

 

 

0.0

 

 

Ireland

 

 

-

 

 

 

-

 

 

 

 

2,763

 

 

 

0.3

 

 

Denmark

 

 

-

 

 

 

-

 

 

 

 

1,107

 

 

 

0.1

 

 

Total Investments

 

$

944,685

 

 

 

100.0

 

%

 

$

879,592

 

 

 

100.0

 

%

 

Note 5. Fair Value of Financial Instruments

Investments

The following table presents fair value measurements of investments as of June 30, 2026 (in thousands):

 

Fair Value Hierarchy

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Senior Secured First Lien

$

-

 

 

$

133,148

 

 

$

163,456

 

 

$

296,604

 

Unitranche First Lien

 

-

 

 

 

-

 

 

 

564,417

 

 

 

564,417

 

Unitranche First Lien - Last Out

 

-

 

 

 

-

 

 

 

2,369

 

 

 

2,369

 

Senior Secured Second Lien

 

-

 

 

 

-

 

 

 

25,386

 

 

 

25,386

 

Unsecured Debt

 

-

 

 

 

-

 

 

 

22,621

 

 

 

22,621

 

Equity

 

-

 

 

 

-

 

 

 

20,623

 

 

 

20,623

 

Subtotal

$

-

 

 

$

133,148

 

 

$

798,872

 

 

$

932,020

 

Investments Measured at NAV (1)

 

-

 

 

 

-

 

 

 

-

 

 

 

12,665

 

Total Investments

$

-

 

 

$

133,148

 

 

$

798,872

 

 

$

944,685

 

Foreign Currency Forward Contracts - Assets

$

-

 

 

$

104

 

 

$

-

 

 

$

104

 

Foreign Currency Forward Contracts - Liabilities

$

-

 

 

$

(58

)

 

$

-

 

 

$

(58

)

Cash Equivalents

$

15,534

 

 

$

-

 

 

$

-

 

 

$

15,534

 

 

The following table presents fair value measurements of investments as of December 31, 2025 (in thousands):

 

Fair Value Hierarchy

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Senior Secured First Lien

$

-

 

 

$

379,082

 

 

$

79,368

 

 

$

458,450

 

Unitranche First Lien

 

-

 

 

 

-

 

 

 

383,346

 

 

 

383,346

 

Unitranche First Lien - Last Out

 

-

 

 

 

-

 

 

 

2,613

 

 

 

2,613

 

Senior Secured Second Lien

 

-

 

 

 

-

 

 

 

10,300

 

 

 

10,300

 

Unsecured Debt

 

-

 

 

 

-

 

 

 

3,633

 

 

 

3,633

 

Equity

 

-

 

 

 

-

 

 

 

10,791

 

 

 

10,791

 

Subtotal

$

-

 

 

$

379,082

 

 

$

490,051

 

 

$

869,133

 

Investments Measured at NAV (1)

 

-

 

 

 

-

 

 

 

-

 

 

 

10,459

 

Total Investments

$

-

 

 

$

379,082

 

 

$

490,051

 

 

$

879,592

 

Cash Equivalents

$

34,566

 

 

$

-

 

 

$

-

 

 

$

34,566

 

 

58


 

 

 

(1) In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. These investments are generally not redeemable. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities.

The following table provides a reconciliation of the beginning and ending balances for total investments that use Level 3 inputs for the six months ended June 30, 2026 based off of the fair value hierarchy as of June 30, 2026 (in thousands):

 

 

Senior Secured
First Lien

 

 

Unitranche
First Lien

 

 

Unitranche
First Lien -
Last Out

 

 

Senior
Secured
Second Lien

 

 

Unsecured
Debt

 

 

Equity

 

 

Total

 

Balance as of December 31, 2025

$

79,368

 

 

$

383,346

 

 

$

2,613

 

 

$

10,300

 

 

$

3,633

 

 

$

10,791

 

 

$

490,051

 

Amortized discounts/premiums

 

157

 

 

 

996

 

 

 

8

 

 

 

32

 

 

 

61

 

 

-

 

 

 

1,254

 

Paid in-kind interest

 

177

 

 

 

312

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

489

 

Net realized gain (loss)

 

(1,452

)

 

 

(238

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(1,690

)

Net change in unrealized appreciation (depreciation)

 

240

 

 

 

(5,146

)

 

 

(142

)

 

 

(110

)

 

 

(734

)

 

 

(399

)

 

 

(6,291

)

Purchases

 

99,398

 

 

 

228,869

 

 

 

-

 

 

 

17,664

 

 

 

23,187

 

 

 

10,231

 

 

 

379,349

 

Sales/principal repayments/paydowns

 

(15,176

)

 

 

(43,722

)

 

 

(110

)

 

 

(2,500

)

 

 

(3,526

)

 

 

-

 

 

 

(65,034

)

Transfers in

 

3,246

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

3,246

 

Transfers out

 

(2,502

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(2,502

)

Balance as of June 30, 2026

$

163,456

 

 

$

564,417

 

 

$

2,369

 

 

$

25,386

 

 

$

22,621

 

 

$

20,623

 

 

$

798,872

 

Net change in unrealized appreciation (depreciation) from investments still held as of June 30, 2026

 

(94

)

 

 

(3,589

)

 

 

(137

)

 

 

(110

)

 

 

(531

)

 

 

(395

)

 

 

(4,856

)

During the six months ended June 30, 2026, the Company recorded $3,246 in transfers from Level 2 to Level 3 due to a decrease in observable inputs in market data and $2,502 in transfers from Level 3 to Level 2 due to an increase in observable inputs in market data.

The following table provides a reconciliation of the beginning and ending balances for total investments that use Level 3 inputs for the six months ended June 30, 2025 based off of the fair value hierarchy as of June 30, 2025 (in thousands):

 

 

Senior Secured
First Lien

 

 

Unitranche
First Lien

 

 

Unitranche
First Lien -
Last Out

 

 

Senior
Secured
Second Lien

 

 

Unsecured Debt

 

 

Equity

 

 

Total

 

Balance as of December 31, 2024

$

31,659

 

 

$

134,095

 

 

$

-

 

 

$

-

 

 

$

3,176

 

 

$

4,260

 

 

$

173,190

 

Amortized discounts/premiums

 

(51

)

 

 

304

 

 

 

(22

)

 

 

-

 

 

 

2

 

 

 

-

 

 

 

233

 

Paid in-kind interest

 

-

 

 

 

523

 

 

 

-

 

 

 

-

 

 

 

213

 

 

 

-

 

 

 

736

 

Net realized gain (loss)

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Net change in unrealized appreciation (depreciation)

 

1,480

 

 

 

2,091

 

 

 

81

 

 

 

-

 

 

 

4

 

 

 

1,284

 

 

 

4,940

 

Purchases

 

27,710

 

 

 

108,053

 

 

 

2,618

 

 

 

-

 

 

 

-

 

 

 

1,996

 

 

 

140,377

 

Sales/principal repayments/paydowns

 

(5,188

)

 

 

(6,171

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(11,359

)

Transfers in

 

7,670

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

7,670

 

Transfers out

 

(699

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(699

)

Balance as of June 30, 2025

$

62,581

 

 

$

238,895

 

 

$

2,677

 

 

$

-

 

 

$

3,395

 

 

$

7,540

 

 

$

315,088

 

Net change in unrealized appreciation (depreciation) from investments still held as of June 30, 2025

 

1,510

 

 

 

2,148

 

 

 

81

 

 

 

-

 

 

 

4

 

 

 

1,284

 

 

 

5,027

 

During the six months ended June 30, 2025, the Company recorded $699 in transfers out from Level 3 to Level 2 due to an increase in observable inputs in market data and $7,670 in transfers from Level 2 to Level 3 due to a decrease in observable inputs in market data.

59


 

The following tables present the fair value of Level 3 investments and the ranges of significant unobservable inputs used to value the Company’s Level 3 investments as of June 30, 2026 and December 31, 2025. These ranges represent the significant unobservable inputs that were used in the valuation of each type of investment. These inputs are not representative of the inputs that could have been used in the valuation of any one investment. For example, the highest market yield presented in the table for senior secured first lien investments is appropriate for valuing a specific investment but may not be appropriate for valuing any other investment. Accordingly, the ranges of inputs presented below do not represent uncertainty in, or possible ranges of, fair value measurements of the Company’s Level 3 investments.

 

Security Type

 

Fair Value as of
June 30, 2026
(in thousands)

 

 

Valuation Technique

 

Unobservable Input

 

Range (Weighted Avg)

Senior Secured First Lien

 

$

145,163

 

 

Discounted Cash Flows

 

Discount Rate

 

6.3%

-

9.7%

(8.6%)

 

 

14,889

 

 

Transaction Precedent

 

Transaction Price

 

 

 

N/A

 

 

 

3,404

 

 

Broker Quoted

 

Broker Quote

 

 

 

N/A

 

 

$

163,456

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unitranche First Lien

 

$

464,852

 

 

Discounted Cash Flows

 

Discount Rate

 

7.0%

-

12.0%

(8.8%)

 

 

4,588

 

 

Enterprise Value

 

Comparable EBITDA Multiple

 

9.4x

-

9.4x

(9.4x)

 

 

94,977

 

 

Transaction Precedent

 

Transaction Price

 

 

 

N/A

 

 

$

564,417

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unitranche First Lien - Last Out

 

$

2,369

 

 

Discounted Cash Flows

 

Discount Rate

 

7.6%

-

17.1%

(16.5%)

 

$

2,369

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Senior Secured Second Lien

 

$

7,722

 

 

Discounted Cash Flows

 

Discount Rate

 

9.3%

-

9.3%

(9.3%)

Senior Secured Second Lien

 

 

17,664

 

 

Transaction Precedent

 

Transaction Price

 

 

 

N/A

 

 

$

25,386

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unsecured Debt

 

$

22,621

 

 

Discounted Cash Flows

 

Discount Rate

 

9.5%

-

14.3%

(10.2%)

 

$

22,621

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity

 

$

13,651

 

 

Enterprise Value

 

Comparable EBITDA Multiple

 

10.5x

-

25.1x

(17.3x)

 

 

6,972

 

 

Transaction Precedent

 

Transaction Price

 

 

 

N/A

 

 

$

20,623

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

$

798,872

 

 

 

 

 

 

 

 

 

 

 

 

 

60


 

Security Type

 

Fair Value as of
December 31, 2025
(in thousands)

 

 

Valuation Technique

 

Unobservable Input

 

Range (Weighted Avg)

Senior Secured First Lien

 

$

59,591

 

 

Discounted Cash Flows

 

Discount Rate

 

5.5%

-

9.4%

(8.4%)

 

 

2,230

 

 

Transaction Precedent

 

Transaction Price

 

 

 

N/A

 

 

 

17,547

 

 

Broker Quoted

 

Broker Quote

 

 

 

N/A

 

 

$

79,368

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unitranche First Lien

 

$

296,442

 

 

Discounted Cash Flows

 

Discount Rate

 

7.6%

-

14.8%

(9.1%)

 

 

85,091

 

 

Transaction Precedent

 

Transaction Price

 

 

 

N/A

 

 

 

1,813

 

 

Broker Quoted

 

Broker Quote

 

 

 

N/A

 

 

$

383,346

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unitranche First Lien - Last Out

 

$

2,613

 

 

Discounted Cash Flows

 

Discount Rate

 

7.6%

-

12.9%

(12.6%)

 

$

2,613

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Senior Secured Second Lien

 

$

10,300

 

 

Discounted Cash Flows

 

Discount Rate

 

9.4%

-

9.4%

(9.4%)

 

$

10,300

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unsecured Debt

 

$

3,633

 

 

Discounted Cash Flows

 

Discount Rate

 

 

 

13.6%

 

 

$

3,633

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity

 

$

10,791

 

 

Enterprise Value

 

Comparable EBITDA Multiple

 

7.8x

-

26.6x

(16.3x)

 

$

10,791

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

$

490,051

 

 

 

 

 

 

 

 

 

 

 

The significant unobservable inputs used in the fair value measurement of the Company’s debt and equity securities are primarily earnings before interest, taxes, depreciation and amortization (“EBITDA”) comparable multiples and market discount rates. The Company typically uses comparable EBITDA multiples on its equity securities to determine the fair value of investments. The Company uses discount rates for debt securities to determine if the effective yield on a debt security is commensurate with the market yields for that type of debt security. Weighted average is calculated based upon fair value.

 

The significant unobservable inputs used in the discounted cash flow approach is the discount rate used to discount the estimated future cash flows expected to be received from the underlying investment, which include both future principal and interest payments. Increases and decreases in the discount rate would result in a decrease and increase in the fair value, respectively. Included in the consideration and selection of discount rates is risk of default, rating of the investment, call provisions and comparable company investments.
The significant unobservable inputs used in the market multiple approach are the multiples of similar companies’ EBITDA, revenue and comparable market transactions. Increases and decreases in market EBITDA multiples and revenue would result in an increase or decrease in the fair value, respectively.

 

Note 6. Debt

Debt consisted of the following:

 

 

As of June 30, 2026

 

 

As of December 31, 2025

 

(in $ thousands)

Aggregate Principal
Amount Committed

 

 

Drawn Amount

 

 

Amount
Available
(1)

 

 

Carrying
Value
(2)(3)

 

 

Aggregate Principal
Amount Committed

 

 

Drawn Amount

 

 

Amount
Available
(1)

 

 

Carrying
Value
(2)(3)

 

JPM Funding Facility III

$

650,000

 

 

$

418,835

 

 

$

231,165

 

 

$

418,835

 

 

$

575,000

 

 

$

419,972

 

 

$

155,028

 

 

$

419,972

 

Total Debt

$

650,000

 

 

$

418,835

 

 

$

231,165

 

 

$

418,835

 

 

$

575,000

 

 

$

419,972

 

 

$

155,028

 

 

$

419,972

 

(1)
The amount available is subject to any limitations related to the credit facility borrowing base.
(2)
The amount presented excludes netting of deferred financing costs.

61


 

(3)
As of June 30, 2026 and December 31, 2025, the carrying amount of the Company’s outstanding debt approximated fair value, unless otherwise noted.

The weighted average interest rate of the aggregate borrowings outstanding for the six months ended June 30, 2026 and 2025 was 5.72% and 7.10%, respectively. The weighted average borrowings outstanding for the six months ended June 30, 2026 and 2025 were $441,626 and $136,899, respectively.

The fair values of the Company’s debt are determined in accordance with ASC 820, which defines fair value in terms of the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date under current market conditions. The fair value of the Company’s debt is calculated by discounting remaining payments using comparable market rates or market quotes for similar instruments at the measurement date. As of June 30, 2026 and December 31, 2025, the debt would be deemed to be Level 3 of the fair value hierarchy.

As of June 30, 2026 and December 31, 2025, the Company was in compliance with the terms and covenants of its debt arrangements.

JPM Funding Facility

On December 8, 2023, the Company entered into a Loan and Security Agreement (as amended, the “JPM Funding Facility”), as servicer, with CPCI Funding SPV, LLC, the Company’s wholly owned subsidiary (the “Borrower I”), as borrower, the lenders party thereto, U.S. Bank Trust Company, National Association, as collateral agent and collateral administrator, U.S. Bank National Association, as securities intermediary, and JPMorgan Chase Bank, National Association, as administrative agent, that provided a secured credit facility of $375,000 with a reinvestment period ending December 8, 2026 and a final maturity date of December 8, 2028. The JPM Funding Facility also provided for a feature that allowed the Borrower I, under certain circumstances, to increase the overall size of the JPM Funding Facility to a maximum of $500,000. The Company consolidated the Borrower I in its consolidated financial statements and no gain or loss was recognized from the transfer of assets to and from the Borrower I.

The obligations of the Borrower I under the JPM Funding Facility were secured by substantially all assets held by the Borrower I, which were not available to the Company’s creditors. The interest rate charged on the JPM Funding Facility was based on an applicable benchmark (Term SOFR or other applicable benchmark based on the currency of the borrowing) plus a margin of 2.25% prior to May 29, 2025 and 2.13% from May 29, 2025 through October 17, 2025. In addition, the Borrower I paid, among other fees, an administrative agency fee on the facility commitment and a commitment fee on the undrawn balance.

 

In connection with the entry into the JPM Funding Facility III (as defined below) on October 17, 2025, the Company voluntarily prepaid all amounts outstanding under the JPM Funding Facility. In connection with such repayment, all obligations (including in respect of unfunded commitments) under the facility were terminated, and the related security interests and other liens on the assets securing such facility were terminated and released.

JPM Funding Facility II

 

On March 31, 2025, the Company entered into a Loan and Security Agreement (as amended, the “JPM Funding Facility II”), as servicer, with CPCI Funding SPV II, LLC, the Company’s wholly owned subsidiary (the “Borrower II” and together with Borrower I, the “Borrowers”), as borrower, the lenders party thereto, U.S. Bank Trust Company, National Association, as collateral agent and collateral administrator, U.S. Bank National Association, as securities intermediary, and JPMorgan Chase Bank, National Association, as administrative agent, that provided a secured credit facility of $100,000 with a reinvestment period ending September 30, 2027 and a final maturity date of March 31, 2028. The JPM Funding Facility II also provided for a feature that allowed the Borrower II, under certain circumstances, to increase the overall size of the JPM Funding Facility II to a maximum of $200,000. The Company consolidated the Borrower II in its consolidated financial statements and no gain or loss was recognized from the transfer of assets to and from the Borrower II.

The obligations of the Borrower II under the JPM Funding Facility II were secured by substantially all assets held by the Borrower II, which were not available to the Company’s creditors. The interest rate charged on the JPM Funding Facility II was based on an applicable benchmark (Term SOFR or other applicable benchmark based on the currency of the borrowing) plus a margin of 1.35%, subject to increase from time to time pursuant to the terms of the JPM Funding Facility II. In addition, the Borrower II paid, among other fees, a commitment fee on the undrawn balance.

In connection with the entry into the JPM Funding Facility III on October 17, 2025, the Company voluntarily prepaid all amounts outstanding under the JPM Funding Facility II. In connection with, such repayment, all obligations (including in respect of unfunded commitments) under the facility were terminated, and the related security interests and other liens on the assets securing such facilities were terminated and released.

 

JPM Funding Facility III

 

62


 

On October 17, 2025, the Company entered into a Loan and Security Agreement (the “JPM Funding Facility III” and together with the JPM Funding Facility and the JPM Funding Facility II, the “credit facilities”), as servicer, with the borrowers, the lenders party thereto, U.S. Bank Trust Company, National Association, as collateral agent and collateral administrator, U.S. Bank National Association, as securities intermediary, and JPMorgan Chase Bank, National Association, as administrative agent, that provides a secured credit facility of $575,000 with a reinvestment period ending October 17, 2028 and a final maturity date of October 17, 2030. On January 17, 2026, as part of a scheduled commitment increase, the JPM Funding Facility III commitment size increased from $575,000 to $650,000. The JPM Funding Facility III also provides for a feature that allows the overall size of the JPM Funding Facility III to be increased to a maximum of $875,000. In addition, on October 17, 2025, the Company, as seller, and Borrower I, as purchaser, entered into a Sale and Contribution Agreement and the Company, as seller, and Borrower II, as purchaser, entered into a Sale and Contribution Agreement, pursuant to which the Company will sell or contribute to the Borrower I and the Borrower II, as applicable, certain originated or acquired loans and other corporate debt securities and related assets (collectively, the “Loans”) from time to time.

 

The obligations of the Borrowers under the JPM Funding Facility III are secured by substantially all assets held by each Borrower, including the Loans. The interest rate charged on the JPM Funding Facility III is based on an applicable benchmark (Term SOFR or other applicable benchmark based on the currency of the borrowing) plus a margin of (i) 1.35% (or 1.4693% in the case of borrowings in British Pounds) or (ii) 1.90% (or 2.0193% in the case of borrowings in British Pounds) depending on the nature of the advances being requested under the JPM Funding Facility III. In connection with the entry into the JPM Funding Facility III, the Company voluntarily prepaid all amounts outstanding under each of the JPM Funding Facility and the JPM Funding Facility II (together, the “Existing JPM Facilities”). In connection with such repayment, all obligations (including in respect of unfunded commitments) under the Existing JPM Facilities were terminated, and the related security interests and other liens on the assets securing such facilities were terminated and released.

Costs incurred in connection with obtaining the JPM Funding Facility III were recorded as deferred financing costs and are being amortized over the life of the JPM Funding Facility III on a straight-line basis which approximates the effective interest method. As of June 30, 2026 and December 31, 2025, deferred financing costs related to the JPM Funding Facility III were $6,163 and $6,873, respectively, and were netted against debt outstanding on the Consolidated Statements of Assets and Liabilities.

Summary of Interest and Credit Facility Expenses

The borrowing expenses incurred by the Company’s credit facilities were as follows:

 

For the three months ended

 

 

For the six months ended

(in $ thousands)

June 30, 2026

 

June 30, 2025

 

 

June 30, 2026

 

 

June 30, 2025

 

 

Borrowing interest expense

$

5,700

 

 

$

2,266

 

 

$

11,376

 

 

$

4,245

 

 

Unused facility fees

 

327

 

 

 

315

 

 

 

606

 

 

 

367

 

 

Amortization of financing costs

 

357

 

 

 

184

 

 

 

710

 

 

 

274

 

 

Total interest and other debt financing costs

$

6,384

 

 

$

2,765

 

 

$

12,692

 

 

$

4,886

 

 

Weighted average outstanding balance

$

435,095

 

 

$

149,552

 

 

$

441,626

 

 

$

136,899

 

 

 

Note 7. Derivatives

The Company enters into foreign currency forward contracts from time to time to help mitigate the impact that an adverse change in foreign exchange rates would have on the value of the Company’s investments denominated in foreign currencies.

For financial reporting purposes, cash collateral that has been pledged to cover obligations of the Company and cash collateral received from the counterparty, if any, are included under restricted cash and cash equivalents on the Consolidated Statements of Assets and Liabilities. There has been no cash collateral received or paid from the counterparty. The Company minimizes counterparty credit risk by only entering into agreements with counterparties that they believe to be of good standing and by monitoring the financial stability of those counterparties. All of the forward contracts qualify as Level 2 financial instruments.

During the six months ended June 30, 2026, the Company’s average USD notional exposure, calculated daily on a weighted average basis on the duration of each forward contract, of foreign currency forward contracts was $1,412. During the six months ended June 30, 2025, the Company did not hold any derivatives.

The following table sets forth the Company’s net exposure to a foreign currency forward contract that is subject to ISDA Master Agreements or similar agreements (in thousands). As of December 31, 2025, the Company did not hold any derivatives.

63


 

Reporting Date

 

Counterparty

 

Gross Amount
of Assets on
the Consolidated
Statements of
Assets and
Liabilities

 

 

Gross Amount
of (Liabilities) on
the Consolidated
Statements of
Assets and
Liabilities

 

 

Net Amount of Assets
or (Liabilities)

 

 

Collateral
(Received)
Pledged
(1)

 

 

Net
Amounts
(2)

 

June 30, 2026

 

NatWest Markets Plc

 

$

104

 

 

$

(58

)

 

$

46

 

 

$

-

 

 

$

46

 

 

(1) Amount excludes excess cash collateral paid.

(2) Net amount represents the net amount due (to) from counterparty in the event of a default based on the contractual setoff rights

under the agreement. Net amount excludes any over-collateralized amounts.

The effect of transactions in derivative instruments to the Consolidated Statements of Operations was as follows (in thousands):

 

 

For the three months ended June 30,

 

 

For the six months ended June 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Net realized gain (loss) on foreign currency forward contracts

 

$

473

 

 

$

-

 

 

$

473

 

 

$

-

 

Net change in unrealized appreciation (depreciation) on foreign currency forward contracts

 

 

(193

)

 

 

-

 

 

 

46

 

 

 

-

 

Total net realized and unrealized gains (losses) on foreign currency forward contracts

 

$

280

 

 

$

-

 

 

$

519

 

 

$

-

 

 

Note 8. Commitments and Contingencies

The Company’s investment portfolio may contain investments that are in the form of lines of credit or unfunded commitments, which require the Company to provide funding when requested by portfolio companies in accordance with the terms of the underlying agreements. Unfunded commitments to provide funds to portfolio companies are not reflected on the Company’s Consolidated Statements of Assets and Liabilities. These commitments are subject to the same underwriting and ongoing portfolio maintenance as are the on-balance sheet financial instruments that the Company holds. Since these commitments may expire without being drawn, the total commitment amount does not necessarily represent future cash requirements.

The Company has the following unfunded commitments to portfolio companies (in thousands):

64


 

 

 

 

 

As of June 30, 2026

 

 

As of December 31, 2025

 

Company

 

Investment
Type

 

Commitment
Expiration Date
(1)

Unfunded
Commitment
(2)

 

 

Commitment
Expiration Date
(1)

Unfunded
Commitment
(2)

 

 Accurate Finance Sub, LLC (7)

 

 Delayed Draw Term Loan

 

9/2/2027

 

300

 

 

9/2/2027

 

300

 

 Accurate Finance Sub, LLC (7)

 

 Revolver

 

9/2/2032

 

101

 

 

9/2/2032

 

150

 

 Americana Partners LLC (7)

 

 Delayed Draw Term Loan

 

5/2/2027

 

1,925

 

 

5/2/2027

 

1,925

 

 Americana Partners LLC (7)

 

 Revolver

 

5/2/2031

 

425

 

 

5/2/2031

 

425

 

 Ancora Bidco PTY LTD (11)

 

 Delayed Draw Term Loan

 

5/6/2027

 

114

 

 

5/6/2027

 

723

 

 Angels of Care (7)

 

 Delayed Draw Term Loan

 

3/25/2028

 

1,050

 

 

n/a

 

-

 

 Angels of Care (7)

 

 Revolver

 

2/11/2030

 

400

 

 

2/11/2030

 

400

 

 Angels of Care (3)

 

 Delayed Draw Term Loan

 

n/a

 

-

 

 

2/9/2026

 

576

 

 Arrow Management Acquisition, LLC (9)

 

 Delayed Draw Term Loan

 

7/25/2027

 

5,932

 

 

7/25/2027

 

6,871

 

 Arrow Management Acquisition, LLC (7)

 

 Revolver

 

7/25/2032

 

1,580

 

 

7/25/2032

 

1,512

 

 Aryeh Bidco Investment Ltd. (7)

 

 Delayed Draw Term Loan

 

1/14/2028

 

3,939

 

 

n/a

 

-

 

 Aryeh Bidco Investment Ltd. (7)

 

 Revolver

 

1/14/2033

 

2,889

 

 

n/a

 

-

 

 Avalign Technologies, Inc. (7)

 

 Revolver

 

12/20/2028

 

294

 

 

12/20/2028

 

461

 

 Avidity Acquisition B.V. (9)

 

 Delayed Draw Term Loan

 

3/4/2029

 

28

 

 

3/4/2029

 

29

 

 Beyond Risk Management, Inc. (7)

 

 Delayed Draw Term Loan

 

3/9/2028

 

900

 

 

n/a

 

-

 

 Beyond Risk Management, Inc. (7)

 

 Revolver

 

3/13/2033

 

400

 

 

n/a

 

-

 

 Bonterra LLC (7)

 

 Revolver

 

3/5/2032

 

1,077

 

 

3/5/2032

 

1,145

 

 Bonterra LLC (9)

 

 Delayed Draw Term Loan

 

10/8/2027

 

2,609

 

 

10/8/2027

 

3,940

 

 Bristol Hospice, LLC (7)

 

 Revolver

 

8/26/2032

 

2,313

 

 

8/26/2032

 

2,313

 

 Buyer Cascade Acquiror, Inc. (7)

 

 Revolver

 

5/18/2033

 

3,647

 

 

n/a

 

-

 

 BV MRP Buyer, LLC (7)

 

 Revolver

 

1/21/2032

 

1,825

 

 

n/a

 

-

 

 BV MRP Buyer, LLC (9)

 

 Delayed Draw Term Loan

 

1/21/2028

 

6,076

 

 

n/a

 

-

 

 BVI Medical Inc. (7)

 

 Delayed Draw Term Loan

 

9/7/2027

 

86

 

 

9/7/2027

 

227

 

 BVI Medical Inc. (7)

 

 Revolver

 

3/7/2032

 

556

 

 

3/7/2032

 

657

 

 C-4 Analytics (3)

 

 Delayed Draw Term Loan

 

n/a

 

-

 

 

5/14/2026

 

1,850

 

 C-4 Analytics (7)

 

 Revolver

 

5/14/2030

 

525

 

 

5/14/2030

 

525

 

 CallRevu, LLC (7)

 

 Revolver

 

10/10/2032

 

25

 

 

10/10/2032

 

25

 

 Career Certified LLC (7)

 

 Revolver

 

2/19/2031

 

100

 

 

2/19/2031

 

100

 

 Career Certified LLC (9)

 

 Delayed Draw Term Loan

 

2/19/2027

 

51

 

 

2/19/2027

 

51

 

 Cary Street Partners (7)

 

 Revolver

 

5/30/2031

 

350

 

 

5/30/2031

 

350

 

 Cary Street Partners (9)

 

 Delayed Draw Term Loan

 

5/30/2027

 

2,540

 

 

5/30/2027

 

2,672

 

 CCI Buyer, Inc (7)

 

 Revolver

 

5/13/2032

 

1,653

 

 

5/13/2032

 

1,653

 

 Chicago US Midco III (3)

 

 Delayed Draw Term Loan

 

n/a

 

-

 

 

10/29/2032

 

362

 

 CLI Bidco B.V. (5)

 

 Delayed Draw Term Loan

 

2/3/2033

 

97

 

 

n/a

 

-

 

 CMG Holdco (7)

 

 Revolver

 

10/31/2028

 

143

 

 

10/31/2028

 

526

 

65


 

 CMG Holdco (7)

 

 Revolver

 

11/19/2030

 

702

 

 

11/19/2030

 

702

 

 CMG Holdco (9)

 

 Delayed Draw Term Loan

 

10/31/2028

 

92

 

 

10/31/2028

 

395

 

 CMG Holdco (9)

 

 Delayed Draw Term Loan

 

10/31/2028

 

617

 

 

10/31/2028

 

617

 

 CMG Holdco (9)

 

 Delayed Draw Term Loan

 

7/17/2027

 

4,430

 

 

7/17/2027

 

4,430

 

 Concord III, LLC (7)

 

 Revolver

 

12/20/2028

 

81

 

 

12/20/2028

 

81

 

 Conservice Midco LLC (7)

 

 Revolver

 

2/10/2033

 

4,204

 

 

n/a

 

-

 

 Constellation Wealth Capital Fund II (3) (14)

 

 Partnership Interests

 

n/a

 

7,688

 

 

n/a

 

-

 

 CRS TH Holdings, Corp. (7)

 

 Revolver

 

12/31/2032

 

300

 

 

12/31/2032

 

300

 

 CRS TH Holdings, Corp. (9)

 

 Delayed Draw Term Loan

 

12/31/2027

 

450

 

 

12/31/2027

 

450

 

 Dawson Logan 2025-L5 LP (3)

 

 Delayed Draw Commitment

 

10/9/2040

 

3,483

 

 

n/a

 

-

 

 DecisionHR Holdings, Inc (7)

 

 Delayed Draw Term Loan

 

12/8/2027

 

200

 

 

12/8/2027

 

200

 

 DecisionHR Holdings, Inc (7)

 

 Revolver

 

12/8/2031

 

100

 

 

12/8/2031

 

100

 

 Dispatch Acquisition Holdings, LLC (7)

 

 Revolver

 

11/19/2032

 

2,731

 

 

11/19/2032

 

2,942

 

 Duraserv LLC (3)

 

 Delayed Draw Term Loan

 

n/a

 

-

 

 

6/10/2026

 

735

 

 Duraserv LLC (7)

 

 Revolver

 

6/10/2030

 

571

 

 

6/10/2030

 

774

 

 Duraserv LLC (7)

 

 Delayed Draw Term Loan

 

11/12/2027

 

3,571

 

 

11/12/2027

 

3,571

 

 Essential Services Holding Corporation (3)

 

 Delayed Draw Term Loan

 

n/a

 

-

 

 

6/17/2026

 

744

 

 Essential Services Holding Corporation (7)

 

 Revolver

 

6/17/2030

 

260

 

 

6/17/2030

 

279

 

 Evergreen IX Borrower 2023, LLC (7)

 

 Revolver

 

9/29/2029

 

500

 

 

9/29/2029

 

500

 

 Foreside Financial Group, LLC (7)

 

 Delayed Draw Term Loan

 

6/26/2028

 

3,516

 

 

n/a

 

-

 

 Foreside Financial Group, LLC (7)

 

 Revolver

 

9/30/2029

 

1,159

 

 

n/a

 

-

 

 Galway Borrower, LLC (3)

 

 Revolver

 

n/a

 

-

 

 

9/30/2028

 

598

 

 Galway Borrower, LLC (3)

 

 Delayed Draw Term Loan

 

n/a

 

-

 

 

2/7/2026

 

4,368

 

 GB Eagle Buyer, Inc. (3)

 

 Delayed Draw Term Loan

 

n/a

 

-

 

 

11/14/2027

 

10,404

 

 GB Eagle Buyer, Inc. (7)

 

 Revolver

 

12/1/2030

 

513

 

 

12/1/2030

 

513

 

 GB Eagle Buyer, Inc. (7)

 

 Revolver

 

12/1/2030

 

4,141

 

 

12/1/2030

 

4,141

 

 Granicus, Inc. (7)

 

 Revolver

 

1/17/2031

 

504

 

 

1/17/2031

 

548

 

 Granicus, Inc. (7)

 

 Delayed Draw Term Loan

 

8/2/2026

 

66

 

 

8/2/2026

 

66

 

 Halo Buyer Inc (7)

 

 Revolver

 

8/7/2029

 

278

 

 

8/7/2029

 

335

 

 Hamsard 3778 Limited (12)

 

 Delayed Draw Term Loan

 

10/28/2031

 

582

 

 

10/28/2031

 

590

 

 Hanger, Inc. (3)

 

 Delayed Draw Term Loan

 

n/a

 

-

 

 

10/23/2031

 

93

 

 Headlands Buyer, Inc. (7)

 

 Delayed Draw Term Loan

 

9/29/2027

 

2,747

 

 

9/29/2027

 

2,747

 

 Headlands Buyer, Inc. (7)

 

 Revolver

 

9/29/2032

 

1,173

 

 

9/29/2032

 

1,283

 

 HES Facilities (7)

 

 Delayed Draw Term Loan

 

3/2/2028

 

3,527

 

 

n/a

 

-

 

 HES Facilities (7)

 

 Revolver

 

3/2/2033

 

2,740

 

 

n/a

 

-

 

66


 

 HP Irish Merger Sub, Inc. (3)

 

 Delayed Draw Term Loan

 

5/14/2028

 

2,895

 

 

n/a

 

-

 

 HP Irish Merger Sub, Inc. (4)

 

 Revolver

 

5/14/2033

 

2,533

 

 

n/a

 

-

 

 HPOne (7)

 

 Delayed Draw Term Loan

 

8/18/2027

 

1,200

 

 

8/18/2027

 

1,200

 

 HPOne (7)

 

 Revolver

 

8/18/2031

 

3,000

 

 

8/18/2031

 

3,000

 

 Husky Holding LLC (3)

 

 Delayed Draw Term Loan

 

n/a

 

-

 

 

2/15/2029

 

59

 

 Iris Buyer, LLC (7)

 

 Revolver

 

10/2/2029

 

505

 

 

10/2/2029

 

505

 

 Iris Buyer, LLC (9)

 

 Delayed Draw Term Loan

 

10/2/2030

 

234

 

 

10/2/2030

 

235

 

 IVX Health Holdings, Inc. (7)

 

 Revolver

 

6/7/2030

 

2,559

 

 

n/a

 

-

 

 IVX Health Holdings, Inc. (7)

 

 Revolver

 

6/7/2030

 

1,408

 

 

6/7/2030

 

1,408

 

 Just Right HVAC, LLC (9)

 

 Revolver

 

2/13/2029

 

40

 

 

n/a

 

-

 

 Just Right HVAC, LLC (9)

 

 Delayed Draw Term Loan

 

2/13/2029

 

45

 

 

n/a

 

-

 

 King Risk Partners LLC (7)

 

 Revolver

 

4/23/2031

 

450

 

 

4/23/2031

 

450

 

 King Risk Partners LLC (8)

 

 Delayed Draw Term Loan

 

1/30/2028

 

3,250

 

 

n/a

 

-

 

 King Risk Partners LLC (8)

 

 Delayed Draw Term Loan

 

4/23/2027

 

404

 

 

4/23/2027

 

1,031

 

 Klick Inc. (7)

 

 Delayed Draw Term Loan

 

11/5/2027

 

-

 

 

11/5/2027

 

3,516

 

 Klick Inc. (7)

 

 Revolver

 

11/5/2032

 

3,516

 

 

11/5/2032

 

3,516

 

 Landscape Workshop LLC (7)

 

 Revolver

 

5/16/2031

 

3,405

 

 

5/16/2031

 

2,841

 

 Landscape Workshop LLC (9)

 

 Delayed Draw Term Loan

 

5/16/2027

 

95

 

 

5/16/2027

 

3,826

 

 Landscape Workshop LLC (9)

 

 Delayed Draw Term Loan

 

3/12/2028

 

7,297

 

 

n/a

 

-

 

 Lawn Star Buyer, LLC (6)

 

 Revolver

 

6/2/2031

 

560

 

 

6/2/2031

 

700

 

 Lightspeed Buyer, Inc. (7)

 

 Revolver

 

2/6/2032

 

1,695

 

 

n/a

 

-

 

 Lightspeed Buyer, Inc. (7)

 

 Delayed Draw Term Loan

 

2/6/2032

 

7,477

 

 

n/a

 

-

 

 LTC Ally Inc (7)

 

 Revolver

 

4/30/2031

 

200

 

 

4/30/2031

 

200

 

 Marlabs (7)

 

 Revolver

 

8/5/2030

 

143

 

 

8/5/2030

 

283

 

 Marlabs (9)

 

 Delayed Draw Term Loan

 

2/5/2028

 

1,350

 

 

2/5/2028

 

1,350

 

 MB2 Dental (7)

 

 Revolver

 

2/13/2031

 

326

 

 

2/13/2031

 

315

 

 MB2 Dental (7)

 

 Delayed Draw Term Loan

 

3/11/2027

 

555

 

 

n/a

 

-

 

 Medical Review Institute of America (7)

 

 Revolver

 

7/1/2030

 

800

 

 

7/1/2030

 

736

 

 Medicus IT (7)

 

 Revolver

 

7/9/2030

 

963

 

 

7/9/2030

 

1,018

 

 Medicus IT (7)

 

 Revolver

 

6/30/2032

 

772

 

 

6/30/2032

 

816

 

 Medicus IT (9)

 

 Delayed Draw Term Loan

 

6/30/2027

 

262

 

 

6/30/2027

 

262

 

 Medicus IT (9)

 

 Delayed Draw Term Loan

 

7/9/2026

 

2,800

 

 

7/9/2026

 

2,800

 

 National Mentor Holdings, Inc. (3)

 

 Delayed Draw Term Loan

 

n/a

 

-

 

 

12/5/2030

 

369

 

 Net Health Acquisition Corp. (7)

 

 Revolver

 

7/5/2031

 

1,136

 

 

7/5/2031

 

1,136

 

 Olyos Group (10)

 

 Delayed Draw Term Loan

 

6/26/2028

 

430

 

 

6/26/2028

 

3,424

 

 Olyos Group (10)

 

 Delayed Draw Term Loan

 

6/26/2028

 

4,571

 

 

n/a

 

-

 

 Online Labels Group, LLC (7)

 

 Revolver

 

12/19/2029

 

200

 

 

12/19/2029

 

200

 

 Online Labels Group, LLC (9)

 

 Delayed Draw Term Loan

 

12/16/2027

 

88

 

 

12/19/2025

 

88

 

67


 

 Online Labels Group, LLC (9)

 

 Delayed Draw Term Loan

 

12/16/2027

 

175

 

 

12/19/2025

 

175

 

 Parts Town (3)

 

 Delayed Draw Term Loan

 

n/a

 

-

 

 

4/16/2026

 

318

 

 Pegasus Steel (9)

 

 Delayed Draw Term Loan

 

7/26/2026

 

139

 

 

1/19/2026

 

197

 

 Pegasus Steel (9)

 

 Delayed Draw Term Loan

 

7/26/2026

 

343

 

 

1/19/2026

 

343

 

 Pegasus Steel (9)

 

 Delayed Draw Term Loan

 

7/26/2026

 

385

 

 

1/19/2026

 

431

 

 PI Buyer LLC (9)

 

 Delayed Draw Term Loan

 

8/29/2032

 

210

 

 

8/29/2032

 

300

 

 PI Buyer LLC (7)

 

 Revolver

 

8/29/2032

 

100

 

 

8/29/2032

 

100

 

 Pipe Bidco GmbH (9)

 

 Delayed Draw Term Loan

 

1/13/2033

 

4,994

 

 

n/a

 

-

 

 Pitch MidCo B.V. (11)

 

 Delayed Draw Term Loan

 

4/26/2028

 

1,143

 

 

4/26/2028

 

1,174

 

 Premier Care Dental Management, LLC (8)

 

 Delayed Draw Term Loan

 

7/16/2027

 

2,057

 

 

7/16/2027

 

5,738

 

 Qinetic, Inc. (7)

 

 Delayed Draw Term Loan

 

10/30/2028

 

4,000

 

 

n/a

 

-

 

 Qinetic, Inc. (7)

 

 Revolver

 

4/30/2033

 

2,000

 

 

n/a

 

-

 

 Rightworks LLC (7)

 

 Revolver

 

5/21/2029

 

150

 

 

5/21/2029

 

285

 

 RN Enterprises, LLC (7)

 

 Revolver

 

10/17/2031

 

652

 

 

10/17/2031

 

932

 

 RN Enterprises, LLC (9)

 

 Delayed Draw Term Loan

 

10/17/2026

 

1,239

 

 

10/17/2026

 

1,572

 

 RWA Wealth Partners, LLC. (7)

 

 Revolver

 

11/15/2030

 

400

 

 

11/15/2030

 

400

 

 RWA Wealth Partners, LLC. (8)

 

 Delayed Draw Term Loan

 

11/15/2026

 

1,068

 

 

11/15/2026

 

1,068

 

 Saarni (3)

 

 Delayed Draw Term Loan

 

n/a

 

-

 

 

3/19/2032

 

5

 

 Schellman Holdings, LLC (3)

 

 Delayed Draw Term Loan

 

4/21/2028

 

2,857

 

 

n/a

 

-

 

 Schellman Holdings, LLC (7)

 

 Revolver

 

4/21/2033

 

4,286

 

 

n/a

 

-

 

 Security Risk Advisors Intl, LLC (9)

 

 Delayed Draw Term Loan

 

9/30/2031

 

650

 

 

9/30/2031

 

650

 

 Security Risk Advisors Intl, LLC (9)

 

 Revolver

 

9/30/2031

 

433

 

 

9/30/2031

 

433

 

 SIG Parent Holdings, LLC (6)

 

 Delayed Draw Term Loan

 

2/25/2028

 

16,500

 

 

n/a

 

-

 

 SIG Parent Holdings, LLC (7)

 

 Revolver

 

8/21/2031

 

809

 

 

n/a

 

-

 

 Solvias AG LP (7)

 

 Revolver

 

2/27/2032

 

1,555

 

 

2/27/2032

 

1,586

 

 SPI Holdco, LLC (7)

 

 Revolver

 

4/21/2032

 

200

 

 

n/a

 

-

 

 SPI Holdco, LLC (9)

 

 Delayed Draw Term Loan

 

4/21/2028

 

250

 

 

n/a

 

-

 

 The Hilb Group, LLC (7)

 

 Delayed Draw Term Loan

 

10/31/2026

 

344

 

 

10/31/2026

 

947

 

 The Hilb Group, LLC (7)

 

 Revolver

 

10/31/2031

 

504

 

 

10/31/2031

 

580

 

 Trace3 (Escape Velocity Holdings) (7)

 

 Delayed Draw Term Loan

 

10/29/2032

 

168

 

 

10/29/2032

 

178

 

 Tree Guardians Holdings LLC (7)

 

 Revolver

 

1/26/2032

 

200

 

 

n/a

 

-

 

 Tree Guardians Holdings LLC (9)

 

 Delayed Draw Term Loan

 

1/26/2028

 

1,315

 

 

n/a

 

-

 

 Trintech, Inc. (7)

 

 Revolver

 

1/29/2028

 

968

 

 

n/a

 

-

 

 Trintech, Inc. (8)

 

 Delayed Draw Term Loan

 

1/29/2033

 

1,290

 

 

n/a

 

-

 

 Tropolis Holdings LLC (7)

 

 Revolver

 

2/28/2031

 

100

 

 

2/28/2031

 

100

 

68


 

 Tropolis Holdings LLC (9)

 

 Delayed Draw Term Loan

 

10/4/2027

 

603

 

 

10/4/2027

 

721

 

 UHY Advisors , Inc. (7)

 

 Revolver

 

11/21/2031

 

355

 

 

11/21/2031

 

320

 

 UHY Advisors , Inc. (8)

 

 Delayed Draw Term Loan

 

11/21/2026

 

595

 

 

11/21/2026

 

1,563

 

 Unosquare, LLC (7)

 

 Revolver

 

6/2/2031

 

550

 

 

6/2/2031

 

550

 

 Unosquare, LLC (9)

 

 Delayed Draw Term Loan

 

6/2/2027

 

1,400

 

 

6/2/2027

 

1,400

 

 USALCO (3)

 

 Delayed Draw Term Loan

 

n/a

 

-

 

 

9/30/2031

 

177

 

 Van Der Steen (13)

 

 Delayed Draw Term Loan

 

5/7/2028

 

1,164

 

 

n/a

 

-

 

 Vrs Buyer (3)

 

 Delayed Draw Term Loan

 

n/a

 

-

 

 

10/11/2032

 

62

 

 WCT Group Holdings, LLC (7)

 

 Revolver

 

12/12/2029

 

229

 

 

n/a

 

-

 

 WCT Group Holdings, LLC (7)

 

 Revolver

 

12/12/2029

 

457

 

 

12/12/2029

 

457

 

 WCT Group Holdings, LLC (7)

 

 Delayed Draw Term Loan

 

8/25/2027

 

-

 

 

8/25/2027

 

43

 

 WCT Group Holdings, LLC (9)

 

 Revolver

 

12/12/2029

 

229

 

 

12/12/2029

 

229

 

Total

 

 

 

 

$

209,106

 

 

 

$

130,592

 

 

(1)
Commitments are generally subject to borrowers meeting certain criteria such as compliance with covenants and certain operational metrics. These amounts may remain outstanding until the commitment period of an applicable loan expires, which may be shorter than its maturity.
(2)
Unfunded commitments denominated in currencies other than USD have been converted to USD using the applicable foreign currency exchange rate as of June 30, 2026 and December 31, 2025.
(3)
Investment pays no fee on the unfunded portion of the revolving credit facility, delayed draw term loan facility or partnership interests.
(4)
Investment pays 0.25% fee on the unfunded portion of the revolving credit facility or delayed draw term loan facility.
(5)
Investment pays 0.35% fee on the unfunded portion of the revolving credit facility or delayed draw term loan facility.
(6)
Investment pays 0.38% fee on the unfunded portion of the revolving credit facility or delayed draw term loan facility.
(7)
Investment pays 0.50% fee on the unfunded portion of the revolving credit facility or delayed draw term loan facility.
(8)
Investment pays 0.75% fee on the unfunded portion of the revolving credit facility or delayed draw term loan facility.
(9)
Investment pays 1.00% fee on the unfunded portion of the revolving credit facility or delayed draw term loan facility.
(10)
Investment pays 1.25% fee on the unfunded portion of the revolving credit facility or delayed draw term loan facility.
(11)
Investment pays 1.50% fee on the unfunded portion of the revolving credit facility or delayed draw term loan facility.
(12)
Investment pays 1.65% fee on the unfunded portion of the revolving credit facility or delayed draw term loan facility.
(13)
Investment pays 1.73% fee on the unfunded portion of the revolving credit facility or delayed draw term loan facility.
(14)
As of June 30, 2026, the Company had an unfunded capital commitment related to its investment in Constellation Wealth Capital Fund II.

Other Commitments and Contingencies

In the normal course of business, the Company enters into contracts which provide a variety of representations and warranties, and that provide general indemnifications. Such contracts include those with certain service providers, brokers and trading counterparties. Any risk exposure to the Company under these arrangements is unknown as it would involve future claims that may be made against the Company; however, based on the Company’s experience, the risk of loss is remote and no such claims are expected to occur. As such, the Company has not accrued any liability in connection with such indemnifications.

Note 9. Net Assets

The Company determines NAV for each class of shares as of the last day of each calendar month. Share issuances related to monthly subscriptions are effective the first calendar day of each month. Shares are issued at an offering price equivalent to the most recent NAV per share available for each share class, which will be NAV per share for each share class as of the last calendar day of the immediately preceding month (i.e. the prior month-end NAV).

In connection with its formation, the Company has the authority to issue 300,000,000 of Common Shares at $0.01 par value per share. On May 3, 2023, Crescent was issued 1,000 Class I shares at $25.00 per share.

69


 

As of June 30, 2026, pursuant to subscription agreements entered into with the Private Placement Investors and shares issued through its public offering that commenced on August 1, 2024, the Company has issued approximately 21,019,303 of its Class I shares, approximately 7,091 of its Class S shares and approximately 929 of its Class D shares and raised gross proceeds of approximately $557,494, $190 and $25, respectively.

The following table summarizes transactions in common shares during the periods noted.

 

 

 

 

 

 

 

 

For the six months ended June 30, 2026

 

 

For the six months ended June 30, 2025

 

(in $ thousands except share amounts)

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

CLASS I

 

 

 

 

 

 

 

 

 

 

 

Subscriptions

 

3,833,090

 

 

$

102,141

 

 

 

3,009,571

 

 

$

80,925

 

Share transfers between classes

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Distributions reinvested

 

1,165

 

 

 

31

 

 

 

-

 

 

 

-

 

Share repurchases, net of early repurchase deductions

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Net increase (decrease)

 

3,834,255

 

 

$

102,172

 

 

 

3,009,571

 

 

$

80,925

 

CLASS S

 

 

 

 

 

 

 

 

 

 

 

Subscriptions

 

4,624

 

 

$

124

 

 

 

1,786

 

 

$

48

 

Share transfers between classes

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Distributions reinvested

 

108

 

 

 

3

 

 

 

27

 

 

 

1

 

Share repurchases, net of early repurchase deductions

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Net increase (decrease)

 

4,732

 

 

$

127

 

 

 

1,813

 

 

$

49

 

CLASS D

 

 

 

 

 

 

 

 

 

 

 

Subscriptions

 

929

 

 

$

25

 

 

 

-

 

 

$

-

 

Share transfers between classes

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Distributions reinvested

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Share repurchases, net of early repurchase deductions

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Net increase (decrease)

 

929

 

 

$

25

 

 

 

-

 

 

$

-

 

 

Net Asset Value per Share and Offering Price

The following table summarizes each month-end NAV per share for Class I, Class S and Class D shares of beneficial interest for the period from January 1, 2025 through June 30, 2026.

 

Date

Class I

 

 

Class S

 

 

Class D

 

January 31, 2025

 

27.03

 

 

 

-

 

 

 

-

 

February 28, 2025

 

26.99

 

 

 

-

 

 

 

-

 

March 31, 2025

 

26.88

 

 

 

-

 

 

 

-

 

April 30, 2025

 

26.76

 

 

 

26.76

 

 

 

-

 

May 31, 2025

 

26.92

 

 

 

26.92

 

 

 

-

 

June 30, 2025

 

27.14

 

 

 

27.14

 

 

 

-

 

July 31, 2025

 

27.11

 

 

 

27.11

 

 

 

-

 

August 31, 2025

 

27.20

 

 

 

27.20

 

 

 

-

 

September 30, 2025

 

27.02

 

 

 

27.02

 

 

 

-

 

October 31, 2025

 

26.89

 

 

 

26.89

 

 

 

-

 

November 30, 2025

 

26.89

 

 

 

26.89

 

 

 

-

 

December 31, 2025

 

27.06

 

 

 

27.06

 

 

 

-

 

January 31, 2026

 

26.90

 

 

 

26.90

 

 

 

26.90

 

February 28, 2026

 

26.58

 

 

 

26.58

 

 

 

26.58

 

March 31, 2026

 

26.27

 

 

 

26.27

 

 

 

26.27

 

April 30, 2026

 

26.36

 

 

 

26.36

 

 

 

26.36

 

May 31, 2026

 

26.32

 

 

 

26.32

 

 

 

26.32

 

June 30, 2026

 

26.26

 

 

 

26.26

 

 

 

26.26

 

 

70


 

 

Distributions
 

The Company declared monthly regular and special distributions for its Class I shares, Class S shares and Class D shares. The following table presents the monthly regular and special distributions that were declared and payable during the six months ended June 30, 2026.

 

(in $ thousands, except per share amounts)

 

 

Class I Distributions

 

 

Class S Distributions

 

 

Class D Distributions

 

 

Record Date

Declaration Date

Payment Date

 

Per Share

 

Amount

 

 

Per Share

 

Amount

 

 

Per Share

 

Amount

 

 

January 31, 2026

January 30, 2026

February 27, 2026

 

$

0.160

 

$

3,010

 

 

$

0.141

 

$

0

 

 

$

-

 

$

-

 

 

January 31, 2026

January 30, 2026

February 27, 2026

 

 

0.040

 

 

752

 

(1)

 

0.040

 

 

0

 

(1)

 

-

 

 

-

 

 

February 28, 2026

February 25, 2026

March 30, 2026

 

 

0.165

 

 

3,110

 

 

 

0.146

 

 

1

 

 

 

0.159

 

 

0

 

 

March 31, 2026

March 27, 2026

April 30, 2026

 

 

0.165

 

 

3,161

 

 

 

0.146

 

 

1

 

 

 

0.159

 

 

0

 

 

March 31, 2026

March 27, 2026

April 30, 2026

 

 

0.070

 

 

1,341

 

(1)

 

0.070

 

 

0

 

(1)

 

0.070

 

 

0

 

(1)

April 30, 2026

April 28, 2026

May 27, 2026

 

 

0.165

 

 

3,377

 

 

 

0.146

 

 

1

 

 

 

0.160

 

 

0

 

 

May 31, 2026

May 22, 2026

June 30, 2026

 

 

0.165

 

 

3,441

 

 

 

0.146

 

 

1

 

 

 

0.160

 

 

0

 

 

June 30, 2026

June 25, 2026

July 31, 2026

 

 

0.165

 

 

3,468

 

 

 

0.146

 

 

1

 

 

 

0.160

 

 

0

 

 

June 30, 2026

June 25, 2026

July 31, 2026

 

 

0.045

 

 

946

 

(1)

 

0.045

 

 

0

 

(1)

 

0.045

 

 

0

 

(1)

 

 

 

 

$

1.140

 

$

22,606

 

(2)

$

1.026

 

$

6

 

(2)

$

0.913

 

$

1

 

(2)

(1) Represents a special distribution

(2) Totals may not add up due to rounding

 

The following table presents the monthly regular and special distributions that were declared and payable during the six months ended June 30, 2025.

 

(in $ thousands, except per share amounts)

 

 

Class I Distributions

 

 

Class S Distributions

 

 

Class D Distributions

 

 

Record Date

Declaration Date

Payment Date

 

Per Share

 

Amount

 

 

Per Share

 

Amount

 

 

Per Share

 

Amount

 

 

January 31, 2025

January 29, 2025

February 27, 2025

 

$

0.16

 

$

1,119

 

 

$

-

 

$

-

 

 

$

-

 

$

-

 

 

January 31, 2025

January 29, 2025

February 27, 2025

 

 

0.06

 

 

419

 

(1)

 

-

 

 

-

 

 

 

-

 

 

-

 

 

February 28, 2025

February 24, 2025

March 27, 2025

 

 

0.16

 

 

1,119

 

 

 

-

 

 

-

 

 

 

-

 

 

-

 

 

February 28, 2025

February 24, 2025

March 27, 2025

 

 

0.06

 

 

419

 

(1)

 

-

 

 

-

 

 

 

-

 

 

-

 

 

March 31, 2025

March 26, 2025

April 28, 2025

 

 

0.16

 

 

1,119

 

 

 

-

 

 

-

 

 

 

-

 

 

-

 

 

March 31, 2025

March 26, 2025

April 28, 2025

 

 

0.06

 

 

419

 

(1)

 

-

 

 

-

 

 

 

-

 

 

-

 

 

April 30, 2025

April 28, 2025

May 28, 2025

 

 

0.16

 

 

1,509

 

 

 

0.14

 

0

 

 

 

-

 

 

-

 

 

April 30, 2025

April 28, 2025

May 28, 2025

 

 

0.06

 

 

566

 

(1)

 

0.06

 

0

 

(1)

 

-

 

 

-

 

 

May 31, 2025

May 22, 2025

June 27, 2025

 

 

0.16

 

 

1,548

 

 

 

0.14

 

0

 

 

 

-

 

 

-

 

 

May 31, 2025

May 22, 2025

June 27, 2025

 

 

0.06

 

 

580

 

(1)

 

0.06

 

0

 

(1)

 

-

 

 

-

 

 

June 30, 2025

June 25, 2025

July 29, 2025

 

 

0.16

 

 

1,550

 

 

 

0.14

 

0

 

 

 

-

 

 

-

 

 

June 30, 2025

June 25, 2025

July 29, 2025

 

 

0.06

 

 

581

 

(1)

 

0.06

 

0

 

(1)

 

-

 

 

-

 

 

 

 

 

 

$

1.32

 

$

10,948

 

(2)

$

0.60

 

$

1

 

(2)

$

-

 

$

-

 

 

 

(1) Represents a special distribution

(2) Totals may not add up due to rounding

See Note 12 “Subsequent Events” for subsequent events relating to regular and special distributions declared by the Company.

Distribution Reinvestment Plan

The Company has adopted a distribution reinvestment plan pursuant to which stockholders will have their cash distributions automatically reinvested in additional shares of the Company’s same class of common stock to which the distribution relates unless they elect to receive their distributions in cash. As a result, if the Company declares, a cash dividend or other distribution, then stockholders who have not opted out of the Company’s distribution reinvestment plan (or, in the case of Alabama, Arkansas, California, Idaho,

71


 

Kansas, Kentucky, Maine, Maryland, Massachusetts, Nebraska, New Jersey, North Carolina, Ohio, Oregon, Vermont and Washington stockholders and clients of participating brokers that do not permit automatic enrollment in our distribution reinvestment plan, opted to participate in such plan), will have their cash distributions automatically reinvested in additional shares, rather than receiving the cash dividend or other distribution. Distributions on fractional shares will be credited to each participating stockholder’s account to three decimal places.

 

Share Repurchase Program

The Company has commenced a share repurchase program in which the Company intends, at the discretion of the Board, to offer to repurchase, in each quarter, up to 5% of its Common Shares outstanding in each quarter. The Board may amend, suspend, or terminate the share repurchase program at any time if it deems such action to be in the best interest of the Company and its common stockholders. For example, in accordance with the directors’ duties to the Company, the Board may amend, suspend or terminate the share repurchase program during periods of market dislocation where selling assets to fund a repurchase could have a materially negative impact on remaining stockholders. As a result, share repurchases may not be available each quarter, such as when a repurchase offer would place an undue burden on the Company’s liquidity, adversely affect its operations or risk having an adverse impact on the Company that would outweigh the benefit of the repurchase offer. Following any such suspension, the Board will reinstate the share repurchase program when appropriate and subject to the directors’ duties to the Company. All shares purchased by the Company in connection with the share repurchase program will be retired and thereafter will be authorized and unissued shares.

In accordance with the Company’s share repurchase program, the Company made two share repurchase offers in the first two quarters of both 2026 and 2025. There were no share repurchases actually completed for the six months ended June 30, 2026 and 2025.

 

 

Note 10. Financial Highlights

Below is the schedule of the Company’s financial highlights for the six months ended June 30, 2026 and 2025 (in thousands, except share and per share data):

 

 

For the six months ended
June 30, 2026

 

 

For the six months ended
June 30, 2025

 

 

 

 

Class I

 

 

Class S

 

 

Class D

 

 

Class I

 

 

Class S

 

 

Class D

 

 

Per Share Data:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net asset value, beginning of period

 

$

27.06

 

 

$

27.06

 

 

$

-

 

 

$

27.06

 

 

$

-

 

 

$

-

 

 

Capital contribution

 

 

-

 

 

 

-

 

 

 

26.90

 

 

 

-

 

 

 

26.88

 

 

 

-

 

 

Net investment income (1)

 

 

1.08

 

 

 

0.97

 

 

 

0.88

 

 

 

1.29

 

 

 

0.56

 

 

 

-

 

 

Net realized and unrealized gains (losses) on investments (1)(2)

 

 

(0.74

)

 

 

(0.74

)

 

 

(0.61

)

 

 

0.11

 

 

 

0.30

 

 

 

-

 

 

Net increase (decrease) in net assets resulting from operations

 

 

0.34

 

 

 

0.23

 

 

 

0.27

 

 

 

1.40

 

 

 

0.86

 

 

 

-

 

 

Distributions declared from net investment income (8)

 

 

(1.14

)

 

 

(1.03

)

 

 

(0.91

)

 

 

(1.32

)

 

 

(0.60

)

 

 

-

 

 

Total increase (decrease) in net assets

 

 

(0.80

)

 

 

(0.80

)

 

 

26.26

 

 

 

0.08

 

 

 

27.14

 

 

 

-

 

 

Net asset value, end of period

 

$

26.26

 

 

$

26.26

 

 

$

26.26

 

 

$

27.14

 

 

$

27.14

 

 

$

-

 

 

Shares outstanding, end of period

 

 

21,019,303

 

 

 

7,091

 

 

 

929

 

 

 

9,687,327

 

 

 

1,813

 

 

-

 

 

Weighted average shares outstanding

 

 

19,855,113

 

 

 

6,068

 

 

 

929

 

 

 

8,301,845

 

 

 

1,791

 

 

-

 

 

Total return based on net asset value (3)

 

 

1.26

%

 

 

0.82

%

 

 

1.00

%

 

 

5.17

%

 

 

3.20

%

 

-

 

 

Ratio/Supplemental Data:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net assets, end of period

 

$

552,006

 

 

$

186

 

 

$

24

 

 

$

262,915

 

 

$

49

 

 

$

-

 

 

Ratio of total expenses (excluding expense support and expense support reimbursement) to average net assets (4)(5)(6)

 

 

7.16

%

 

 

8.07

%

 

 

7.48

%

 

 

9.97

%

 

 

9.69

%

 

-

 

 

Ratio of net expenses (excluding expense support and expense support reimbursement, and without incentive fees and interest and other debt expenses) to average net assets (6)

 

 

2.31

%

 

 

3.18

%

 

 

2.57

%

 

 

5.13

%

 

 

5.25

%

 

-

 

 

Ratio of net investment income to average net assets (6)

 

 

8.18

%

 

 

7.37

%

 

 

7.98

%

 

 

10.28

%

 

 

8.34

%

 

-

 

 

Ratio of interest and other debt financing costs to average net assets (6)

 

 

4.85

%

 

 

4.90

%

 

 

4.91

%

 

 

4.68

%

 

 

4.32

%

 

-

 

 

Portfolio turnover (7)

 

 

34.91

%

 

 

34.91

%

 

 

34.91

%

 

 

18.65

%

 

 

18.65

%

 

-

 

 

Asset coverage ratio

 

 

230

%

 

 

230

%

 

 

230

%

 

 

233

%

 

 

233

%

 

-

 

 

(1)
The per share data was derived by using the weighted average shares outstanding during the period.

72


 

(2)
The amount shown does not correspond with the aggregate amount for the period as it includes the effect of the timing of capital transactions.
(3)
Total return based on NAV is calculated as the change in NAV per share during the period plus declared dividends per share during the period, divided by the beginning NAV per share, and not annualized.
(4)
The ratio of total expenses to average net assets in the table above reflects the Adviser’s voluntary waivers of its right to receive a portion of the management fees and income incentive fees.
(5)
The ratio of total expenses to average net assets in the table above includes the Adviser’s voluntary waivers of its right to receive the management, income and capital gains incentive fees. Excluding the effects of the voluntary waivers and including the impact of the expense support, the annualized ratio of total expenses to average net assets for Class I shares would have been 8.28% and 10.97%, respectively, for the six months ended June 30, 2026 and 2025. Excluding the effects of the voluntary waivers and expense support, the annualized ratio of total expenses to average net assets for Class S shares would have been 9.30% and 11.06% for the six months ended June 30, 2026 and 2025. Excluding the effects of the voluntary waivers and expense support, the annualized ratio of total expenses to average net assets for Class D shares would have been 8.54% for the six months ended June 30, 2026.
(6)
Annualized.

(7) Not annualized.

(8) The per share data for distributions was derived by using the actual shares outstanding at the date of the relevant transactions (refer to Note 9 Net Assets).

 

 

Note 11. Income Taxes

For the three and six months ended June 30, 2026, the Company recognized $46 and $73 of excise taxes related to its status as a RIC, respectively. For the three and six months ended June 30, 2025, the Company recognized $81 and $162 of excise taxes related to its status as a RIC, respectively. As of June 30, 2026, and December 31, 2025, $100 and $222 of accrued excise taxes remained payable, respectively.

For the three and six months ended June 30, 2026 and 2025 the Company recognized $0 benefits (provisions) for taxes on realized and unrealized appreciation and depreciation on investments. As of June 30, 2026 and December 31, 2025, no deferred tax assets or liabilities were recorded on the Consolidated Statements of Assets and Liabilities.

The Company’s aggregate investment unrealized appreciation and depreciation for federal income tax purposes was as follows (in thousands):

 

As of
June 30, 2026

 

 

As of
December 31, 2025

 

Tax Cost (1)

 

$

960,878

 

 

$

905,241

 

Gross Unrealized Appreciation

 

$

12,594

 

 

$

13,386

 

Gross Unrealized Depreciation

 

 

(12,334

)

 

 

(4,469

)

Net Unrealized Investment Appreciation (Depreciation)

 

$

260

 

 

$

8,917

 

(1) Tax cost includes cash equivalents

Note 12. Subsequent Events

The Company’s management evaluated subsequent events through the date of issuance of the consolidated financial statements included herein. Other than the items below, there have been no subsequent events that occurred during such period that would require disclosure or would be required to be recognized in the consolidated financial statements as of June 30, 2026.

On July 28, 2026, the Company announced the declaration of the amounts per share set forth below for its Class I shares, Class S shares, and Class D shares. The distributions for Class I shares, Class S shares, and Class D shares were payable to stockholders of record as of the open of business on July 31, 2026 and will be paid on or about August 31, 2026. The distributions will be paid in cash or reinvested in the Class I shares, Class S shares or Class D shares, respectively, for stockholders participating in the Company’s distribution reinvestment plan.

 

 

Gross Distribution

 

 

Stockholder Servicing and/or Distribution Fee

 

 

Net Distribution

 

 

 

Class I Common Shares

 

$

0.16500

 

 

$

-

 

 

$

0.16500

 

 

 

Class S Common Shares

 

 

0.16500

 

 

 

0.01860

 

 

 

0.14640

 

 

 

Class D Common Shares

 

 

0.16500

 

 

 

0.00547

 

 

 

0.15953

 

 

 

 

 

73


 

 

On August 1, 2026, pursuant to the Offering, the Company received approximately $33,675 in subscriptions from third party unaffiliated investors. The purchase price per Class I share, Class S share and Class D share will equal the Company’s net asset value per Class I share, Class S share and Class D share, respectively, as of the last calendar day of July 31, 2026 (the “July NAV”), which is generally expected to be available within 20 business days after August 1, 2026. At that time, the number of Class I shares, Class S shares and Class D shares issued to each investor based on the July NAV and such investor’s subscription amount will be determined and Class I shares, Class S shares and Class D shares, as applicable, will be credited to the investor’s account as of the effective date of the share purchase, August 1, 2026.

74


 

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The information contained in this section should be read in conjunction with the financial statements and notes thereto appearing elsewhere in this Quarterly Report. Some of the statements in this section (including in the following discussion) constitute forward-looking statements, which relate to future events or the future performance or financial condition of Crescent Private Credit Income Corp. (the “Company,” “we,” “us,” or “our”). The forward-looking statements contained in this section involve a number of risks and uncertainties. Please see “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” for a discussion of uncertainties, risks and assumptions associated with these statements.

OVERVIEW

We are an externally managed, non-diversified closed-end management investment company that has elected to be treated as a BDC under the Investment Company Act. Formed as a Maryland corporation on November 10, 2022, we are externally managed by our investment adviser, which is responsible for sourcing potential investments, conducting due diligence on prospective investments, analyzing investment opportunities, structuring investments and monitoring our portfolio on an ongoing basis. Our investment adviser is registered as an investment adviser with the SEC. We have also elected to be treated, and intend to qualify annually, as a RIC under the Code.

We are externally managed by our investment adviser, Crescent Cap NT Advisors, LLC (the “Adviser”), an affiliate of Crescent, pursuant to our Investment Advisory and Management Agreement (as defined below). Our administrator, CCAP Administration LLC (the “Administrator”), an affiliate of Crescent, provides certain administrative and other services necessary for us to operate. CCAP Administration LLC also serves as the Administrator of Crescent Capital BDC, Inc. (“CCAP”), a publicly-traded BDC affiliated with the Company, since 2015.

Our investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation through debt and related equity investments. We seek to invest primarily in directly originated assets, including first lien senior secured loans (including “unitranche” loans, which are loans that combine both senior and subordinated debt, generally in a first lien position), second lien senior secured loans, subordinated secured and unsecured loans, subordinated debt, which in some cases includes an equity component and preferred component and other types of credit instruments, made to or issued by U.S. middle-market companies. Our primary focus is to invest in companies with EBITDA of $35 million to $120 million; however, we may invest in larger or smaller companies. The first and second lien senior secured loans generally have terms of five to eight years. In connection with our first and second lien senior secured loans, we generally receive security interests in certain assets of our portfolio companies that could serve as collateral in support of the repayment of such loans. First and second lien senior secured loans generally have floating interest rates, which may have interest rate floors, and also may provide for some amortization of principal and excess cash flow payments, with the remaining principal balance due at maturity. To a lesser extent, we may make investments in syndicated loans and other liquid credit investment opportunities, including in publicly traded debt instruments, for cash management purposes, while also presenting an opportunity for attractive investment returns. The credit instruments we may invest in include distressed securities, securitized products, notes, bills, debentures, bank loans, convertible and preferred securities and government and municipal obligations. We may also invest in foreign instruments and illiquid and restricted securities.

Under normal circumstances, we will invest at least 80% of our total assets (net assets plus borrowings for investment purposes) in private credit investments (loans, bonds and other credit instruments that are issued in private offerings or issued by private companies). While most of our investments will be in private U.S. companies, we also expect to invest from time to time in non-U.S. companies (we generally have to invest at least 70% of our total assets in “qualifying assets,” including private U.S. companies). We believe that our liquid credit investments will help maintain liquidity to satisfy any share repurchases we choose to make in our sole discretion and manage cash before investing subscription proceeds into directly originated loans while also seeking attractive investment returns. We expect these investments to enhance our risk/return profile and serve as a source of liquidity for the Company. Subject to the limitations of the Investment Company Act, we may invest in loans or other securities, the proceeds of which may refinance or otherwise repay debt or securities of companies whose debt is owned by other Crescent funds. From time to time, we may co-invest with other Crescent funds.

“First lien” investments are senior loans that have the benefit of a first-priority security interest on all existing and future assets of the issuer. The security interest ranks above the security interest of any second-lien lenders in those assets.

“Unitranche” investments are loans that may extend deeper in a company’s capital structure than traditional first lien debt and may provide for a waterfall of cash flow priority among different lenders in the unitranche loan. In certain instances, we may find another lender to provide the “first out” portion of such loan and retain the “last out” portion of such loan, in which case, the “first out” portion of the loan would generally receive priority with respect to payment of principal, interest and any other amounts due thereunder over the “last out” portion that we would continue to hold. In exchange for the greater risk of loss, the “last out” portion earns a higher interest rate.

75


 

“Second lien” investments are loans with a second priority lien on all existing and future assets of the portfolio company. The security interest ranks below the security interests of any first lien and unitranche lenders in those assets.

“Unsecured debt” investments are loans that generally rank senior to a borrower’s equity securities and junior in right of payment to such borrower’s other senior indebtedness.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Changes in the economic environment, financial markets and any other parameters used in determining such estimates could cause actual results to differ materially. The critical accounting policies and estimates should be read in connection with our risk factors as disclosed herein.

For a description of our critical accounting policies and estimates, see Note 2 “Significant Accounting Policies” to our consolidated financial statements included in this report. We consider the most significant accounting policies to be those related to our Valuation of Portfolio Investments, Revenue Recognition, Non-Accrual Investments, Distribution Policy, and Income Taxes.

COMPONENTS OF OPERATIONS

Investments

We expect our investment activity to vary substantially from period to period depending on many factors, the general economic environment, the amount of capital we have available to us, the level of merger and acquisition activity for middle-market companies, including the amount of debt and equity capital available to such companies and the competitive environment for the type of investments we make. In addition, as part of our risk strategy on investments, we may reduce certain levels of investments through partial sales or syndication to additional investors.

We may not invest in any assets other than “qualifying assets” specified in the Investment Company Act, unless, at the time the investments are made, at least 70% of our total assets are qualifying assets (with certain limited exceptions). Qualifying assets include investments in “eligible portfolio companies.” Pursuant to rules adopted by the SEC, “eligible portfolio companies” include certain companies that do not have any securities listed on a national securities exchange and public companies whose securities are listed on a national securities exchange but whose market capitalization is less than $250 million.

The Investment Adviser

Our investment activities are managed by the Adviser, which is responsible for originating prospective investments, conducting research and due diligence investigations on potential investments, analyzing investment opportunities, negotiating and structuring our investments and monitoring our investments and portfolio companies on an ongoing basis. Crescent is wholly owned by Sun Life Financial Inc. (together with its subsidiaries and joint ventures, “Sun Life”).

Revenues

We generate revenue primarily in the form of interest income on debt investments and capital gains and distributions, if any, on equity securities that we may acquire in portfolio companies.

Certain investments may have contractual PIK interest or dividends. PIK represents accrued interest or accumulated dividends that are added to the loan principal or cost basis of the investment on the respective interest or dividend payment dates rather than being paid in cash and generally becomes due at maturity or upon being called by the issuer. PIK is recorded as interest or dividend income, as applicable. If at any point we believe PIK is not expected to be realized, the investment generating PIK will be placed on non-accrual status. Accrued PIK interest or dividends are generally reversed through interest or dividend income, respectively, when an investment is placed on non-accrual status. We also generate revenue in the form of commitment or origination fees. Loan origination fees, original issue discount and market discount or premium are capitalized, and we accrete or amortize such amounts into income over the life of the loan using the effective yield method.

Dividend income from common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly-traded portfolio companies. Dividend income from preferred equity securities is recorded on an accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected.

We may receive other income, which may include income such as consent, waiver, amendment, underwriting, and arranger fees associated with our investment activities as well as any fees for managerial assistance services rendered to the portfolio companies. Such fees are recognized as income when earned or the services are rendered.

76


 

Expenses

Except as specifically provided below, all investment professionals of the Adviser and their respective staff, when and to the extent engaged in providing investment advisory services to us, and the base compensation, bonus and benefits, and the routine overhead expenses, of such personnel allocable to such services, will be provided and paid for by the Adviser. We bear all other costs and expenses of our operations, administration and transactions, including, but not limited to:

investment advisory fees, including management fees and incentive fees, to the Adviser, pursuant to the Investment Advisory and Management Agreement;
our allocable portion of the costs, expenses and benefits paid by the Administrator or its affiliates to our chief compliance officer, chief financial officer, general counsel and secretary, their respective staffs and our operations and finance staffs who provide services to us; provided that such reimbursement does not conflict with section 7.8 of our charter;
the cost of calculating our NAV;
fidelity bond, directors’ and officers’ liability insurance and other insurance premiums;
fees and expenses associated with independent audits and outside legal costs;
independent directors’ fees and expenses;
U.S. federal, state and local taxes;
costs associated with our reporting and compliance obligations under the Investment Company Act and other applicable U.S. federal and state securities laws;
debt service and other costs of borrowings or other financing arrangements; and
all other expenses reasonably incurred by us in operating the business.

 

Organization and offering expenses were incurred by the Adviser on our behalf until the commencement of the Offering (as defined below). Any organization and offering expenses incurred by us, including reimbursements to the Adviser, are expensed as incurred subject to the Expense Support Agreement. We are obligated to reimburse the Adviser for such advanced expenses (including any additional expenses the Adviser elects to pays on our behalf), subject to certain conditions. See “Components of Operations - Expenses - Expense Support and Conditional Reimbursement Agreement.” Any reimbursements will not exceed actual expenses incurred by the Adviser and its affiliates.

From time to time, the Adviser, the Administrator, or their respective affiliates, may pay third party providers of goods or services. We will reimburse the Adviser, the Administrator, or such affiliates thereof for any such amounts paid on our behalf. Each of the Adviser or the Administrator will waive its right to be reimbursed in the event that such reimbursements would cause any distributions to our common stockholders to constitute a return of capital to stockholders. All of these expenses will ultimately be borne by our common stockholders.

Expense Support and Conditional Reimbursement Agreement

We have entered into the Expense Support Agreement with the Adviser. For additional information see Note 3 “Agreements and Related Party Transactions” to the consolidated financial statements included in this report.

 

Leverage

In accordance with applicable SEC staff guidance and interpretations, we, as a BDC, are permitted to borrow amounts such that our asset coverage ratio is at least 150% after such borrowing (if certain requirements are met). Short-term credits necessary for the settlement of securities transactions and arrangements with respect to securities lending will not be considered borrowings for these purposes. The amount of leverage that we may employ depends on our Adviser’s and our Board’s assessment of market conditions and other factors at the time of any proposed borrowing.

PORTFOLIO INVESTMENT ACTIVITY

Our portfolio at fair value was comprised of the following:

 

77


 

($ in millions)

 

As of June 30, 2026

 

 

 

As of December 31, 2025

Investment Type

 

Fair Value

 

 

Percentage

 

 

 

Fair Value

 

 

Percentage

 

 

 Senior Secured First Lien

 

$

296.6

 

 

 

31.4

 

%

 

$

458.5

 

 

 

52.1

 

 %

 Unitranche First Lien

 

 

564.4

 

 

 

59.7

 

 

 

 

383.3

 

 

 

43.6

 

 

 Unitranche First Lien - Last Out

 

 

2.4

 

 

 

0.3

 

 

 

 

2.6

 

 

 

0.3

 

 

 Senior Secured Second Lien

 

 

25.4

 

 

 

2.7

 

 

 

 

10.3

 

 

 

1.2

 

 

 Unsecured Debt

 

 

22.6

 

 

 

2.4

 

 

 

 

3.6

 

 

 

0.4

 

 

 Equity

 

 

20.6

 

 

 

2.2

 

 

 

 

10.8

 

 

 

1.2

 

 

 LLC/LP Equity Interests

 

 

12.7

 

 

 

1.3

 

 

 

 

10.5

 

 

 

1.2

 

 

Total Investments

 

$

944.7

 

 

 

100.0

 

%

 

$

879.6

 

 

 

100.0

 

%

The following table presents certain selected information regarding our investment portfolio:

($ in millions)

 

For the three months ended

 

 

For the six months ended

 

June 30, 2026

 

June 30, 2025

 

 

June 30, 2026

 

June 30, 2025

 

New investments at cost:

 

 

 

 

 

Senior Secured First Lien

$

3.2

 

$

107.7

 

 

$

116.8

 

$

137.6

 

Unitranche First Lien

 

129.0

 

 

79.2

 

 

 

227.9

 

 

118.0

 

Unitranche First Lien - Last Out

 

-

 

 

0.4

 

 

 

-

 

 

3.0

 

Senior Secured Second Lien

 

 

 

17.7

 

 

 

-

 

 

 

17.7

 

 

 

-

 

Unsecured Debt

 

10.5

 

 

-

 

 

 

23.2

 

 

-

 

Equity

 

6.9

 

 

1.8

 

 

 

10.2

 

 

3.0

 

LLC/LP Equity Interests

 

1.7

 

 

3.0

 

 

 

2.3

 

 

3.0

 

     Total Investments

$

169.0

 

$

192.1

 

 

$

398.1

 

$

264.6

 

Proceeds from investments sold or repaid:

 

 

 

 

 

Senior Secured First Lien

$

64.7

 

$

(8.5

)

 

$

269.3

 

$

36.9

 

Unitranche First Lien

 

36.8

 

 

23.0

 

 

 

43.8

 

 

24.0

 

Unitranche First Lien - Last Out

 

-

 

 

-

 

 

 

0.1

 

 

2.0

 

Senior Secured Second Lien

 

 

 

-

 

 

 

-

 

 

 

2.5

 

 

 

-

 

Unsecured Debt

 

-

 

 

-

 

 

 

3.5

 

 

-

 

Equity

 

-

 

 

-

 

 

 

-

 

 

2.0

 

LLC/LP Equity Interests

 

-

 

 

-

 

 

 

-

 

 

-

 

    Total Proceeds

$

101.5

 

$

14.5

 

 

$

319.2

 

$

64.9

 

    Net increase (decrease) in portfolio

$

67.5

 

$

177.7

 

 

$

78.9

 

$

199.8

 

 

The following table presents certain selected information regarding our investment portfolio:

As of June 30, 2026

 

As of December 31, 2025

 

Weighted average yield on income producing securities (at cost) (1)

 

8.6

 

%

 

8.3

 

%

Percentage of debt bearing a floating rate (at fair value)

 

 

97.9

 

%

 

 

99.6

 

%

Percentage of debt bearing a fixed rate (at fair value)

 

2.1

 

%

 

0.4

 

%

Number of portfolio companies

 

185

 

 

246

 

(1) Includes performing debt and other income producing investments (excluding investments on non-accrual).

The following table shows the amortized cost and fair value of our performing and non-accrual debt and income producing debt securities:

($ in millions)

As of June 30, 2026

 

 

As of
December 31, 2025

 

 

Cost

 

% of Cost

 

Fair Value

 

% of Fair Value

 

 

Cost

 

% of Cost

 

Fair Value

 

% of Fair Value

 

Performing

$

905.6

 

 

99.1

%

$

906.8

 

 

99.5

%

 

$

852.6

 

 

100.0

%

$

858.3

 

 

100.0

%

Non-Accrual

 

7.8

 

 

0.9

%

 

4.6

 

 

0.5

%

 

 

-

 

 

0.0

%

 

-

 

 

0.0

%

Total

$

913.4

 

 

100.0

%

$

911.4

 

 

100.0

%

 

$

852.6

 

 

100.0

%

$

858.3

 

 

100.0

%

 

78


 

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected in full. Non-accrual loans are restored to accrual status when past due principal and interest is paid current and, in management’s judgment, are likely to remain current. Management may determine to not place a loan on non-accrual status if the loan has sufficient collateral value and is in the process of collection. As of June 30, 2026, we had investments in one portfolio company on non-accrual status, which represented 0.9% and 0.5% of the total debt investments at cost and fair value, respectively. As of December 31, 2025, we had no investments on non-accrual status.

The Adviser monitors our portfolio companies on an ongoing basis. The Adviser monitors the financial trends of each portfolio company to determine if it is meeting its business plans and to assess the appropriate course of action for each company. The Adviser has a number of methods of evaluating and monitoring the performance and fair value of our investments, which may include the following:

assessment of success of the portfolio company in adhering to its business plan and compliance with covenants;
review of monthly and quarterly financial statements and financial projections for portfolio companies;
contact with portfolio company management and, if appropriate, the financial or strategic sponsor, to discuss financial position, requirements and accomplishments;
comparisons to other companies in the industry; and
attendance and participation in board meetings.

As part of the monitoring process, the Adviser regularly assesses the risk profile of each of our investments and, on a quarterly basis, grades each investment on a risk scale of 1 to 5. Risk assessment is not standardized in our industry and our risk assessment may not be comparable to ones used by our competitors. Our assessment is based on the following categories:

(1)
Involves the least amount of risk relative to cost or amortized cost. Investment performance is above expectations since origination or acquisition. Trends and risk factors are generally favorable, which may include financial performance or a potential exit.
(2)
Involves a level of risk that is similar to the risk at the time of origination or acquisition. The investment is generally performing as expected, and the risks around our ability to ultimately recoup the cost of the investment are neutral to favorable relative to the time of origination or acquisition. New investments are generally assigned a rating of 2 at origination or acquisition.
(3)
Indicates an investment performing below expectations where the risks around our ability to ultimately recoup the cost of the investment have increased since origination or acquisition. For debt investments, borrowers are more likely than not in compliance with debt covenants and loan payments are generally not past due. An investment rating of 3 requires closer monitoring.
(4)
Indicates an investment performing materially below expectations where the risks around our ability to ultimately recoup the cost of the investment have increased materially since origination or acquisition. For debt investments, borrowers may be out of compliance with debt covenants and loan payments may be past due (but generally not more than 180 days past due). Non-accrual status is strongly considered for debt investments rated 4.
(5)
Indicates an investment performing substantially below expectations where the risks around our ability to ultimately recoup the cost of the investment have substantially increased since origination or acquisition. We do not expect to recover our initial cost basis from investments rated 5. Debt investments with an investment rating of 5 are generally in payment and/or covenant default and are on non-accrual status.

The following table shows the composition of our portfolio on the 1 to 5 investment performance rating scale. Investment performance ratings are accurate only as of those dates and may change due to subsequent developments relating to a portfolio company’s business or financial condition, market conditions or developments, and other factors.

 

($ in millions)

As of June 30, 2026

As of December 31, 2025

 

 

Investments at

 

 

Percentage of

 

Investments at

 

 

Percentage of

 

Investment Performance Rating

 

Fair Value

 

 

Total Portfolio

 

 

 

Fair Value

 

 

Total Portfolio

 

 

1

$

47.8

 

 

5.1

 

%

$

20.0

 

 

2.3

 

%

2

 

890.1

 

 

94.2

 

 

852.5

 

 

96.9

 

3

 

2.2

 

 

0.2

 

 

7.1

 

 

0.8

 

4

 

4.6

 

 

0.5

 

 

-

 

 

-

 

5

 

-

 

 

-

 

 

-

 

 

-

 

Total

$

944.7

 

 

100.0

 

%

$

879.6

 

 

100.0

 

%

 

79


 

RESULTS OF OPERATIONS

Summarized statement of operations

 

 

 

For the three months ended June 30,

 

 

For the six months ended June 30,

 

 

($ in millions)

 

2026

 

 

2025

 

 

2026

 

 

2025

 

 

Total investment income

 

$

20.6

 

 

$

9.5

 

 

$

40.7

 

 

$

17.1

 

 

Total net expenses, including taxes

 

 

9.9

 

 

 

3.6

 

 

 

19.3

 

 

 

6.4

 

 

Net investment income

 

$

10.7

 

 

$

5.9

 

 

$

21.4

 

 

$

10.7

 

 

Net realized gain (loss) on investments

 

 

0.6

 

 

 

(0.4

)

 

 

(7.1

)

 

 

(0.7

)

 

Net unrealized appreciation (depreciation) on investments and foreign currency translation

 

 

(0.3

)

 

 

3.4

 

 

 

(6.9

)

 

 

2.2

 

 

Net realized and unrealized gains (losses)

 

$

0.3

 

 

$

3.0

 

 

$

(14.0

)

 

$

1.5

 

 

Net increase (decrease) in net assets resulting from operations

 

$

11.0

 

 

$

8.9

 

 

$

7.4

 

 

$

12.2

 

 

 

Investment income

 

 

 

For the three months ended June 30,

 

 

For the six months ended June 30,

 

 

(in $ millions)

 

2026

 

 

2025

 

 

2026

 

 

2025

 

 

Interest from investments

 

$

19.9

 

 

$

8.9

 

 

$

39.1

 

 

$

15.8

 

 

Paid-in-kind interest

 

 

0.3

 

 

 

0.3

 

 

 

0.5

 

 

 

0.7

 

 

Dividend income

 

 

0.3

 

 

 

0.1

 

 

 

0.8

 

 

 

0.2

 

 

Other income

 

 

0.1

 

 

 

0.2

 

 

 

0.3

 

 

 

0.4

 

 

Total investment income

 

$

20.6

 

 

$

9.5

 

 

$

40.7

 

 

$

17.1

 

 

For the three and six months ended June 30, 2026, total investment income, which includes interest income and accretion of OID, was $20.6 million and $40.7 million, respectively. For the three and six months ended June 30, 2025, total investment income, which includes interest income and accretion of OID, was $9.5 million and $17.1 million, respectively. The increase was primarily a result of an increase in the average size of our investment portfolio. We expect total investment income to continue to increase with the growing portfolio.

 

Net expenses

 

 

For the three months ended June 30,

 

 

For the six months ended June 30,

 

 

(in $ millions)

 

2026

 

 

2025

 

 

2026

 

 

2025

 

 

Interest and other debt financing costs

 

$

6.4

 

 

$

2.8

 

 

$

12.7

 

 

$

4.9

 

 

Offering costs

 

 

0.2

 

 

 

1.0

 

 

 

0.4

 

 

 

2.0

 

 

Management fees

 

 

1.7

 

 

 

0.8

 

 

 

3.3

 

 

 

1.4

 

 

Income based incentive fees

 

 

1.4

 

 

 

0.5

 

 

 

2.8

 

 

 

0.8

 

 

Capital gains based incentive fees

 

 

-

 

 

 

0.4

 

 

 

(0.5

)

 

 

0.2

 

 

Professional fees

 

 

0.2

 

 

 

0.4

 

 

 

0.7

 

 

 

0.5

 

 

Directors’ fees

 

 

0.0

 

 

 

0.1

 

 

 

0.1

 

 

 

0.1

 

 

Administrative services expenses

 

 

0.5

 

 

 

0.3

 

 

 

0.7

 

 

 

0.7

 

 

Other general and administrative expenses

 

 

0.3

 

 

 

0.1

 

 

 

0.8

 

 

 

0.6

 

 

Total expenses

 

$

10.7

 

 

$

6.4

 

 

$

21.0

 

 

$

11.2

 

 

Management fees waiver

 

 

(0.0

)

 

 

(0.0

)

 

 

(0.0

)

 

 

(0.0

)

 

Income based incentive fees waiver

 

 

(1.4

)

 

 

(0.5

)

 

 

(2.8

)

 

 

(0.8

)

 

Capital gains based incentive fees waiver

 

 

-

 

 

 

(0.4

)

 

 

0.5

 

 

 

(0.2

)

 

Expense support

 

 

-

 

 

 

(2.0

)

 

 

-

 

 

 

(4.0

)

 

Expense support reimbursement

 

 

0.6

 

 

 

-

 

 

 

0.6

 

 

 

-

 

 

Net expenses

 

$

9.9

 

 

$

3.5

 

 

$

19.3

 

 

$

6.2

 

 

Provision for excise taxes

 

 

0.0

 

 

 

0.1

 

 

 

0.0

 

 

 

0.2

 

 

Total

 

$

9.9

 

 

$

3.6

 

 

$

19.3

 

 

$

6.4

 

 

 

80


 

For the three and six months ended June 30, 2026, total net expenses, including the impact of the fee waivers, were $9.9 million and $19.3 million, respectively. For the three and six months ended June 30, 2025, total net expenses, including the impact of the fee waivers and expense support, were $3.6 million and $6.4 million, respectively. The increase was primarily as a result of an increase in the average size of our investment portfolio and the associated increase in weighted average debt outstanding. We expect our general and administrative expenses to be relatively stable or decline as a percentage of total assets during periods of asset growth and to increase during periods of asset declines.

Net investment income

For the three and six months ended June 30, 2026, net investment income was $10.7 million and $21.4 million, respectively. For the three and six months ended June 30, 2025, net investment income was $5.9 million and $10.7 million, respectively. Net investment income can vary substantially from period to period due to various factors including net deployment, credit facilities usage and market base rates. The increase was primarily a result of an increase in the average size of our investment portfolio.

Net realized and unrealized gains (losses) on investments

For the three and six months ended June 30, 2026, we recorded net realized and unrealized appreciation (depreciation) on investments of $0.3 million and $(14.0) million, respectively. For the three and six months ended June 30, 2025, we recorded net realized and unrealized appreciation (depreciation) on investments of $3.0 million and $1.5 million, respectively. The change in net unrealized gains on investments is primarily driven by the performance of our investment portfolio.

Hedging

We may, but are not required to, enter into interest rate, foreign exchange or other derivative agreements to hedge interest rate,currency, credit or other risks. Generally, we do not intend to enter into any such derivative agreements for speculative purposes. Any derivative agreements entered into for speculative purposes are not expected to be material to our business or results of operations.These hedging activities, which are in compliance with applicable legal and regulatory requirements, may include the use of various instruments, including futures, options and forward contracts. We bear the costs incurred in connection with entering into,administering and settling any such derivative contracts. There can be no assurance any hedging strategy we employ will be successful.

 

During the six months ended June 30, 2026 and 2025, our average USD notional exposure, calculated daily on a weighted average basis on the duration of each forward contract, of foreign currency forward contracts was $1.4 million and $0, respectively.

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

The primary uses of our cash and cash equivalents are for (1) investments in portfolio companies and other investments; (2) the cost of operations (including paying the Adviser and expense reimbursements paid to the Administrator); (3) debt service, repayment, and other financing costs; and (4) future cash distributions to the holders of our common stock. We expect to generate additional liquidity from (1) future offerings of securities, (2) future borrowings and (3) cash flows from operations, including investment sales and repayments as well as income earned on investments.

As of June 30, 2026, we had $29.5 million in cash and cash equivalents and $231.2 million of undrawn capacity on our credit facilities (as defined below) subject to borrowing base and other limitations. As of June 30, 2026, we believe that we had sufficient assets and liquidity to adequately cover future obligations under our unfunded commitments based on current cash, availability under our credit facility, short-term investments and ongoing principal repayments on debt investment assets.

As of June 30, 2026, we were in compliance with our asset coverage requirements under the Investment Company Act. In addition, we were in compliance with all the financial covenant requirements of our credit facilities as of June 30, 2026. However, an increase in realized losses or unrealized depreciation of our investment portfolio or significant reductions in our NAV as a result of the effects of the rising rate environment and the potential for a recession increase the risk of breaching the relevant covenants requirements. Any breach of these requirements may adversely affect the access to sufficient debt and equity capital.

Debt

 

As of June 30, 2026

 

 

As of December 31, 2025

 

(in $ millions)

Aggregate Principal
Amount Committed

 

 

Drawn Amount

 

 

Amount
Available
(1)

 

 

Carrying
Value
(2)(3)

 

 

Aggregate Principal
Amount Committed

 

 

Drawn Amount

 

 

Amount
Available
(1)

 

 

Carrying
Value
(2)(3)

 

JPM Funding Facility III

$

650.0

 

 

$

418.8

 

 

$

231.2

 

 

$

418.8

 

 

$

575.0

 

 

$

420.0

 

 

$

155.0

 

 

$

420.0

 

Total Debt

$

650.0

 

 

$

418.8

 

 

$

231.2

 

 

$

418.8

 

 

$

575.0

 

 

$

420.0

 

 

$

155.0

 

 

$

420.0

 

(1) The amount available is subject to any limitations related to the credit facility borrowing base.

81


 

(2) Amount presented excludes netting of deferred financing costs.

(3) As of June 30, 2026 and December 31, 2025, the carrying amount of the outstanding debt approximated fair value, unless otherwise noted.

The combined weighted average interest rate of the aggregate borrowings outstanding for the six months ended June 30, 2026 and 2025 was 5.72% and 7.10%, respectively. The weighted average borrowings outstanding for the six months ended June 30, 2026 and 2025 were $441.6 million and $136.9 million, respectively.

JPM Funding Facility

On December 8, 2023, we entered into a Loan and Security Agreement (as amended, the “JPM Funding Facility”), as servicer, with CPCI Funding SPV, LLC, our wholly owned subsidiary (the “Borrower”), as borrower, the lenders party thereto, U.S. Bank Trust Company, National Association, as collateral agent and collateral administrator, U.S. Bank National Association, as securities intermediary, and JPMorgan Chase Bank, National Association, as administrative agent, that provided a secured credit facility of $375.0 million with a reinvestment period ending December 8, 2026 and a final maturity date of December 8, 2028. The JPM Funding Facility also provided for a feature that allowed the Borrower, under certain circumstances, to increase the overall size of the JPM Funding Facility to a maximum of $500.0 million. We consolidated the Borrower in our consolidated financial statements and no gain or loss was recognized from the transfer of assets to and from the Borrower.

The obligations of the Borrower under the JPM Funding Facility were secured by substantially all assets held by the Borrower, which were not available to our creditors. The interest rate charged on the JPM Funding Facility was based on an applicable benchmark (Term SOFR or other applicable benchmark based on the currency of the borrowing) plus a margin of 2.25% prior to May 29, 2025 and 2.13% from May 29, 2025 through October 17, 2025. In addition, the Borrower paid, among other fees, an administrative agency fee on the facility commitment and a commitment fee on the undrawn balance. The JPM Funding Facility included customary covenants, including certain limitations on the incurrence of additional indebtedness and liens, as well as usual and customary events of default for revolving credit facilities of this nature.

 

In connection with the entry into the JPM Funding Facility III (as defined below) on October 17, 2025, we voluntarily prepaid all amounts outstanding under the JPM Funding Facility. In connection with such repayment, all obligations (including in respect of unfunded commitments) under the facility were terminated, and the related security interests and other liens on the assets securing such facility were terminated and released.

 

JPM Funding Facility II

 

On March 31, 2025, we entered into a Loan and Security Agreement (as amended, the “JPM Funding Facility II”), as servicer, with CPCI Funding SPV II, LLC, our wholly owned subsidiary (the “Borrower II” and together with Borrower I, the “Borrowers”), as borrower, the lenders party thereto, U.S. Bank Trust Company, National Association, as collateral agent and collateral administrator, U.S. Bank National Association, as securities intermediary, and JPMorgan Chase Bank, National Association, as administrative agent, that provided a secured credit facility of $100.0 million with a reinvestment period ending September 30, 2027 and a final maturity date of March 31, 2028. The JPM Funding Facility II also provided for a feature that allowed the Borrower II, under certain circumstances, to increase the overall size of the JPM Funding Facility II to a maximum of $200.0 million. We consolidated the Borrower II in our consolidated financial statements and no gain or loss was recognized from the transfer of assets to and from the Borrower II.

The obligations of the Borrower II under the JPM Funding Facility II were secured by substantially all assets held by the Borrower II, which were not available to our creditors. The interest rate charged on the JPM Funding Facility II was based on an applicable benchmark (Term SOFR or other applicable benchmark based on the currency of the borrowing) plus a margin of 1.35%, subject to increase from time to time pursuant to the terms of the JPM Funding Facility II. In addition, the Borrower II paid, among other fees, a commitment fee on the undrawn balance. The JPM Funding Facility II included customary covenants, including certain limitations on the incurrence of additional indebtedness and liens, as well as usual and customary events of default for revolving credit facilities of this nature.

In connection with the entry into the JPM Funding Facility III on October 17, 2025, we voluntarily prepaid all amounts outstanding under the JPM Funding Facility II. In connection with, such repayment, all obligations (including in respect of unfunded commitments) under the facility were terminated, and the related security interests and other liens on the assets securing such facilities were terminated and released.

JPM Funding Facility III

On October 17, 2025, we entered into a Loan and Security Agreement (the “JPM Funding Facility III” and together with the JPM Funding Facility and the JPM Funding Facility II, the “credit facilities”), as servicer, with the Borrowers, the lenders party thereto, U.S. Bank Trust Company, National Association, as collateral agent and collateral administrator, U.S. Bank National Association, as securities intermediary, and JPMorgan Chase Bank, National Association, as administrative agent, that provides a secured credit facility of $575.0 million with a reinvestment period ending October 17, 2028 and a final maturity date of October 17, 2030. On January 17,

82


 

2026, as part of a scheduled commitment increase, the JPM Funding Facility III commitment size increased from $575.0 to $650.0 million. The JPM Funding Facility III also provides for a feature that allows the overall size of the JPM Funding Facility III to be increased to a maximum of $875.0 million. In addition, on October 17, 2025, we, as seller, and the Borrower I, as purchaser, entered into a Sale and Contribution Agreement and we, as seller, and the Borrower II, as purchaser, entered into a Sale and Contribution Agreement, pursuant to which we will sell or contribute to the Borrower I and the Borrower II, as applicable, certain originated or acquired loans and other corporate debt securities and related assets (collectively, the “Loans”) from time to time.

 

The obligations of the Borrowers under the JPM Funding Facility III are secured by substantially all assets held by each Borrower, including the Loans. The interest rate charged on the JPM Funding Facility III is based on an applicable benchmark (Term SOFR or other applicable benchmark based on the currency of the borrowing) plus a margin of (i) 1.35% (or 1.4693% in the case of borrowings in British Pounds) or (ii) 1.90% (or 2.0193% in the case of borrowings in British Pounds) depending on the nature of the advances being requested under the JPM Funding Facility III. In connection with the entry into the JPM Funding Facility III, we voluntarily prepaid all amounts outstanding under each of the JPM Funding Facility and the JPM Funding Facility II (together, the “Existing JPM Facilities”). In connection with such repayment, all obligations (including in respect of unfunded commitments) under the Existing JPM Facilities were terminated, and the related security interests and other liens on the assets securing such facilities were terminated and released.

 

The summary of costs incurred in connection with our credit facilities is presented below:

 

For the three months ended

 

 

For the six months ended

(in $ millions)

June 30, 2026

 

 

June 30, 2025

 

 

June 30, 2026

 

 

June 30, 2025

 

 

 Borrowing interest expense

$

5.7

 

 

$

2.3

 

 

$

11.4

 

 

$

4.2

 

 

 Unused facility fees

 

0.3

 

 

 

0.3

 

 

 

0.6

 

 

 

0.4

 

 

 Amortization of financing costs

 

0.4

 

 

 

0.2

 

 

 

0.7

 

 

 

0.3

 

 

Total interest and other debt financing costs

$

6.4

 

 

$

2.8

 

 

$

12.7

 

 

$

4.9

 

 

Weighted average outstanding balance

$

435.1

 

 

$

149.6

 

 

$

441.6

 

 

$

136.9

 

 

 

To the extent we determine that additional capital would allow us to take advantage of additional investment opportunities, if the market for debt financing presents attractively priced opportunities, or if our Board otherwise determines that leveraging our portfolio would be in our best interest and the best interests of our stockholders, we may enter into new debt financing opportunities in addition to our existing debt. The pricing and other terms of any such opportunities would depend upon market conditions and the performance of our business, among other factors.

In accordance with applicable SEC staff guidance and interpretations, with the stockholder approval, we, as a BDC, are now permitted to borrow amounts such that our asset coverage ratio is at least 150% after such borrowing (if certain requirements are met), rather than 200%, as previously required. Short-term credits necessary for the settlement of securities transactions and arrangements with respect to securities lending will not be considered borrowings for these purposes. The amount of leverage that we employ depends on our Adviser’s and our Board’s assessment of market conditions and other factors at the time of any proposed borrowing.

As of June 30, 2026 and December 31, 2025, our asset coverage ratio was 230% and 221%, respectively. We may also refinance or repay any of our indebtedness at any time based on our financial condition and market conditions. See Note 6 “Debt” to our consolidated financial statements for more detail on the credit facilities.

Capital Share Activity

We have authorized three classes of common stock, par value $0.01 per share, Class S Common Stock (“Class S shares”), Class D Common Stock (“Class D shares”) and Class I Common Stock (“Class I shares” and, together with Class S shares and Class D shares, “Common Shares”). Pursuant to a subscription agreement entered into between us and Crescent, Crescent purchased 1,000 Class I shares at an initial offering price of $25.00 per share.

Additionally, we have sold Class I shares to certain investors (the “Private Placement Investors”) in transactions (each, a “Private Placement”) exempt from the registration provisions of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to Section 4(a)(2) thereof and/or Regulation S promulgated thereunder.

The Private Placement Investors’ subscriptions were initially drawn down at a price of $25.00 per share, and subsequent subscriptions were priced at our current NAV at the time of contribution. Since our commencement of operations through June 30, 2026, we received $168.0 million of committed capital from the Private Placements, and in exchange therefore, we issued approximately 6,543,033 Class I shares to four stockholders, including the investment from our sole initial stockholder.

83


 

On August 1, 2024, we held the first closing in our public offering on a continuous basis of our Common Shares, including Class I shares, Class S shares and Class D shares, pursuant to a Registration Statement on Form N-2 (the “Offering”). As of June 30, 2026, pursuant to the Private Placements and our Offering that commenced on August 1, 2024, we have issued approximately 21,027,323 Class I, Class S and Class D shares and raised gross proceeds of approximately $557.7 million since inception through June 30, 2026. See “Recent Developments” for details on a subsequent issuance of shares.

The following table summarizes transactions in common shares for periods listed.

 

 

 

 

 

 

 

 

For the six months ended June 30, 2026

 

 

For the six months ended June 30, 2025

 

(in $ millions except share amounts)

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

CLASS I

 

 

 

 

 

 

 

 

 

 

 

Subscriptions

 

3,833,090

 

 

$

102.1

 

 

 

3,009,571

 

 

$

80.9

 

Share transfers between classes

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Distributions reinvested

 

1,165

 

 

 

0.0

 

 

 

-

 

 

 

-

 

Share repurchases, net of early repurchase deductions

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Net increase (decrease)

 

3,834,255

 

 

$

102.2

 

(1)

 

3,009,571

 

 

$

80.9

 

CLASS S

 

 

 

 

 

 

 

 

 

 

 

Subscriptions

 

4,624

 

 

$

0.1

 

 

 

1,786

 

 

$

0.1

 

Share transfers between classes

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Distributions reinvested

 

108

 

 

 

0.0

 

 

 

27

 

 

 

0.0

 

Share repurchases, net of early repurchase deductions

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Net increase (decrease)

 

4,732

 

 

$

0.1

 

 

 

1,813

 

 

$

0.1

 

CLASS D

 

 

 

 

 

 

 

 

 

 

 

Subscriptions

 

929

 

 

$

0.0

 

 

 

-

 

 

$

-

 

Share transfers between classes

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Distributions reinvested

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Share repurchases, net of early repurchase deductions

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Net increase (decrease)

 

929

 

 

$

0.0

 

 

 

-

 

 

$

-

 

 

(1) Totals may not add up due to rounding

 

The following table lists the Common Shares issued and total consideration for both the Offering and the Private Placements as of June 30, 2026. The table below does not include Common Shares issued through our distribution reinvestment plan. We intend to continue selling Common Shares in the Offering on a monthly basis.

 

(dollar amounts in millions)

 

Common Shares issued

 

 

Total consideration

 

Registered Offering:

 

 

 

 

 

 

Class I

 

 

14,474,664

 

 

$

389.4

 

Class S

 

 

6,858

 

 

 

0.2

 

Class D

 

929

 

 

 

-

 

Private Placements:

 

 

 

 

 

 

Class I

 

 

6,543,033

 

 

$

168.0

 

Class S

 

 

-

 

 

 

-

 

Class D

 

 

-

 

 

 

-

 

Total:

 

 

21,025,484

 

 

$

557.6

 

See Recent Developments for a subsequent event related to subscriptions pursuant to the Offering.

Capital Share Distributions

We currently intend to pay regular monthly distributions. Any distributions we make will be at the sole discretion of our Board, which will consider factors such as our earnings, cash flow, capital needs and general financial condition and the requirements of Maryland law. As a result, our distribution rates and payment frequency may vary from time to time.

84


 

Our Board’s discretion as to the payment of distributions will be directed, in substantial part, by its determination to cause us to comply with the RIC (as defined below) requirements. To maintain our treatment as a RIC, we generally are required to make aggregate annual distributions to our common stockholders of at least 90% of our taxable income and tax exempt interest.

We declared monthly regular and special distributions for our Class I shares, Class S shares and Class D shares. The following table presents the monthly regular and special distributions that were declared and payable for the six months ended June 30, 2026.

 

(in $ millions, except per share amounts)

 

 

Class I Distributions

 

 

Class S Distributions

 

 

Class D Distributions

 

 

Record Date

Declaration Date

Payment Date

 

Per Share

 

Amount

 

 

Per Share

 

Amount

 

 

Per Share

 

Amount

 

 

January 31, 2026

January 30, 2026

February 27, 2026

 

$

0.160

 

$

3.0

 

 

$

0.141

 

$

0.0

 

 

$

-

 

$

-

 

 

January 31, 2026

January 30, 2026

February 27, 2026

 

 

0.040

 

 

0.8

 

(1)

 

0.040

 

 

0.0

 

(1)

 

-

 

 

-

 

 

February 28, 2026

February 25, 2026

March 30, 2026

 

 

0.165

 

 

3.1

 

 

 

0.146

 

 

0.0

 

 

 

0.159

 

 

0.0

 

 

March 31, 2026

March 27, 2026

April 30, 2026

 

 

0.165

 

 

3.2

 

 

 

0.146

 

 

0.0

 

 

 

0.159

 

 

0.0

 

 

March 31, 2026

March 27, 2026

April 30, 2026

 

 

0.070

 

 

1.3

 

(1)

 

0.070

 

 

0.0

 

(1)

 

0.070

 

 

0.0

 

(1)

April 30, 2026

April 28, 2026

May 27, 2026

 

 

0.165

 

 

3.4

 

 

 

0.146

 

 

0.0

 

 

 

0.160

 

 

0.0

 

 

May 31, 2026

May 22, 2026

June 30, 2026

 

 

0.165

 

 

3.4

 

 

 

0.146

 

 

0.0

 

 

 

0.160

 

 

0.0

 

 

June 30, 2026

June 25, 2026

July 31, 2026

 

 

0.165

 

 

3.5

 

 

 

0.146

 

 

0.0

 

 

 

0.160

 

 

0.0

 

 

June 30, 2026

June 25, 2026

July 31, 2026

 

 

0.045

 

 

0.9

 

(1)

 

0.045

 

 

0.0

 

(1)

 

0.045

 

 

0.0

 

(1)

 

 

 

 

$

1.140

 

$

22.6

 

(2)

$

1.026

 

$

0.0

 

(2)

$

0.913

 

$

0.0

 

(2)

(1)
Represents a special distribution.
(2)
Totals may not add up due to rounding.

 

The following table presents the monthly regular and special distributions that were declared and payable for the six months ended June 30, 2025.

 

(in $ millions, except per share amounts)

 

 

Class I Distributions

 

 

Class S Distributions

 

 

Class D Distributions

 

 

Record Date

Declaration Date

Payment Date

 

Per Share

 

Amount

 

 

Per Share

 

Amount

 

 

Per Share

 

Amount

 

 

January 31, 2025

January 29, 2025

February 27, 2025

 

$

0.16

 

$

1.1

 

 

$

-

 

$

-

 

 

$

-

 

$

-

 

 

January 31, 2025

January 29, 2025

February 27, 2025

 

 

0.06

 

 

0.4

 

(1)

 

-

 

 

-

 

 

 

-

 

 

-

 

 

February 28, 2025

February 24, 2025

March 27, 2025

 

 

0.16

 

 

1.1

 

 

 

-

 

 

-

 

 

 

-

 

 

-

 

 

February 28, 2025

February 24, 2025

March 27, 2025

 

 

0.06

 

 

0.4

 

(1)

 

-

 

 

-

 

 

 

-

 

 

-

 

 

March 31, 2025

March 26, 2025

April 28, 2025

 

 

0.16

 

 

1.1

 

 

 

-

 

 

-

 

 

 

-

 

 

-

 

 

March 31, 2025

March 26, 2025

April 28, 2025

 

 

0.06

 

 

0.4

 

(1)

 

-

 

 

-

 

 

 

-

 

 

-

 

 

April 30, 2025

April 28, 2025

May 28, 2025

 

 

0.16

 

 

1.5

 

 

 

0.14

 

 

0.0

 

 

 

-

 

 

-

 

 

April 30, 2025

April 28, 2025

May 28, 2025

 

 

0.06

 

 

0.6

 

(1)

 

0.06

 

 

0.0

 

(1)

 

-

 

 

-

 

 

May 31, 2025

May 22, 2025

June 27, 2025

 

 

0.16

 

 

1.5

 

 

 

0.14

 

 

0.0

 

 

 

-

 

 

-

 

 

May 31, 2025

May 22, 2025

June 27, 2025

 

 

0.06

 

 

0.6

 

(1)

 

0.06

 

 

0.0

 

(1)

 

-

 

 

-

 

 

June 30, 2025

June 25, 2025

July 29, 2025

 

 

0.16

 

 

1.6

 

 

 

0.14

 

 

0.0

 

 

 

-

 

 

-

 

 

June 30, 2025

June 25, 2025

July 29, 2025

 

 

0.06

 

 

0.6

 

(1)

 

0.06

 

 

0.0

 

(1)

 

-

 

 

-

 

 

 

 

 

 

$

1.32

 

$

11.0

 

(2)

$

0.60

 

$

0.0

 

(2)

$

-

 

$

-

 

 

 

(1)
Represents a special distribution.
(2)
Totals may not add up due to rounding.

See “Recent Developments” for subsequent events relating to regular and special distributions declared by the Company.

Distribution Reinvestment Plan

 

We have adopted a distribution reinvestment plan pursuant to which stockholders will have their cash distributions automatically reinvested in additional shares of the Company’s same class of common stock to which the distribution relates unless they elect to receive their distributions in cash. As a result, if we declare, a cash dividend or other distribution, then stockholders who have not opted out of our distribution reinvestment plan (or, in the case of Alabama, Arkansas, California, Idaho, Kansas, Kentucky, Maine,

85


 

Maryland, Massachusetts, Nebraska, New Jersey, North Carolina, Ohio, Oregon, Vermont and Washington stockholders and clients of participating brokers that do not permit automatic enrollment in our distribution reinvestment plan, opted to participate in such plan), will have their cash distributions automatically reinvested in additional shares, rather than receiving the cash dividend or other distribution. Distributions on fractional shares will be credited to each participating stockholder’s account to three decimal places.

Share Repurchase Program

We have commenced a share repurchase program in which we intend, at the discretion of our Board, to offer to repurchase up to 5% of our Common Shares outstanding in each quarter. Our Board may amend, suspend or terminate the share repurchase program at any time if it deems such action to be in our best interests and those of our common stockholders. For example, in accordance with our directors’ duties to the Company, our Board may amend, suspend or terminate the share repurchase program during periods of market dislocation where selling assets to fund a repurchase could have a materially negative impact on remaining stockholders. As a result, share repurchases may not be available each quarter, such as when a repurchase offer would place an undue burden on our liquidity, adversely affect our operations or risk having an adverse impact on the Company that would outweigh the benefit of the repurchase offer. Following any such suspension, the Board will reinstate the share repurchase program when appropriate and subject to our directors’ duties to us. All shares purchased by us in connection with the share repurchase program will be retired and thereafter will be authorized and unissued shares.

 

In accordance with our share repurchase program, we made a share repurchase offer in the first two quarters of both 2026 and 2025. There were no share repurchases completed for the six months ended June 30, 2026 or 2025.

OFF BALANCE SHEET ARRANGEMENTS

Other than contractual commitments and other legal contingencies incurred in the normal course of our business, we do not expect to have any off-balance sheet financings or liabilities. Our investment portfolio may contain investments that are in the form of lines of credit or unfunded commitments which require us to provide funding when requested by portfolio companies in accordance with the terms of the underlying agreements. Unfunded commitments to provide funds to portfolio companies are not reflected on our Consolidated Statements of Assets and Liabilities. These commitments are subject to the same underwriting and ongoing portfolio maintenance as are the on-balance sheet financial instruments that we hold. Since these commitments may expire without being drawn, the total commitment amount does not necessarily represent future cash requirements. As of June 30, 2026 and December 31, 2025, we had aggregate unfunded commitments totaling $209.1 million and $130.6 million, respectively. See Note 8 “Commitments and Contingencies” to our consolidated financial statements for more information on our commitments.

 

RECENT DEVELOPMENTS

On July 28, 2026, we announced the declaration of the amounts per share set forth below for our Class I shares, Class S shares, and Class D shares. The distributions for Class I shares, Class S shares, and Class D shares were payable to stockholders of record as of the open of business on July 31, 2026 and will be paid on or about August 31, 2026. The distributions will be paid in cash or reinvested in the Class I shares, Class S shares or Class D shares, as applicable, for stockholders participating in our distribution reinvestment plan.

 

 

 

Gross Distribution

 

 

Stockholder Servicing and/or Distribution Fee

 

 

Net Distribution

 

 

 

Class I Common Shares

 

$

0.16500

 

 

$

-

 

 

$

0.16500

 

 

 

Class S Common Shares

 

 

0.16500

 

 

 

0.01860

 

 

 

0.14640

 

 

 

Class D Common Shares

 

 

0.16500

 

 

 

0.00547

 

 

 

0.15953

 

 

 

 

 

On August 1, 2026, pursuant to the Offering, we received approximately $33.7 million in subscriptions from third party unaffiliated investors. The purchase price per Class I share, Class S share and Class D share will equal the Company’s net asset value per Class I share, Class S share and Class D share, respectively, as of the last calendar day of July 31, 2026 (the “July NAV”), which is generally expected to be available within 20 business days after August 1, 2026. At that time, the number of Class I shares, Class S shares and Class D shares issued to each investor based on the July NAV and such investor’s subscription amount will be determined and Class I shares, Class S shares and Class D shares, as applicable, will be credited to the investor’s account as of the effective date of the share purchase, August 1, 2026.

 

86


 

Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are subject to financial market risks, including valuation risk and interest rate risk.

Valuation Risk

We have invested, and plan to continue to invest, in illiquid debt and equity securities of private companies. These investments will generally not have a readily available market price, and we will value these investments at fair value as determined in good faith by our Adviser, as the Board’s valuation designee, in accordance with our valuation policy. There is no single standard for determining fair value in good faith. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each portfolio investment while employing a consistently applied valuation process for the types of investments we make. If we were required to liquidate a portfolio investment in a forced or liquidation sale, we may realize amounts that are different from the amounts presented and such differences could be material. See Note 2 “Summary of Significant Accounting Policies” to our consolidated financial statements for more details on estimates and judgments made by us in connection with the valuation of our investments.

Interest Rate Risk

Interest rate sensitivity refers to the change in earnings that may result from changes in the level of interest rates. We plan to fund a portion of our investments with borrowings and our net investment income will be affected by the difference between the rate at which we invest and the rate at which we borrow. There can be no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income.

We regularly measure our exposure to interest rate risk. We assess interest rate risk and manage our interest rate exposure on an ongoing basis by comparing our interest rate-sensitive assets to our interest rate-sensitive liabilities. Based on that review, we determine whether or not any hedging transactions are necessary to mitigate exposure to changes in interest rates.

As of June 30, 2026, 97.9% of the investments at fair value in our portfolio were at variable rates, subject to interest rate floors.

Assuming that our Consolidated Statements of Assets and Liabilities as of June 30, 2026 were to remain constant and that we took no actions to alter our existing interest rate sensitivity, the following table shows the annualized impact of hypothetical base rate changes in interest rates (considering interest rate floors for floating rate instruments):

($ in millions)

Basis Point Change

 

Interest Income

 

 

Interest Expense

 

 

Net Interest Income (1)

 

Up 100 basis points

 

$

8.9

 

 

$

4.2

 

 

$

4.7

 

Up 75 basis points

 

 

6.7

 

 

 

3.1

 

 

 

3.6

 

Up 50 basis points

 

 

4.5

 

 

 

2.1

 

 

 

2.4

 

Up 25 basis points

 

 

2.2

 

 

 

1.0

 

 

 

1.2

 

Down 25 basis points

 

 

(2.2

)

 

 

(1.0

)

 

 

(1.2

)

Down 50 basis points

 

 

(4.5

)

 

 

(2.1

)

 

 

(2.4

)

Down 75 basis points

 

 

(6.7

)

 

 

(3.1

)

 

 

(3.6

)

Down 100 basis points

 

 

(8.9

)

 

 

(4.2

)

 

 

(4.7

)

 

(1)
Excludes the impact of income incentive fees. See Note 3 “Agreements and Related Party Transactions” to our consolidated financial statements for more information on the income incentive fees.

Although we believe that this analysis is indicative of our existing sensitivity to interest rate changes, it does not adjust for changes in the credit market, credit quality, the size and composition of the assets in our portfolio and other business developments that could affect our net income. Accordingly, we cannot assure you that actual results would not differ materially from the analysis above.

We may in the future hedge against interest rate fluctuations by using hedging instruments such as interest rate swaps, futures, options and forward contracts. While hedging activities may mitigate our exposure to adverse fluctuations in interest rates, certain hedging transactions that we may enter into in the future, such as interest rate swap agreements, may also limit our ability to participate in the benefits of lower interest rates with respect to our portfolio investments.

87


 

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures (as that term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934, as amended (the “Exchange Act”)) that are designed to ensure that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosures. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2026. Based upon that evaluation and subject to the foregoing, our principal executive officer and principal financial officer concluded that, as of June 30, 2026, the design and operation of our disclosure controls and procedures were effective to accomplish their objectives at the reasonable assurance level.

Changes in Internal Control over Financial Reporting.

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended June 30, 2026, that have materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.

88


 

PART II. OTHER INFORMATION

We are not currently subject to any material legal proceedings, nor, to our knowledge, are any material legal proceedings threatened against us. We may be a party to certain lawsuits in the normal course of business, including proceedings relating to the enforcement of our rights under loans to or other contracts with our portfolio companies. Furthermore, third parties may try to seek to impose liability on us in connection with our activities or the activities of our portfolio companies. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors.

Item 1A. RISK FACTORS

In addition to the other information set forth in this report, you should carefully consider the risk factors discussed herein and in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and “Risk Factors” of our registration statement on Form N-2 filed on April 29, 2026, which could materially affect our business, financial condition and/or operating results. These risks are not the only risk factors facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business, financial condition and/or operating results.

 

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Refer to Item 8.01 in our Current Reports on Form 8-K filed with the SEC on April 28, 2026, May 22, 2026, June 25, 2026 and July 28, 2026 for information about unregistered sales of our equity securities during the quarter and subsequent to the quarter end.

Item 3. DEFAULTS UPON SENIOR SECURITIES

None.

Item 4. MINE SAFETY DISCLOSURES

Not applicable.

Item 5. OTHER INFORMATION

Rule 10b5-1 Trading Plans

During the fiscal quarter ended June 30, 2026, none of our directors or executive officers adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement.”

 

89


 

ITEM 6. EXHIBITS

The following documents are filed as part of this Quarterly Report:

 

Exhibit Number

Description

3.1

Third Amended & Restated Articles of Amendment and Restatement (incorporated by reference to Exhibit 3.1 to the Registrant’s Form 8-K (File No. 814-01599), filed on August 2, 2024).

3.2

Second Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to the Registrant’s Form 8-K (File No. 814-01599), filed on August 2, 2024.

31.1

Certification of Chief Executive Officer, Pursuant to Rule 13a-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).

31.2

Certification of Chief Financial Officer, Pursuant to Rule 13a-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).

32.1

Certification of Chief Executive Officer and Chief Financial Officer, Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).

101.INS

Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.

101.SCH

Inline XBRL Taxonomy Extension Schema with Embedded Linkbase Document

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

90


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By:

/s/ Eric Hall

 

Eric Hall

 

Chief Executive Officer (Principal Executive Officer)

 

Date: August 14, 2026

 

 

By:

/s/ Kirill Bouek

 

Kirill Bouek

 

Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

 

Date: August 14, 2026

 

91


 

 

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

Pursuant to Exchange Act Rule 13a-14(a) and Rule 15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Eric Hall, certify that:

(1) I have reviewed this Quarterly Report on Form 10-Q of Crescent Private Credit Income Corp.;

(2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(4) The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

(5) The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

Crescent Private Credit Income Corp.

Date: August 14, 2026

By:

/s/ Eric Hall

Eric Hall

Chief Executive Officer

 

 


 

 


 

 

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

Pursuant to Exchange Act Rule 13a-14(a) and Rule 15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Kirill Bouek, certify that:

(1) I have reviewed this Quarterly Report on Form 10-Q of Crescent Private Credit Income Corp.;

(2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(4) The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

(5) The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Crescent Private Credit Income Corp.

Date: August 14, 2026

By:

/s/ Kirill Bouek

Kirill Bouek

Chief Financial Officer

 

 


 

 


 

 

Exhibit 32.1

Certifications of Chief Executive Officer and Chief Financial Officer Pursuant to

18 U.S.C. Section 1350,

as Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

 

In connection with the Quarterly Report on Form 10-Q of Crescent Private Credit Income Corp. (the “Company”) for the quarter ended June 30, 2026, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Eric Hall, as the Chief Executive Officer of the Company and Kirill Bouek, as the Chief Financial Officer of the Company, each hereby certifies, to the best of such officer’s knowledge and belief, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Eric Hall

Name:

Eric Hall

Title:

Chief Executive Officer

Date:

August 14, 2026

 

 

/s/ Kirill Bouek

Name:

Kirill Bouek

Title:

Chief Financial Officer

Date:

August 14, 2026

 

 

 

1